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Abstract  
Gut microbiota plays an important role in the gut-brain axis.  Symbiosis of the gut 
microbiota maintains the physiological integrity of the host so as to ensure the normal 
functions of the gut and the brain. Probiotics have beneficial effects on both, physical and 
mental health, when administered in adequate amount. Thus, probiotics are considered as 
“psychobiotics”, for their effects on central nervous system functions such as stress-related 
mental disorders and memory abilities, through the gut-brain axis.  However, the efficacy of 
the probiotics on these central functions was in need to be systematically summarized. While 
there is a host of animal studies on microbiota, it has not yet been studied much how and 
where in the brain of humans they unfold their effects. Furthermore, antibiotics, having 
effects on commensal gut bacteria by eliminating and inhibiting them, have so far not been 
studied for their role in affecting brain functions.  
In the current thesis, I performed two literature reviews and two experimental studies 
on central effects of pro- and antibiotics. The first review systematically analyzed previous 
research studying the effects of probiotics on central nervous system functions in both, 
animals and humans. The review concluded the most efficient probiotic interventions and 
evaluated the possibility of translating preclinical studies to clinical trials. In the second 
review, we aimed to evaluate the feasibility of a socio-psychological paradigm (Cyberball 
game) to be used in the following experimental studies with neuroimaging methods and 
manipulations of the GM. We examined the current neuroimaging literature employing the 
Cyberball game to induce social stress and feelings of exclusion. The review was intended to 
generate a framework describing neural processes during the stress.  
Following the results of the two reviews, we conducted two clinical trials, to 
investigate effects of antibiotic rifaximin and probiotic Bifidobacterium longum 1714 on 
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neural activations during resting state and during the Cyberball game by using 
magnetoencephalography.  
In both studies, the stress induced by the Cyberball game enhanced oscillatory brain 
activity in different areas and in different frequency bands. Both, rifaximin and probiotics had 
effects on specific neural oscillatory activities in response to the social stress – rifaximin 
improved subjects’ relaxation status by reducing frontal and cingulate beta-1 band power, and 
B.longum 1714 enhanced emotion regulation process by increasing frontal and cingulate theta 
and alpha bands power. In addition, during the resting state, rifaximin favored individuals’ 
relaxation status by increasing frontal alpha band power, and B.longum 1714 increased 
subject’s arousal state by increasing theta band power in frontal and cingulate cortex and 
reducing the beta-3 band power in hippocampus and temporal cortex.  
Rifaximin and B.longum 1714, both showed neural effects on the stress response 
through an “eubiotic” effect, which refers to a healthy balance of the micro-flora in the 
gastrointestinal tract. Our results provide evidence for gut microbiota alerting CNS functions. 
Both, reviews and experimental work give clues for further studies targeting the underlying 
mechanisms of interaction between gut microbiota and CNS function using neuroimaging in 
patients with psychiatric disorders or gastrointestinal diseases.  
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1 Introduction  
The current dissertation describes a PhD project conduced at the MEG center of the 
University Hospital Tübingen. The whole project is part of a European training network – 
NeuroGut, investigating neural regulation of intestinal function. The topic of the project is on 
the gut-brain axis, and specially on the effects of probiotics on central nervous system 
functions in humans.  
In the Chapter 1, I provided the scientific background and logic flow of the project. I 
started by introducing gut-brain axis, describing the gut microbiota and its important role in 
the gut-brain axis (Chapter 1.1, 1.2, & 1.3).  Following, probiotics were introduced and 
discussed for their effects on the central functions through gut-brain axis (Chapter 1.4). The 
response to social stress was chosen as the central function to study potential effects of 
probiotics, for its close relation to other mental states (e.g. anxiety, depression levels) and 
cognitive abilities. Thus, stress and its role in the gut-brain axis was discussed (Chapter 1.5), 
and a social psychological paradigm (the Cyberbgall game) for inducing stress and the 
relevant humans’ neural activities during this kind of stress was presented (Chapter 1.6). In 
Chapter 1.7, I provided current evidence supporting the usage of probiotics and antibiotics 
as a treatment strategy for stress regulation.  
Later in Chapter 2, 3, 4, & 5, summaries of Study I, II, III & IV were given. Study I 
was a systematic review summarizing the current efficient probiotic interventions on 
affecting central functions (both in animals and humans), and the manuscript was published 
in Journal of Neurogastroenterology and Motility in October 2016. Study II was a scoping 
review summarizing the neural processing under the social stress during the Cyberball game, 
and the manuscript was published in Neuroscience and Biobehavioral Reviews in May 2017. 
Study III represents experimental research on effects of antibiotic rifaximin on neural 
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responses to social stress during the Cyberball game. The manuscript is currently under 
review of Neurotherapeutics. Study IV was also an experiment on effects of probiotic 
Bifidobacterium longum 1714 on neural responses to social stress during the Cyberball game. 
The corresponding manuscript is in preparation. 
In Chapter 6 & 7, attached are the published work of Study I & II. In Chapter 8, 
attached is the submitted work of Study III. In Chapter 9, attached is the manuscript draft of 
Study IV. Conclusions of the whole study and according indication were given in Chapter 
10. In Chapter 11, I expressed my acknowledgement to the people I sincerely appreciate. 
Lastly, a list of references cited in this dissertation is provided in Chapter 12. 
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1.1 Gut-brain axis  
There is bidirectional communication between the gut and the brain through different 
pathways, integrating neural, endocrine and immune systems (3). The communication has 
effects on the homeostasis in the gut and also on brain functions including cognitive and 
affective abilities. Thus disruption of the communication may cause on the one hand 
intestinal diseases and on the other hand mental disorders (4). Some patients with irritable 
bowel syndrome (IBS) or inflammatory bowel disorder have been found to have mental 
comorbidities such as anxiety, depression and autism, indicating the connection between the 
gut and brain (5). 
Mechanisms by which the gut-brain axis exerts its effects involve the neural, immune 
and endocrine systems (6).  The involved neural connections include the enteric, autonomic 
and central nervous systems. The enteric nervous system (ENS) does not only receive signals 
from the brain but also sends input to the brain via ascending neural fibers. The autonomic 
nervous system (ANS) consists of the sympathetic and parasympathetic nerves, co-operating 
with immune and endocrine system to communicate with the brain. The sympathetic system 
releases neurotransmitters like noradrenaline to inhibit intestinal motor and secretion. The 
parasympathetic system which is mediated by hypothalamic-pituitary-adrenal (HPA) axis is 
related to stress responses. The vagus nerve interfaces with parasympathetic system and has 
emotional effects as it is excessively activated during emotional stress. Several brain regions 
in the limbic system of the brain are connected to the ANS such as the hippocampus, the 
amygdala and the limbic cortex, and these regions also receive input from some other 
important regions such as prefrontal cortex, the anterior cingulate gyrus and so on. The 
mucosal immune system modulates cytokine production and thus interacts with the brain. 
Stress or mental state can influence gut functions. The activity of the HPA axis can affect the 
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level of cytokines in the gut. The GI tract produces hormones like gastrin and cholecystokinin 
that influence certain neurotransmitters such as serotonin (5-HT). Also, the gut microbiota is 
influential on tryptophan metabolites, which is a precursor of the 5-HT. Thus, the gut affects 
the brain also via the endocrine system. Overall, the gut-brain axis reveals bidirectional 
communication, integrating the host gut and brain activities.  
 
1.2 Gut microbiota   
Microbiota, as the ecological community of commensal, symbiotic and pathogenic 
microorganisms literally sharing our body space, host cells over 10 times the human cells (7). 
The majority of the microbiome lives in the human gastrointestinal (GI) tract and is 
composed of 10 to 100 trillion microorganisms containing 100 times as many genes as our 
genome (8). Bacteria are the most numerous class of microorganisms as compared to the 
other two domains of microorganisms (archaea and eukarya) in the GI. Bacteria  consist of 
three divisions named Phyla – the Bacteroides, the Firmicutes and the Actinobacteria (9). 
The microbiota in the GI tract change though life: the initial inoculum in neonates depend on 
the way of delivery, early microbiota develops unstably but increase in diversity in the first 1-
3 years of infancy, the microbial community becomes much more stable during adulthood yet 
individually very distinct according to different genetics, diet and environmental exposure 
etc. (10).  
Although the gut microbiota (GM) in adults is a relatively stable community, it varies 
depending among individuals and changes due to altered environments (11). Besides the 
fundamental impact of host genotype, the GM can be modulated by diet, intake of 
antimicrobials and probiotics, and also fecal microbiota transplantation which is recently 
widely used for treatment of many disease (12). Keeping a healthy diet with low fat, low 
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calories and high fiber is getting more and more support as it helps stabilizing the GM and 
thus having beneficial effects on the hosts. Also, psychological stress can alter the GM 
though the gut-brain axis (13, 14), which will be discussed in more detail in the following 
Chapter 1.5.  
 
1.3 Gut microbiota and gut-brain axis 
GM is important, because of its role of modulating both, gut functions and brain 
functions, through the gut-brain axis. An increasing number of studies has found that GM 
influences the central nervous system (CNS) (3, 15). Multiple direct and indirect pathways 
exist, though which the GM influences the CNS through the gut-brain axis: the GM can 
influence activity of immune cells and alter levels of pro-inflammatory and anti-
inflammatory cytokines which affect brain functions; tryptophan metabolism and 
neurotransmitter metabolism can be affected by the GM so as to influence the brain; short-
chain fatty acids (SCFAs) are neuroactive bacterial metabolites and can also modulate brain 
activity and behaviors, etc. (13).  
Many studies using germ-free (GF) animals have reported that the commensal 
microbes in the gut can affect behavior via immune, endocrine and/or neural systems. GF 
animals are maintained in a sterile environment to avoid postnatal colonization and can be 
used for comparing them with conventionally reared animals. Sudo’s study was the first 
study to link the GM and behavior by showing increased HPA stress response and decreased 
brain-derived neurotrophic factor (BDNF) in the hippocampus of GF mice (16). Also, the GF 
mice had impaired memory function compared to mice with an intact intestinal microbiota, 
and had reduced preference for social novelty and increased repetitive self-grooming 
behavior (17, 18). 
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To study the role of the GM in affecting CNS functions, there are many methods to 
manipulate the GM. By means of exposing the GF mice to a natural environment, 
colonization them with specific microbiota, changing their diet or by means of infection, 
manipulation of the GM can be achieved.  
Specifically, GM mice showed less anxiety-like behavior after 24 hours’ exposure to 
the environment outside the sterile one, which suggested the importance of natural and intact 
composition of the GM for behavior (19). Also, GF mice showed less HPA stress response 
and less anxious behavior by reconstitution with Bifidobacterium infantis and enhanced HPA 
stress response after monoassociation with enteropathogenic Escherichia coli (16). The 
relationship between the behavioral phenotype of the GM mice and the corresponding brain 
regions has been described (6). The key regions consist of the striatum, a region integrating 
movement and emotional responses; the hippocampus, known for its functions of memory 
and spatial navigation; the amygdala, always considered as the “emotional brain”, sending 
signals to the other key region for emotional regulation - hypothalamus.  
Other methods for manipulating GM include changing diet and inducing infections. 
Mice on high-fat diet showed altered GM, and less burrowing behavior and disrupted 
memory compared to mice on a control diet. In addition, altered levels of BDNF and 
cytokines were also found, indicating the role of the GM in behavior through the immune 
system. In a study inducing infection with parasite Trichuris muris in mice, increased 
anxiety-like behavior was found. The altered behavior was also coupled with changes in the 
central nervous system biochemistry including decreased hippocampal BDNF mRNA and 
kynurenine, etc. (21). Citrobacter rodentium - infected mice also showed impaired memory 
function when exposed to acute stress (18). 
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Increasingly, studies have induced manipulations of GM using probiotics, described 
as gut bacteria, whose consumption has been advocated due to its beneficial effects on the 
hosts’ health. Early studies using probiotics can be traced back 10 years. In humans, probiotic 
L. casei Shirota contained in milk has improved questionnaire-based mood and memory 
performance in healthy volunteers (22). In rats, B. infantis 35624 reduced depression-like 
behavior along with improved brain monoamines and metabolites (23, 24). 
Compared to the animal studies, there are fewer studies in humans on the role of GM 
in central nervous system functions. One reason for the fewer studies in humans is the 
challenge to measure and manipulate the GM in human gut because of its diversity due to 
genetic and environmental differences among individual humans. Recently, however, 
researchers have found relations between the GM and behavior-related disorders such as 
Parkinson’s disease and autism. Patients with Parkinson's disease had reduced abundance of 
Prevotellaceae in their feces. These changes of the GM composition could be related to the 
gastrointestinal dysfunction and motor symptoms in these patients via the ENS and the CNS 
(25). In individuals with autism, there were decreases in the Bacteroidetes/Firmicutes ratio 
and in the amount of Bifidobacterium, and increases in bacteria Clostridium and 
Desulfovibrio (26). 
Nevertheless, maintaining a symbiosis of the GM is important for health, physically 
and mentally. In contrast, dysbiosis of the GM can disrupt the balance and may induce 
diseases. Probiotics as a means of stabilizing and improving the GM have lately received 
much attention due to its beneficial impact on CNS functions and mental health.  
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1.4 Psychobiotics and gut-brain axis  
Briefly mentioned in the last chapter, probiotics are defined as “live micro-organisms 
which, when administered in adequate amounts, confer a health benefit on the host” (27, 28). 
Certain types of probiotics have been used to treat GI disorders, such as IBS (29, 30), and 
have also been studied in relation to treating visceral pain (31). Recently, probiotics have 
been described as “Psychobiotics” that “when ingested in adequate amounts have a positive 
mental health benefit” (32).  They have been reported to influence the CNS by altering the 
GM composition. CNS functions mostly reported of being altered by probiotics are 
psychiatric disorders and memory abilities. Studies in animals and humans have suggested 
potential mechanisms underlining these probiotic effects. First, probiotics may directly alter 
CNS biochemistry, by affecting levels of BDNF, gaminobutyric acid (GABA), serotonin (5 
hydroxytryptamine; 5 HT), and dopamine (DA), and thus influence mind and behavior (33-
37). Both the vagus and the enteric nerves are involved in this gut-brain interaction and can 
be affected by certain probiotics (33, 34). The HPA stress response, which regulates mood 
and emotion has frequently been shown to be attenuated by probiotics via decreased 
corticosteroid (CORT) levels (38). The immune system can be influenced by probiotics, 
limiting pro-inflammatory cytokine production and inflammation, which, in turn, can affect 
the endocrine and nervous systems (23, 24). Probiotics manipulate GM by increasing 
microbiota diversity and beneficial bacteria compositions (39-41). Improved GM changes 
metabolites, such as short-chain fatty acids and tryptophan, which can indirectly improve 
CNS function (23, 42). 
 
 
Anxiety 
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Anxiety has been characterized as emotional response to real or perceived imminent 
threat or the anticipation of future threat (43). Anxiety-like behaviors can be induced by 
experimental manipulation. Mice with chronic inflammation and infection showed enlarged 
anxiety-like behavior. High levels of anxiety could be reduced by B.longum NC3001 in two 
studies (21, 33). This strain also reduced enteric neurons excitability and BDNF expression. 
L.helveticus normalized the increased anxiety-like behavior of mice under chronic stress. 
Together with increased anti-inflammatory cytokine, decreased CORT and ACTH, increased 
brain 5-HT, NE and BDNF expression, L.helveticus has anxiolytic effects through the 
immune, the endocrine and the nervous systems (44). Healthy volunteers showed decreased 
subjective anxiety level after receiving probiotics L. helveticus and B.longum (45, 46). In 
patients with chronic fatigue syndrome, anxiety levels were decreased and fecal 
Lactobacillus and Bifidobacteria were raised by L. casei Shirota (47). 
 
Depression 
Depression is a common psychiatric disorder that can be long-lasting and impair 
people’s life (48). Depression is associated with stress experience and dysregulation of the 
immune system (49). Probiotic L. plantarum PS128 showed antidepressant effects in GF 
mice and mice with early life stress, and also changed cytokine levels (decreased 
inflammatory cytokine TNF-a and IL-6, increased anti-inflammatory cytokine IL-10) and 
metabolites of 5-HT and DA in the brain (35, 36). L. rhamnosus JB-1 showed vagus 
dependent effects of antidepressant effects and also altered GABA receptor expressions in the 
brain (34). In healthy volunteers, in addition to an anxiolytic effect, formulation of probiotics 
L. helveticus and B.longum also reduced depression compared to placebo (45, 46).  
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Autism 
Autism spectrum disorder (ASD) describes a set of neurodevelopmental disorders 
characterized by defects in social interaction and communication (50). Probiotic B. fragilis 
NCT9343 has been shown to reduce ASD-related behaviors in animals. It also reduced 
intestinal permeability and tryptophan metabolites. Previous studies have reported that SCFA 
administration could result in some autistic-like behavior (51), however, B. fragilis did not 
show an effect on SCFA level. In humans, studies have examined effects of probiotic 
supplements in ASD. One study has reported that probiotics improved the ability of children 
to carry out orders and to concentrate (52). However, no effects on emotional response have 
been reported.  Another study used questionnaires and obtained improvements in behavior 
after probiotic intake, i. e. showing lower scores of disruptive antisocial behavior and 
communication disturbances compared to placebo group (53). However, evidence for 
probiotics being able to alter behaviors in ASD is still limited, and further studies are needed 
(54). 
 
Memory ability  
Memory abilities, including spatial and non-spatial memory such as object 
recognition and emotional memory, have been improved by probiotics in animals in several 
studies (18, 40, 41, 44, 55-59). Some of the studies also found that probiotic increased BDNF 
and c-fos, two proteins that play important roles in the regulation of hippocampal-dependent 
memory (Liang, 2015; Smith 2014; Jeong, 2015). BDNF modulates synaptic plasticity of the 
hippocampus during neurogenesis, whereas c-fos is an immediate early gene that is required 
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for hippocampus-dependent long-term memory formation (60, 61). In humans, one study 
used scales to test different memory abilities (e.g. episodic memory, long-term memory), on 
which probiotics showed improving effects (22). A recent study using the Paired Associate 
Learning test from the Cambridge Neuropsychological Test, showed improvements of 
visuospatial memory performance following intake of B.longum 1714 (62). In short, animal 
studies have provided more convincing evidence for probiotic related memory effects than 
studies in humans. Clinical studies with standardized behavioral models are needed to test 
effects of probiotics on memory.  
 
Stress response  
One important central function is the response to stress, which is closely related to 
many psychiatric disorders (e.g. anxiety and depression) (65). In animals, probiotics of L. 
rhamnosus R0011and L.helveticus R0052 restored memory impairments and anxiety-like 
behavior induced by water avoidance stress as an acute stressor (18). Probiotic B. infantis 
35624 reduced depression-like behavior caused by chronic stress such as maternal separation 
(24). In humans, cortisol levels as stress response have been measured and found to be 
reduced after probiotic treatments such as Lactobacillus casei Shirota and B.longum 1714 
(63, 64). Due to the important role of the stress in brain functions, I expanded the discussion 
of the gut-brain axis to the role of stress in current paradigms for inducing stress, and to the 
regulation of stress responses by probiotics in Chapter 1.5, 1.6 &1.7. In Chapter 8 & 9, I 
have tested the effects of antibiotic rifaximin and probiotic B.longum 1714 on the stress 
response in healthy volunteers via the modulation of GM and its effects on the CNS. Stress 
was induced by a social psychology paradigm, called Cyberball game. I used 
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magnetoencephalography to measure the brain activations related to the processing of stress 
because of its fine spatial and high temporal resolution as neuroimaging method. 
 
Cortical activity 
In humans, clinical studies using neuroimaging methods have started to emerge, 
linking neural effects of probiotics with brain activity. The first study to demonstrate 
alterations in cortical activations by probiotics has used functional magnetic resonance 
imaging (fMRI) (8). A fermented dairy drink with probiotics affected the activity of brain 
regions controlling central processing of emotion and sensation – reduced activation in 
widely distributed areas including frontal and temporal cortices, parahippocampal gyrus, 
primary interoceptive and somatosensory cortices, in response to negative emotional stimuli 
(66). A recent study administrated B.longum NCC3001 to IBS patients and found that, in 
addition to an improvement in psychiatric comorbidity, brain activations to negative 
emotional stimuli were reduced in amygdala and fronto-limic regions (67). By now, findings 
of neural effects of probiotics largely come from animal studies, while evidence from human 
studies is much demanded for the potential applications in treatments and called for to be 
conducted with neuroimaging methods. 
 
1.5 Stress and Gut-brain axis   
Stress describes the effects of psychosocial and environmental factors on physical or 
mental well-being. Today almost everyone seems to be affected by the negative effects of 
stress (68, 69). Stress response, is considered as reactions that is elicited to counteract a 
possible threat and to adjust the organism to the stressor, which is individual specific (70). 
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There are two stress-responsive systems: the sympathetic nervous system (SNS) and the 
hypothalamic-pituitary-adrenal (HPA) axis (70, 71). Through these two systems, stress elicits 
emotional and behavioral reactions. When stress is uncontrollable and chronic, it can trigger 
mal-adaptive changes in the CNS and can give rise to structural and/or functional changes of 
the brain (72, 73). Specially, chronic stress can cause chronic sympathetic activation and 
leading to anxiety disorders and depression. The HPA axis and the SNS are involved in the 
onset, the development and the progression of anxiety and depression. In addition, memory 
abilities can be impaired by prolonged and high level of stress (74). Stress may raise 
corticosteroid secretion and inhibit hippocampal activity, which is a main brain area for 
memory and learning processes (75, 76).  
Stress is also related to gut functions and is one of the factors for GI disorders. Stress 
has an impact on physiological gut functions including gut motility, secretion, visceral 
sensitivity and mucosal blood flow (77). IBS is a typical stress-sensitive disorder with an 
irritable bowl and irritable brain. Research has revealed that early life stress contributes to 
development of IBS symptoms (78, 79).  Another consequence of stress on IBS is the 
induction of co-morbid psychiatric disorders (e.g. depression and/or anxiety) (5). To treat 
IBS, antidepressants such as selective serotonin reuptake inhibitors, have been utilized (80).  
Furthermore, preclinical and clinical studies have shown that stress has a negative 
influence on the GM, which plays a crucial role in the gut-brain axis. Stress influences the 
composition and the function of the GM - stress is able to increase gut permeability and allow 
bacteria and bacterial antigens to cross the epithelial barrier; meanwhile this change also 
activates a mucosal immune response which in turn alters the composition of the GM (81, 
82). Subsequently, alteration of the GM is related to a variety of GI and mental disorders 
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(83). Again, IBS as gut-brain axis disorder accompanying with anxiety and/or depression 
symptoms, has been demonstrated to have a disrupted GM (84).  
By linking impacts of stress on both, CNS and gut functions, it seems that keeping a 
life style that avoides exaggerated stress may be good for the both, physical and mental 
health. However, given the fact that people suffer to certain degrees from stress and have 
different tolerances and responses to stress, one may consider the modulation of stress as a 
target to improve brain and gut functions. Due to the crucial role of GM for the processing of 
stress, improving GM to modulate stress responses is believed to be a beneficial strategy. 
Recently, microbiota-brain-gut axis has been discussed in different stress-related CNS 
disorders and has been demonstrated of being capable to regulate stress response (6, 85, 86).  
As reviewed by our pervious study (see Chapter 6), probiotics reduce stress response 
through brain-gut interactions ("microbiome-gut-brain axis") and also attenuate the 
development of stress-induced disorders – both mental disorders or GI disorders (87). For 
example, a probiotic combination of L. rahmnosus and L. helveticus normalized memory 
dysfunction induced by an acute water avoidance stress (18); single probiotic strain of B. 
infantis prevented depression-like behavior caused by maternal separation – one of the best 
characterized animal models to induce chronic stress (24).  
Following the discussion of the important role of stress in the gut-brain axis, and the 
strategy of using probiotics intervention as a manipulation of GM to modulate stress 
management, we next will discuss a standardized social psychology paradigm for inducing 
social stress in humans. The paradigm is presented as model to study effects of GM 
experimentally. This part summarizes the neural process of the social stress induced by the 
paradigm (presented fully in Chapter 4). 
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1.6 Social stress – Cyberball game  
To study effects of probiotics neural and behavioral models can be translated from 
animal research to human studies, - however limitations also exist (see more details in 
Chapter 6). Briefly, most of the standardized animal models for measuring anxiety- and 
depression- like behaviors are not translatable to humans, because measurements of anxiety 
and depression in humans rely primarily on psychology scales. Measurement of learning and 
memory abilities of humans are relatively more standardized compared to psychiatric 
conditions. For example, the Morris water maze for animals has a computerized version for 
humans: the object recognition tasks and fear conditioning are widely used in humans. Stress 
can be induced in a physical way as heat or cold stressor (88, 89), or in a psychological way 
as social stressor. The Trier Social stressor is widely used for inducing a stressful situation by 
letting participants give a public speech (90), which however, is difficult to be accomplished 
in a scanner.  
In search of a stress paradigm that would allow the testing of social stress and 
psychobiotic effects on the stress response with neuroimaging methods in humans, we have 
identified the “Cyberball game” (CBG). This is a virtual online game that is often used to 
study social stress by social exclusion/rejection (91). Chronic experience of the social 
exclusion may also be regarded as a stressful situation, which may lead to the development of 
depression. Numerous studies using different methods such as fMRI and 
electroencephalography (EEG) have discovered widely distributed brain regions involved in 
social exclusion versus inclusion. However, various experimental designs have led to 
divergent results regarding the neural activations during this kind of social stress. Therefore, 
there was a need for a review aiming at the conclusive evaluation of the neural processes 
involved in the social stress/exclusion induced by the CBG.  
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Hence, we have conducted a scoping review on the current literature that has used 
neurophysiological measurements such as using fMRI and EEG to investigate the neuronal 
processes underlying the responses to social stress induced by the Cyberball game (see 
Chapter 7) (92). Considering methodologies and results of published work, we have 
identified a common spatio-temporal pattern of neural activations related to social 
stress/exclusion, and analyzed influential factors modulating neural activations (see more 
details in Chapter 7). Based on the results, we have developed our research hypotheses of 
how probiotics might influence subjects’ neural activity. In Study III and IV (see Chapter 8 
& 9), we have conducted two randomized, placebo-controlled, double-blinded trial, to test 
these hypotheses for the effects of administration of the antibiotic rifaximin and the probiotic 
B.longum 1714 on neural responses to the CBG.  
 
1.7 Stress response regulation  
Antibiotics  
In Chapter 1.3, we have described usage of GF animals to study effects of the GM in 
the gut-brain axis. Recently, GM manipulations with antibiotics have been suggested as an 
alternatives and complementary strategy (93). Administrations of an antibiotic cocktail of 
bacitracin, neomycin and primaricin in mice reduced anxiety-like behavior and increased 
hippocampal BDNF mRNA expression (94). In another study, reduction of anxiety was also 
observed but along with reduced cognitive abilities and social deficits followed by antibiotic 
treatment (95). In this study brain BDNF levels also showed inconsistency to the last 
mentioned study– reduced in hippocampus. A mixed antibiotic treatment of bacitracin, 
neomycin, ampicillin and vancomycin impaired memory abilities of rats and was at the same 
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time associated with reduced BDNF and HPA activity - two brain molecules related to stress 
response (96).  
Observations of behavioral changes in humans by antibiotics date 30 years back when 
patients treated for inflammations showed enlarged stress responses as becoming irritable and 
aggressive after taking amoxicillin-cavulanate. Patients revealed normal behavior after 
having stopped the mediation (97). However, another study reported a positive effect of 
amoxicillin: children with autism spectrum disorder showed an improvement of autistic 
symptoms, verbal skills and a reduction of repetitive behaviors after consumption of 
amoxicillin (98).  
 In our recent clinical trial in healthy volunteers, a locally acting broad-band antibiotic 
rifaximin, showed a stress-reducing effect along with altered brain activity during a resting-
state recording and during the CBG acting as a social stressor (see more details in Chapter 8) 
(99). Rifaximin has poor bioavailability (<1% systemically absorbed), and little risk for 
provoking antibiotic resistance (100). Due to its property, it is used in healthy volunteers and 
also in patients without severe infection, e.g. in prevention of tropical diseases and traveler’s 
diarrhea (101). A few trials have shown clinical efficacy in IBS (102, 103) and in small 
intestinal bacterial overgrowth (104, 105). Additionally, it is used to prevent a 
neuropsychiatric syndrome caused by the liver disease, hepatic encephalopathy (106). In a 
clinical trial, eight-weeks intake of rifaximin did enhance cognitive abilities in patients with 
liver cirrhosis, which altered brain activations during the relevant tasks (107). The neural 
effects of rifaximin were suggested to be mediated through gut-liver-brain axis by 
modulating gut bacteria, serum bilirubin and endotoxemia. 
However, caution may be needed when coming to a conclusion of effects of 
antibiotics on the CNS, since the effects could be either positive or negative depending on 
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individuals’ health conditions. Antibiotics appear to be effective on improving CNS functions 
in populations in which the disease has already started (98, 107).  However, it needs to be 
noted that those who suffer from diseases and are in need for antibiotic treatments may have 
infections or altered GM already so their central functions may have been distorted by the 
infection. Any central effects by antibiotics would be blurred by indirectly acting 
mechanisms of the antibiotics. Antibiotics have been studied for their disturbing effect on 
stress-related central functions (e.g. anxiety, memory) in animals, due to its antimicrobial 
property. However, they have only rarely been investigated for their beneficial effects on 
central functions so far.  
 
Probiotics 
Probiotics have been much studied for their effects on stress response, stress-related 
central functions and as well as GI disorders (e.g. IBS) (refer again to Chapter 1.4 & 6). In 
animals, stress responses such as corticosterone levels, depressive behaviors and memory 
dysfunction were ameliorated by assumption of probiotics such as L. casei Shirota, L. 
rhamnosus, and B.infantis 35624 (18, 24, 108).  
However, proofs for the beneficial effects of probiotics from human studies are 
limited due to the difficulty of translating animal models into clinic trials. For example, 
probiotics which were effective in rodents turned out to be ineffective in humans. Moreover, 
while changes in stress management in animals are quantified by physical behavioral 
parameters, in humans most often subjective psychological questionnaires are used with 
limited objectivity due to subjects’ biases (81). In a study that targeting effects of B.longum 
1714 on stress responses, not only behavioral effects were found, but also morning cortisol 
level (links to stress-related preparation) was decreased after intervention (62).   The same 
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strain was used in our recent study (Study IV) which measured neural activation in response 
to a social stressor – the CBG (see Chapter 9). It has been indicated that B.longum 1714 
plays a role in managing distress induced by a social stressor, by up-regulating processes of 
appraising the stressful events and down-regulating the negative emotions, indexed by 
increased frontal and cingulate theta and alpha neural oscillatory activities.  
Since accumulating evidences from animal and human studies show that probiotics 
are capable of influencing stress responses by decreasing behavioral and endocrine 
components of stress, and by altering cortical activities in response to stressors, it seems 
promising to verify probiotics as a therapeutic strategy for mood and stress-related disorders.  
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2. Studies in effects of probiotics on CNS functions (study I) 
Numerous studies have investigated the effects of probiotics on CNS functions, but so 
far a systematic summary of the most effective probiotic intervention has been lacking. 
Compared to animal studies which are better established and standardized, clinical studies in 
humans are still at their beginning and need further translation from animal studies.  
The systematic review (study I) aimed to elaborate CNS functions that can be 
influenced by probiotics and summarize effective interventions including strain, dosage and 
duration, by analyzing previous and current studies in animals and humans; and to discuss the 
possibility of translating animal models to human studies. 
In total, 38 studies were included: 25 in animals and 15 in humans (2 studies were 
conducted in both). Most studies used Bifidobacterium and Lactobacillus, with doses 
between 109 and 1010 colony- forming units for 2 weeks in animals and 4 weeks in humans. 
These probiotics showed efficacy in improving psychiatric disorder- related behaviors 
including anxiety, depression, autism spectrum disorder, obsessive-compulsive disorder, and 
memory abilities, including spatial and non-spatial memory. Since the translation of animal 
studies to humans has both, limitations and possibilities, I provide several suggestions of how 
to implement the translation of animal studies.  
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3. Functional neuroimaging studies in Cyberball game (study II) 
Neuroimaging studies have investigated human brain responses to social stress 
induced by the social psychology paradigm – the CBG. Due to the inconsistency of the 
results there is a strong need to conclude the neuronal processes underlying social stress. 
In a scoping review (study II), we aimed to identify a common spatio-temporal 
pattern of neural activations associated with the social stress/exclusion during the CBG, 
through mapping studies using neuropsychological measurements (e.g. fMRI, EEG).  
In total, 42 studies were included and analyzed. An integrated framework describing 
neural activities under social exclusion in terms of both, temporal and spatial processes was 
provided. Regions of the insula, anterior cingulate cortex, temporal and prefrontal cortex 
were activated to social exclusion. These neural activities were pronounced at latencies 
ranging from 200 to 400 ms, and between 400 and 900 ms. Also, exclusion-related changes 
in neural oscillations revealed alpha power increase in frontal cortex and theta power increase 
in insula, subACC and fusiform face area (FFA).  
The results of the review helped me designing my research studies (study II & study 
IV) on effects of antibiotic and probiotic interventions on neural responses to social stress by 
the CBG, and with interpreting the findings.  
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4. Effects of antibiotic rifaximin on central responses to social stress (study 
III) 
As reviewed in our paper in study I (chapter 6), probiotics appear to have beneficial 
effects in improving certain central functions (87), however, how strong the effects are, is 
still a matter of debate. A publication bias toward positive results cannot be excluded and 
negative results in relation the changes of central functions may have been unreported. Even 
for the clinical efficacy of probiotics in IBS, it has been concluded that there is limited 
evidence for positive effects of probiotics in IBS treatment (30). Mechanisms by which 
probiotics affect neural functions are incompletely understood, but there is clear evidence that 
they do affect the commensal GM by increasing diversity and/or competitive colonization. 
An “improved” GM influences metabolites such as short-chain fatty acids and thus improving 
then central functions. In order to see modulations of GM on neural response to social stress, 
we have tested firstly effects of an antibiotic prior to probiotic, since we expected to observe 
a larger effect of antibiotic as it may either kill or inhibit the growth of bacteria, thus 
influencing the GM.  
In an explorative experiment (study III), we aimed to test the efficacy of rifaximin on 
the brain activities during a resting state not performing any tasks and during a social stress 
using magnetoencephalography (MEG). The study aimed to identify neural oscillatory 
responses to the social stress induced by the CBG and its modulation by rifaximin. For these 
purposes, we have conducted a randomized, double-blinded and placebo-controlled study 
with 16 healthy volunteers, whose brain activities were measured during resting state and 
during the social stress, before and after 7-days drug intervention with either rifaximin or 
placebo. 
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With MEG, we observed several brain regions with higher activations during social 
stress/exclusion in different oscillatory bands, which were associated with stress-related 
lower mood and increased subjective exclusion perception. Consumption of rifaximin for 7 
days significantly increased alpha rhythm activity in the prefrontal and cingulate cortex 
during the resting state. Also during social stress, rifaximin decreased beta rhythm activity in 
the prefrontal and cingulate cortex during the social stress condition. The decrease of beta 
activity was correlated with increase of subjective exclusion perception.  
Contrary to our hypothesis that rifaximin would increase the stress response it 
exhibited stress-reducing effects. Following the validation of using MEG to detect the neural 
stress response to the CBG and its modulation by manipulating GM, we moved forward to 
study the neural effects of probiotic in response to this social stressor.   
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5. Effects of Probiotic B.longum 1714 on central responses to social stress 
(study IV) 
Probiotics have been been found to affect CNS functions. We have addressed the 
importance of stress response in the gut-brain axis and summarized effects of probiotics on 
the stress response in the previous studies (see Chapter 1.5 & 1.7). Recent research has 
moved forward to translate animal studies to clinical human studies and specially to utilize 
neuroimaging methods to detect brain activations altered by probiotics.  
Based on evidence from studies in animals and humans, we have selected probiotic 
strain Bifidobacterium longum 1714 to study its neural effects on stress response. This strain 
had previously been demonstrated to modulate stress related behaviors in mice (59, 109). In 
humans, it showed effects of reducing stress responses to a cold stressor and improving 
cognitive abilities following treatment (64). It was interesting to investigate where and how 
probiotics affect cortical activations using neuroimaging method, both, during rest and in 
response to a stressful situation.  
Since MEG was verified in our previous study (study III) on its capacity to detect 
neural oscillation activations during the social stress – CBG, in study IV, we conducted a 
similar clinical trial, by using the same paradigm, same neuroimaging technique and 
probiotic strain B.longum 1714. As a main study, 40 healthy participants were recruited and 
measured on their brain oscillatory activities with MEG during a resting state and during the 
CBG. Participants were examined both, before and after their intervention with either 
B.longum 1714 or placebo for 4 weeks. Also, their health status was assessed using the 36-
item short-form health survey (SF36). 
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We observed that B.longum 1714 affected resting brain activities by increasing the 
frontal and cingulate theta band power and decreasing beta-3 band power in the hippocampus, 
fusiform, and temporal cortex. These neural activity changes were associated with subjective 
vitality changes indexed by SF36. For the neural activity change in response to the social 
stress, B.longum 1714 increased theta and alpha band power in the frontal and cingulate 
cortex, which were correlated with increased distress level during the stressor.  
The results indicated B.longum 1714 enhanced participants’ arousal status and 
reduced their mental fatigue. The strain also affected neural stress response by up-regulating 
emotion regulation. 
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6. Study I. Effect of probiotic on central nervous system functions in 
animals and humans: a systematic review  
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To systematically review the effects of probiotics on central nervous system function in animals and humans, to summarize effective 
interventions (species of probiotic, dose, duration), and to analyze the possibility of translating preclinical studies. Literature searches 
were conducted in Pubmed, Medline, Embase, and the Cochrane Library. Only randomized controlled trials were included. In total, 38 
studies were included: 25 in animals and 15 in humans (2 studies were conducted in both). Most studies used Bifidobacterium (eg, 
B. longum, B. breve, and B. infantis) and Lactobacillus (eg, L. helveticus, and L. rhamnosus), with doses between 109 and 1010 colony-
forming units for 2 weeks in animals and 4 weeks in humans. These probiotics showed efficacy in improving psychiatric disorder-
related behaviors including anxiety, depression, autism spectrum disorder (ASD), obsessive-compulsive disorder, and memory abilities, 
including spatial and non-spatial memory. Because many of the basic science studies showed some efficacy of probiotics on central 
nervous system function, this background may guide and promote further preclinical and clinical studies. Translating animal studies 
to human studies has obvious limitations but also suggests possibilities. Here, we provide several suggestions for the translation of 
animal studies. More experimental designs with both behavioral and neuroimaging measures in healthy volunteers and patients are 
needed in the future.
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Introduction  
The microbiota, the ecological community of commensal, sym-
biotic, and pathogenic microorganisms literally sharing our body 
space, includes more than 10 times the number of host cells to hu-
man cells.1 The majority of the microbiome lives in the gastrointes-
tinal (GI) tract and is composed of 10 100 trillion microorganisms, 
containing 100 times as many genes as our genome.2 Symbiosis of 
the gut microbiota (GM) can maintain a normal physiology in the 
host, while dysbiosis of the GM can shift the balance and may in-
duce diseases. 
Recent studies have found a role for the GM in the gut-brain 
axis, which can alter minds and behaviors through the central ner-
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vous system (CNS).3-8 Maintaining GM symbiosis is important for 
retaining healthy CNS functions. Sudo’s study was the first linking 
the GM and CNS, showing an increased hypothalamic-pituitary-
adrenal (HPA) stress response and decreased brain-derived 
neurotrophic factor (BDNF) levels in the hippocampus of germ-
free (GF) mice.9 Recently, researchers have found a relationship 
between the GM and CNS-related disorders in humans, such as 
Parkinson’s disease and autism: overall diversity and individual ge-
nus abundances were associated with their symptoms.10-12
Probiotics are defined as “live micro-organisms which, when 
administered in adequate amounts, confer a health benefit on the 
host”.13,14 Some types of probiotics have been used to treat gastro-
intestinal disorders, such as irritable bowel syndrome (IBS).15-18 
Also, probiotics have been studied in relation to altering visceral 
pain responses.19 Recently they have been reported to have an in-
fluence in the CNS by altering the GM composition.3,8 Studies 
using probiotics to change CNS functions have increased over the 
last 10 years. The CNS functions mostly reported being altered by 
probiotics are psychiatric disorders and memory abilities. Studies 
in animals and humans have found, and reviews have summarized, 
potential mechanisms underlining these probiotic effects (Fig. 1). 
First, probiotics may directly alter CNS biochemistry, such as by 
affecting levels of BDNF, g-aminobutyric acid (GABA), serotonin 
(5 hydroxytryptamine; 5 HT), and dopamine (DA), thus influenc-
ing mind and behavior.20-24 Both the vagus and the enteric nerves 
are involved in this gut-brain interaction and can be affected by 
certain probiotics.22,23 The HPA stress response, which regulates 
mood and emotion, has frequently been shown to be attenuated by 
probiotics, decreasing corticosteroid (CORT) levels.25 The immune 
system can be influenced by probiotics, limiting pro-inflammatory 
cytokine production and inflammation, which, in turn, can affect 
the endocrine and nervous systems.26,27 Probiotics manipulate GM 
by increasing microbiota diversity and beneficial bacteria composi-
tions.28-30 Improved GM changes metabolites, such as short-chain 
fatty acids and tryptophan, which can indirectly improve CNS 
function.26,31
While there are reviews describing effects of probiotics on CNS 
function, there has been no previous systematic review that analyzes 
all the current animal and human studies in the field and describes 
the most effective probiotic interventions. Furthermore, animal 
studies in this area outnumber human studies, because behavioral 
experiments in animals are better established and standardized, 
while clinical studies in humans on this topic started to increase a 
few years ago and need translation from preclinical studies. How-
Endocrine system:
CORT, ACTH
Immune system:
cytokines Neurochemical: 5-HT, DA,
GABA, BDNF. c-Fos
Neural system:
vagus nerve
GM
Probiotics
Metabolic: SCFA,
tryptophan
Figure 1. Mechanisms of probiotic effects on the central nervous system. Probiotics influence central nervous system (CNS) function through 
direct and indirect mechanisms. Probiotics affect the hypothalamic-pituitary-adrenal (HPA) axis, by altering corticosteroid (CORT) and/or adre-
nocorticotropic hormone (ACTH) levels. The immune system is influenced by limited pro-inflammatory cytokine production and inflammation, 
and this, in turn, has effects on the CNS. Probiotics can also directly alter CNS biochemistry, such as by affecting brain-derived neurotrophic fac-
tor (BDNF), c-Fos, g-aminobutyric acid (GABA), 5 hydroxytryptamine (5-HT), and dopamine (DA) levels, thus influencing mind and behavior. 
The vagus and enteric nerves are also involved in this gut-brain interaction and are affected by certain probiotics. Probiotics manipulate the gut 
microbiota (GM) by increasing microbiota diversity and beneficial bacteria composition. An “improved” GM changes metabolites, such as short-
chain fatty acids (SCFAs) and tryptophan, and so improves CNS function indirectly. The GM also interacts with the endocrine, immune, and neu-
ral systems. 
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ever, from preclinical animal models to clinical trials in humans, 
there is no direct translation. To bridge the gap between preclinical 
and clinical studies, a systematic review is needed to summarize ef-
fective probiotic interventions on CNS function. We first sought to 
describe CNS functions that can be influenced by probiotics. Sec-
ond we provide information about probiotic interventions including 
strain, dosage, and duration. Furthermore, we analyze and discuss 
the potential translation of animal models to human studies.
Methods  
Search Strategy
This systematic review was conducted according to guidelines 
of the “Cochrane Handbook for Systematic Reviews of Interven-
tions”, following the Preferred Items for Systematic Reviews and 
Meta-analysis guidelines.32,33 Relevant studies were found by 
searches in the Pubmed, Medline, Embase, and Cochrane Library 
databases. Articles from 1950 to April 2016 were initially searched 
using the search terms “(probiotic OR gut microbiota) AND 
(behavior OR central nervous system)”. Additional citations were 
sought using references in articles retrieved from searches. We only 
included articles written in English. The first search was under-
taken by analyzing text words contained in the title and abstract, 
and of the key words describing the articles. The second search was 
conducted according to the citations from all identified reports and 
relevant review articles.
Study Selection
We included all animal and human studies using different 
strains of probiotics. In human studies reports of both healthy vol-
unteers and patients were considered.
The abstracts of the retrieved papers were screened for match-
ing the following criteria: (1) the study included a probiotic inter-
vention and (2) the study tested CNS function. After exclusion of 
non-relevant studies, the remaining articles were screened for the 
following criteria: (1) the study was described as a randomized con-
trolled study (RCT), (2) the study was described as double-blind 
if studied in human participants, (3) the study involved use of pro-
biotics in single- and/or multi-strains and those that only used pre-
biotics or antibiotics were not included, and (4) the study included 
measures of behavioral experiments, neuropsychological measures 
(eg, electroencephalography, magnetoencephalography, and func-
tional magnetic resonance imaging). Those that only involved neu-
rophysiological measures were not included in the qualitative analy-
sis but only in the Discussion (eg, measuring neurochemical level, 
HPA axis activity) because different studies tested quite divergent 
aspects of lower-level CNS activity.
Data Collection and Analysis
A data extraction and assessment form from the Cochrane Col-
laboration was used to further exclude inappropriate studies and to 
extract data we needed to analyze.33 Double extraction of data was 
conducted: important data included the source of participants (ani-
mal species/strains, patient types), intervention groups (probiotic, 
placebo, or any other intervention), sample size, duration of inter-
ventions, and outcomes (behavioral changes as the primary outcome 
and lower-level changes [eg, biochemical changes] as secondary 
outcomes).
We assessed the quality of each study included using the Qual-
ity Assessment Tool for Quantitative Studies and the Quality As-
sessment Tool for Quantitative Studies Dictionary developed by 
The Effective Public Health Practice Project (EPHPP) (National 
Collaborating Centre for Methods and Tools [2008]).34
The inclusion of both animals and human studies resulted in 
great heterogeneity of participants, interventions, and CNS func-
tions measured. The outcomes of each study were described. A 
qualitative synthesis of selected studies was made with the aim 
of coming to conclusions about which probiotic interventions, at 
which dose, and for how long, were more/most effective with regard 
to certain CNS functions. Because of the heterogeneity of designs a 
meta-analysis was deemed to be inappropriate.
Results  
In total, 46 potentially relevant citations were obtained through 
the primary search strategy, which included animal and human 
studies, after excluding reviews (n = 98) (systematic reviews, 
narrative reviews, respective reviews, and systematic reviews and 
meta-analyses), other articles including comments, hypotheses, 
viewpoints, opinions, and editorials (n = 13), studies without the 
use of a probiotic (n = 33), and studies not focusing on CNS func-
tion (n = 16) (Fig. 2). Many articles concerned the potential, and 
demonstrated mechanisms of the effects, of GM and/or probiotics 
on CNS function. However, we only included studies that clearly 
described probiotics as interventions, and excluded studies only 
measuring GM composition when investigating CNS function. Af-
ter the full screen, 8 more studies were excluded: four studies lacked 
a control arm or blinding, and 4 studies did not measure CNS 
functions at the behavioral level. In total, 38 studies remained for 
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the qualitative analysis. Of them, 15 were in humans and 25 were in 
animals (2 studies were conducted in humans and animals).
Animal Studies
Of the 25 studies, 19 provided explicit information in the Ma-
terials and Methods section on the numbers of animals allocated 
to each treatment group, and they accounted for all the animals in 
their results, while 6 studies provided specifics regarding treated 
animals only in the pertinent areas of the Results section. Results 
from the quality assessment tool for quantitative studies showed all 
studies were strong in global ratings for selection bias, study design, 
confounders, blinding, data collection method, and withdrawals and 
dropouts (no weak rating): 15 studies described assigning animals 
randomly to treatment groups or control, although these animal 
studies were supposed to be RCTs. Only four studies might have 
confounders because they used both male and female animals while 
the other studies only used single gender animals, excluding the 
effect of gender on the results. Only 13 studies reported that experi-
menters were blinded toward the interventions or exposure status 
of the participants (we included the other 12 studies that did not 
describe blinding, because animals were not aware of the research 
question or intervention, and we ignored potential effects of the ex-
perimenter). Data collection tools shown in all studies were consid-
ered valid and reliable; no study reported withdrawals or drop outs.
Although all of studies examined were on rodents (mice or rats), 
the selection of animals was heterogeneous in some respects: strains 
of animals and health conditions of the animals. Studies were also 
heterogeneous in the CNS functions they were looking at, the ex-
perimental models they used, the probiotics they used, and the dose 
and duration of the probiotic interventions. Due to the heterogeneity 
of the included studies, we only described the results based on the 
interventions and measurements of the CNS functions (Table 1).
Most of the studies (18/25) investigated the effects of a single 
strain of probiotics. In 18 studies using single-strain probiotics, 
seven used Bifidobacterium, eleven used Lactobacillus, and one 
used Clostridium (one used both Bifidobacterium and Lactobacil-
lus). Almost all the studies found significant effects on measured 
CNS functions, except for one testing effect of Bifidobacterium 
infantis on depression-like behavior. The concentration of the effec-
tive probiotic interventions ranged from 107 to 1011 colony-forming 
units (CFU), with the most using 109 (14/25) or 1010 (6/25) CFU 
per animal per day. The duration of the probiotic treatments ranged 
245 of records identified
through database searching
9 of additional records
identified through other sources
54 of records after duplicates removed
200 of records screened 160 of records excluded:
98 reviews
13 other (comment,
hypothesis, viewpoint,
opinion, editorial)
16 not CNS functions
33 not probiotic
46 of full-text articles
assessed for eligibility
38 of studies included in
qualitative synthesis
8 of full-text articles
excluded:
2 no placebo control
2 no blinding
4 no behavioural measure Figure 2. Preferred reporting items for 
systematic reviews and meta-analyses 
(PRISMA) scheme of retrieved litera-
ture. CNS, central nervous system.
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Table 1. Studies of Effects of Probiotics on Central Nervous System Functions in Animals
Study Animal CNS function
Probiotic
(species, dosage  
[CFU/day], duration)
Outcome  
(behavioral level)
Secondary outcome 
Liu et al,20 
2016
ELS mice
Naïve mice 
Locomotor activity  
(open-field test)
Anxiety (open-field test, 
elevated plus maze)
Depression (sucrose-
preference test,  
forced-swimming test)
L. plantarum PS128
109
28 days
Locomotor activity ↑
Anxiety (only in naïve  
mice) ↓
Depression (only in ELS 
mice) ↓
Corticosteroids (CORT) ↓
Cytokine: inflammatory cytokine 
TNF-a, IL-6 ↓, anti-inflammatory 
cytokine IL-10 ↑
Brain monoamines and metabo-
lites: 5-HT ↑, 5-HIAA ↓, DA ↑, 
DOPAC ↓, HVA ↓
Liu et al,21 
2016
GF mice Locomotor activity  
(open-field test)
Anxiety (elevated-plus 
maze)
Depression  
(forced-swimming test)
L. plantarum PS128
109
16 days
Locomotor activity ↑
Anxiety ↓
Depression (-)
CORT: NA 
Brain monoamines and  
metabolites: DA ↑, HVA ↑, 5-HT ↑ 
and 5-HIAA ↑
Liang et al,38 
2015
SPF CRS rats Stress (chronic-restraint 
stress)
Depression (sucrose-
preference test)
Anxiety (elevated-plus 
maze, open-field test)
Non-spatial memory 
(object-recognition test, 
object-placement test)
L. helveticus NS8
109
Initial 21 days
Anxiety ↓
Depression ↓
Non-spatial memory ↑
CORT and ACTH ↓
Cytokines: IL-10 ↑
Brain monoamines: 5-HT ↑ and  
NE ↑
BDNF expression ↑
Wang et al,30 
2015
Ampicillin-treated 
rats
Anxiety (elevate-plus 
maze)
Spatial memory  
(Morris water maze)
L. fermentum N93
109
Initial 30 days
Anxiety ↓
Spatial memory ↑
CORT and ACTH ↓
Brain monoamines: MR ↑,  
NMDA ↑, GR: NA
Brain BDNF: NA 
Colon inflammation:  
myeloperoxidase activity ↓
Fecal microbiota: Bacteroides ↑,  
C. coccoides ↓, Firmicutes ↓,  
Lactobacillus ↑
Smith et al,29 
2014
RagI-/- mice Stress response  
(water-avoidance stress)
Anxiety (light/dark  
box test)
Non-spatial memory 
(novel- object test)
L. rhamnosus R0011 + 
L. helveticus R0052
6 × 109
28 days
Anxiety ↓
Non-spatial memory ↑
CORT: NA 
Brain c-Fos expression ↑
Intestinal permeability ↓
Fecal microbiota: Bacteroides ↑,  
Enterobacteriaceae ↑, Firmicutes ↑
Luo et al,42 
2014
Hyperammone-
mia rats
Anxiety (elevate-plus 
maze)
Spatial memory  
(Morris water maze)
L. helveticus NS8
109
14 days
Anxiety ↓
Spatial memory ↑
Neuroinflammation: PGE2 ↓,  
IL-1β ↓
Brain monoamines: 5-HT ↓
Plasma kynurenine pathway:  
KYN/TRP ↑, KA/KYN ↓
Savignac et 
al,36 2014
Mice Anxiety (defensive marble 
burying, elevated-plus 
maze, open field)
depression (tail-suspen-
sion test, forced-swim 
test)
B. longum 1714/ 
B. breve 1205
109
Initial 21 days
B. longum:
  Anxiety ↓
  Depression ↓
B. breve: 
  Anxiety ↓
CORT: NA 
Ohland et 
al,37 2013
Il-10 deficient 
mice
Anxiety (elevated  
Barnes Maze)
Spatial memory  
(elevated Barnes maze)
L. helveticus R0052
109
21 days
Anxiety ↓
Spatial memory ↑
Colon inflammation ↓
Cytokines: NA 
CORT ↓
SCFA metabolites: NA 
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Table 1. Continued
Study Animal CNS function
Probiotic
(species, dosage  
[CFU/day], duration)
Outcome  
(behavioral level)
Secondary outcome 
Messaoudi 
et al,39 2011
Rats Anxiety (conditioned  
defensive burying)
B. longum R0175 +  
L. helveticus R0052
109
14 days
Anxiety ↓ NA
Bravo et al,23 
2011
Mice Anxiety (open arms, 
elevated-plus maze,  
fear conditioning)
Depression  
(forced-swim test)
L. rhamnosus JB-1
109
28 days
Anxiety ↓
Depression ↓
CORT ↓
GABA receptor expression influence 
depending on brain areas
Probiotic effect via vagus nerve
Bercik et 
al,22 2011
Chronic colitis 
mice
Anxiety (step-down test) B. longum NCC3001
1010
14 days
Anxiety ↓ Colon inflammation: NA 
Brain BDNF expression: NA 
Enteric neurons excitability ↓ 
Probiotic effect via vagus nerve
Bercik et 
al,35 2010
T-muris infected 
mice
Anxiety (light/dark  
behavior, step-down test)
B. longum NCC3001 /  
L. rhamnosus NCC4007
1010
10 days
Anxiety ↓ (B. longum only) Colon inflammation ↓
Plasma cytokines: NA 
BDNF expression ↑  
(only by B. longum)
Tryptophan and kynurenine: NA 
No effect of vagotomy 
Singh et al,40 
2012
Rats CFS and depression 
induced by forced-swim 
test (immobility period, 
post-swim fatigue time)
L. acidophilus as LAB  
or LAB FB
107
7 days
Depression ↓ (larger effect  
of LAB FB than LAB);
Brain oxido-nitrosative stress  
biomarker ↓
Cytokines: TNF-a ↓
Arseneautl-
Bread et 
al,41 2012
MI rats Post-MI depression 
(forced-swim test); 
social behavior  
(social interaction test);  
emotional memory  
(passive avoidance  
step-down test)
B. longum R0175 +  
L. helveticus R0052
109
14 days
Depression ↓ 
Social interaction ↑ 
Non-spatial memory ↑
Cytokines: pro-inflammatory  
cytokine IL-1β ↓
Intestinal barrier permeability ↓
Desbonnet 
et al,27 2010
MS rats Depression  
(forced-swim test)
B. infantis 35624
1010
Initial 40 days
Depression ↓ CORT: NA
Cytokines: IL-10 ↓
Tryptophan: NA
Brain monoamines (-)
Noradrenaline ↑
Desbonnet 
et al,26 2008
Rats Depression  
(forced-swim test)
B. infantis 35624
1010
14 days
No behavioral change Cytokines: pro-inflammatory cytokines 
IL-6, IFN-g ↓; anti-inflammatory 
cytokines IL-10 ↓ 
Tryptophan ↑
Brain monoamines and metabolites – 
5-HIAA ↓, DOPAC ↓
Neuroendocrine: NA, CORT: NA , 
AVP: NA , CRF: NA
Liu etal,44 
2015
VaD (vascular 
dementia) mice 
Locomotor activity  
(open-field test)
Spatial memory  
(Morris water maze)
C. butyricum 
WZMC1016 
(CGMCC 9831)
106/107/108
42 days
Locomotor activity ↑
Spatial memory ↑
Morphological change of  
hippocampus ↓ 
BDNF expression ↑
Butyrate in feces and brain ↑
Fecal bacteria diversity ↑
Jeong et al,47 
2015
Aged rats Spatial memory (Y-maze, 
Morris water maze)
L. plantarum KY1032 +  
L. curvatus HY7601
1010
48 days 
Spatial memory ↑ Cytokines: pro-inflammatory  
cytokines NF-κB, ↓
BDNF ↑
Lipidemia ↓
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Table 1. Continued
Study Animal CNS function
Probiotic
(species, dosage  
[CFU/day], duration)
Outcome  
(behavioral level)
Secondary outcome 
Savignac et 
al,43 2015
Mice Non-spatial memory  
(object recognition,  
fear conditioning)
Spatial memory  
(Barnes Maze)
B. longum 1714/ 
B. breve 1205
109
initial 21 days
B. longum: 
  Non-spatial memory ↑
  Spatial memory ↑
B. breve:
  Non-spatial memory ↑
Visceral sensitivity -colon distension: 
NA 
CORT: NA 
Gareau et 
al,45 2011
C. rodentium  
infected mice
Memory dysfunction 
induced by water  
avoidance (novel-object 
test, T-maze);
L. rhamnosus R0011 +  
L. helveticus R0052
6 × 109
17 days
  Non-spatial memory ↑ CORT ↓
Colon epithelial cell hyperplasia ↓
Cytokine: pro-inflammatory  
cytokines IFN g ↓
Brain BDNF and c-Fos expression ↑
Microbiota: Firmicutes ↓, 
Enterobacteriaceae ↓, Eubacteria  
rectale ↓, Lactobacillus ↑
Davari et 
al,46 2013
Diabetic rats Spatial memory  
(Morris water maze)
L. acidophilus 4356 +  
B. lactis 10140 +  
L. fermentum 
ATCC9338
2 × 1010
56 days
Spatial memory ↑ Hippocampal long-term potentiation ↑
Serum glucose ↓ and insulin ↑
Oxidative stress biomarkers: SOD ↑, 
8-OHdG ↓
Hsiao et 
al,31 2013
MIA mice Autism spectrum disorder:
Anxiety (open field, 
marble burying);
Sensory gating  
(prepulse inhibition);
Communicative behavior 
(ultrasonic vocalizations);
Social interaction 
(3-chamber social test)
B. fragilis NCTC9343
1010
6 days
Anxiety ↓
Sensory gating ↑
Communicative behavior ↑
Social interaction (-) 
Intestinal permeability ↓
Tryptophan metabolites:  
indolepyruvate ↓ 
Microbiota: Lachnospiraceae ↓,  
Bacteroidales ↓
Kantak et 
al,48 2014
Male mice obsessive-compulsive-dis-
order-like behavior (open 
field, marble burying, 
ultrasonic vocalizations, 
intermale aggression)
L. rhamnosus GG 
(ATCC 53103)
109
14, 28 days
Locomotor behavior ↓
Marble burying ↓
Ultrasonic vocalizations (-)
Intermale aggression (-)
NA 
D’Mello et 
al,49 2015
Male mice Inflammation associated 
sickness behavior  
(social exploratory)
VSL#3
1.7 × 109
10 days
Social exploratory behavior 
in bile duct ligation treated 
mice ↑ 
Intestinal permeability: NA 
Cytokine: pro-inflammatory cytokine 
TNF-a ↓
Monocyte infiltration ↓
Microglial activation ↓
Fecal Microbiota (-)
Takada et 
al,50 2016
Male rats Stress response to water 
avoidance stress
L. casei Shirota YIT 9029
3 × 109
14 days
NA CORT ↓
c-Fos expression in the paraventricular 
nucleus ↓
Gastric vagal afferent activity ↑
Neuronal excitability of NTS ↑
ELS, early life stress; CORT, corticosterone; 5-HT, 5-hydroxytryptamine; 5-HIAA, 5-Hydroxyindoleacetic acid; DA, dopamine; DOPAC, 3,4-dihydroxyphen-
ylacetic acid; HVA, homovanillic acid; GF, germ free; NA, not applicable; SPF, specific pathogen free; CRS, chronic restraint stress; ACTH, adrenocorticotropic 
hormone; NE, norepinephrine; BDNF, brain-derived neurotrophic factor; MR, mineralocorticoid; NMDA, N-methyl-D-aspertate; GR, glucocorticoid; RagI-/-, 
RagI knockout; PGE2, prostaglandin E2; KYN, L-kynurenine; TRP, tryptophan; KA, kynurenic acid; SCFA, short-chain fatty acid; GABA, gamma-Aminobu-
tyric acid; CFS, chronic fatigue syndrome; LAB, Lactobacillus acidophilus; FB, floating bead; MI, myocardial infarction; MS, maternal separation; AVP, arginine 
vasopressin; CRF, corticotrophin-releasing factor; VaD, vascular dementia; NF-κB, nuclear factor-kappa B; SOD, superoxide dismutase; 8-OHdG, 8-hydroxy-
2’deoxyguanosine; MIA, maternal immune activation; VSL#3, a high-concentration probiotic preparation of 8 live freeze-dried bacterial (Lactobacillus casei, 
Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium infantis, and Strep-
tococcus thermophiles); NTS, nucleus tractus solitary; B. breve, Bifidobacterium breve; B. fragilis, Bifidobacterium fragilis; B. infantis, Bifidobacterium infantis; 
B. lactis, Bifidobacterium lactis; B. longum, Bifidobacterium longum; C. butyricum, Clostridium butyricum; C. coccoides, Clostridium coccoides; C. rodentium, 
Citrobacter rodentium; L. acidophilus, Lactobacillus acidophilus; L. casei, Lactobacillus casei; L. curvatus, Lactobacillus curvatus; L. fermentum, Lactobacillus 
fermentum; L. helveticus, Lactobacillus helveticus; L. plantarum, Lactobacillus plantarum; L. rhamnosus, Lactobacillus rhamnosus.
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from 6 to 77 days, with the most frequent period being 14 days 
(7/25). Effects of different probiotics on different specific CNS 
functions in animals were analyzed and described in the following 
text.
Anxiety
Twelve studies tested anxiety-like behavior in animals (mice 
or rats). The anxiety-like behaviors were evaluated with the elevate 
plus/Barnes maze, light/dark box, defensive burying, open field/
arms, fear conditioning, and step-down tests. Three of them used a 
single strain of Bifidobacterium longum, all with positive results, ie, 
the animals showed less anxious behavior.22,35,36 Two studies using 
Lactobacillus helveticus also found reduced anxiety-like behaviors 
in immune-deficient mice and chronically restrained rats.29,37,38 
Two studies used Lactobacillus rhamnosus but only one showed 
reduced anxiety behaviors.23,35 Two studies using Lactobacillus 
plantarum also found alleviated anxiety levels in mice after the in-
tervention.20,21 Bifidobacterium breve and Lactobacillus fermentum 
were used once each and showed anxiolytic effects.30,36 Two studies 
using multi-strain probiotic combinations of L. rhamnosus + L. 
helveticus and B. longum + L. helveticus found reduced anxious 
behavior.29,39
Depression
Nine studies focused on depression and all reported positive re-
sults except one. Depression-like behaviors were measured with the 
tail-suspension, forced-swim, and sucrose-preference tests. B. in-
fantis was used twice but only one study found reduced depression-
like behavior. Each of the single strains of B. longum, B. breve, L. 
rhamnosus, and L. helveticus was also used once and all showed 
antidepressant effects.23,26,27,36,40 Two studies tested L. plantarum, 
but it only had an effect in mice with the early life stress of maternal 
separation.20,21 One study used a multi-strain combination of B. 
longum + L. helveticus and also showed positive effects.41
Cognitive function
Eleven studies tested cognitive function, and all showed the 
probiotics to be beneficial for memory performance. Spatial mem-
ory was tested with the Morris water maze and the Barnes maze 
tests; other non-spatial memory abilities were measured with the 
novel object, fear conditioning, passive avoidance step-down, and 
T-maze tests.
Single strains of B. longum, B. breve, and L. helveticus were 
effective on both spatial and non-spatial memories.37,38,42,43 Single 
strains of L. fermentum and Clostridium butyricum improved 
spatial memory ability.30,37,42,44 Multi-strain probiotics that were as-
sessed to be effective with regard to non-spatial memory included 
combinations of L. rhamnosus + L. helveticus29,45 and B. longum 
+ L. helveticus,41 and combinations of Lactobacillus acidophilus 
+ B. lactis + L. fermentum and L. plantarum + Lactobacillus 
curvatus in spatial memory.46,47
Autism spectrum disorder and obsessive-compulsive 
disorder
Autism spectrum disorder-related behaviors were tested with 
the open field and marble- burying tests for anxiety, the pre-pulse 
inhibition test for sensorimotor, ultrasonic vocalization for com-
municative, and the three-chamber social test for social interaction 
behaviors. Bifidobacterium fragilis improved behaviors related to 
the ASD in maternal immune activation mice, including anxiety-
like behavior, sensory gating and communicative behavior, but not 
social interaction behavior.31
Obsessive-compulsive disorder-related behaviors were also 
measured with the open field, marble burying, pre-pulse inhibition, 
ultrasonic vocalization and 3-chamber social tests. L. rhamnosus 
was found to be able to decrease obsessive-compulsive disorder-like 
behaviors in mice, but only locomotor ability and anxiety level. No 
effect was found in communicative or social interaction behaviors.48 
However, a recent study investigated sickness behavior using a so-
cial investigative behavior paradigm, and found VSL#3 improved 
sickness behavior with increased social exploratory behaviors.49
Stress response
Four studies involved stress induction to test behavioral re-
sponse to stress. Stress was induced, with water avoidance stress as 
an acute stressor29,45,50 and maternal separation as a chronic stressor.27 
Acute stress was used to induce anxiety, memory dysfunction and 
HPA response; chronic stress was used to induce depression.
Anxiety behavior was not successfully induced by water 
avoidance stress, while memory dysfunction was induced only in 
Gareau’s study.45 A probiotic combination of L. rhamnosus + L. 
helveticus prevented non-spatial memory dysfunction induced by 
acute stress.45 One study only measured plasma corticosterone levels 
in response to acute stress and found a significant decrease due to 
Lactobacillus casei Shirota intervention.50 For behavioral changes 
caused by chronic stress exposure, B. infantis normalized depres-
sion-like behavior induced by maternal separation.27
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Mechanisms of action
In addition to outcomes on behavioral levels, we also collected 
data at the physiological level, exploring endocrine, immune, neural 
chemical, and metabolic changes due to probiotics. Most of the 
studies investigated serum corticosteroid levels and found they were 
decreased by various probiotics: L. plantarum, L. helveticus, L. 
fermentum, L rhamnosus, and L. casei Shirota.20,23,30,37,44,45,50 Adre-
nocorticotropic hormone (ACTH) could also be decreased by L. 
helveticus and L. fermentum.30,38 Colon inflammation was alleviated 
and cytokine levels were influenced: inflammatory cytokines such as 
IL-6 and TNF-a were decreased and anti-inflammatory cytokines 
such as IL 10 were increased.20,30,35,37,38,40,42,45,47,49 These immune-ef-
fective probiotics were L. plantarum, L. helveticus, L. fermentum, 
L. acidophilus, B. longum, and L. rhamnosus. Brain monoamines, 
such as 5-HT and DA, could be increased by the probiotics L. 
plantarum, L. helveticus, and B. infantis, while their metabolites 
were reduced.20,26,38 GABA receptor expression could be influenced 
by L. rhamnosus, depending on the brain area.23 Brain BDNF 
and c-Fos mRNA expression increased after probiotic intervention 
with L. helveticus, L. plantarum, L. rhamnosus, B. longum, and 
C. butyricum, while c-Fos in the hypothalamus paraventricular 
nucleus was decreased by L. casei Shirota.35,38,44,45,47 Two studies 
found effects of L. rhamnosus and B. longum that were mediated 
via the vagus nerve (ie, no effect in vagotomized mice),22,23 and one 
study found L. casei Shirota to enhance gastric vagal afferent activ-
ity.50 Enteric neuron excitability was inhibited by B. longum,22 while 
visceral sensitivity by colon distension was unaffected.43 One study 
found that a probiotic formulation of B. longum + L. helveticus re-
duced intestinal barrier permeability.31,41 Probiotics L. helveticus, B. 
infantis, and B. fragilis influenced metabolites by enhancing serum 
tryptophan levels and inhibiting its metabolites.26,31,42 Several studies 
conducted microbiota analyses on the fecal samples and found fe-
cal microbiota were altered by probiotics: for example, Bacteroides 
and Lactobacillus were increased and Firmicutes decreased by L. 
fermentum.29-31,44,45 More details are shown in Table 1.
Human Studies
In total, 15 human studies were included. All of the selected 
studies had strong ratings in the quality assessment tool for quanti-
tative studies, although one of the studies did not describe the age 
and gender of the participants in each group.51 Among the 15 stud-
ies, 8 used a single-strain probiotic (L. casei, L. casei subsp. rham-
nosus, L. casei Shirota, L. plantarum, and B. infantis), of which 2 
used probiotic containing milk, and the other 7 studies used multi-
strain probiotics. Eight of the 15 studies found significant effects 
of the probiotic interventions. Doses of the effective interventions 
ranged from 107 to 3.63 × 1010, and the duration of the treatments 
ranged from 20 days to 8 weeks. Doses around 109 (5/8) and 1010 
(3/8) were used most often. Durations were most commonly 4 (6/15) 
and 8 (4/15) weeks. Due to the heterogeneity of the studies (eg, 
probiotic interventions and measurements of CNS functions), we 
only describe the results based on the different interventions (Table 
2).
Psychiatric conditions
Here, we summarize the studies on depression, anxiety, and/or 
mood together, because in most of the studies, questionnaires that 
tested multiple psychiatric conditions were used. Fifteen studies 
tested healthy participants with respect to anxiety, depression, dis-
tress levels, mood state, and behavior problems.39,51-62 The measure-
ment tools included the General Health Questionnaire (GHQ), 
the Depression Anxiety and Stress Scale (DASS), the Leiden 
Index of Depression Sensitivity-Revised (LEIDS-r), the Positive 
and Negative Symptom Scale (PANSS), the State-Trait Anxiety 
Inventory (STAI), the Development Behavior Checklist (DBC), 
the Beck Depression Inventory (BDI), the Beck Anxiety Inventory 
(BAI), the Hopkins Symptom Checklist (HSCL-90), the Hospital 
Anxiety and Depression Scale (HADS), the Perceived Stress Scale 
(PSS), the Coping Checklist (CCL) (also used to counter the stress 
of daily life), and the questionnaire-based Profile of Mood State 
(POMS). Due to the different questionnaires, scales, and their 
combinations used in these studies, we only report here whether the 
probiotics treatment improved mental health/mood.
One study compared a probiotic capsule (containing Lactoba-
cillus casei, L. acidophilus, L. rhamnosus, Lactobacillus bulgaricus, 
B. breve, B. longum, and Streptococcus thermophilus) and a probi-
otic yogurt (containing B. lactis and L. acidophilus) with the com-
bination of conventional yogurt and a placebo capsule, and found 
the former two were more effective in alleviating distress, anxiety, 
and depression in petrochemical workers.52 A recent study using 
multi-strain probiotics found improvement in the LEIDS-r score, 
which is predictive of depression.53 Two studies by Messaoudi et 
al39,61 found probiotic formulations of B. longum and L. helveticus 
could improve anxiety and depression in all participants, and also 
in those who had lower urinary free cortisol levels at baseline. One 
study using L. casei Shirota-containing milk improved mood only 
in the bottom third of the depressed distribution at baseline.62 A 
study in chronic fatigue syndrome patients also used L. casei Shi-
rota and found decreased anxiety levels following treatment.51 One 
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Table 2. Studies of Probiotic Effects on Central Nervous System Functions in Humans
Study Participants Probiotic
Dosage  
(CFU/day)  
and duration
CNS  
function
Outcome
Secondary  
outcome 
Takada et 
al,50 2016
140 healthy  
students
L. casei Shirota YIT 9029 1 × 109
8 weeks
STAI No difference of  
STAI score
Change in salivary 
cortisol level before 
exam ↓
Decrease in physical 
symptoms ↓
Moham-
madi et al,52 
2015
70 petrochemical 
workers
probiotic yogurt  
(L. acidophilus LA5 +  
B. lactis Bb12) +  
placebo capsule;
Conventional yogurt  
(S. thermophilus and  
L. bulgaricus.) +  
probiotic capsule (L. casei,  
L. acidophilus, L. rhamnosus, 
L. bulgaricus, B. breve,  
B. longum, S. thermophilus)
probiotic yogurt: 
107 in total
Probiotic capsule: 3 
× 103, 3 × 107, 7 
× 109, 5 × 108, 2 
× 1010; 109, 3 × 
108, respectively 
(2.88 × 1010 in 
total)/6 weeks
GHQ
DASS
HPA axis activity
Improvement of 
GHQ and DASS in 
probiotics yogurt and 
probiotics capsule 
groups; no difference 
in HPA axis activity
NA
Steenbergen 
et al,53 2015
40 healthy  
volunteers
Ecologic Barrier:
 B. bifidum W23, B. lactis 
W52, L. acidophilus W37, 
L. brevis W63, L. casei 
W56, L. salivarius W24, 
Lactococcus lactis  
(W19 and W58).
5 × 109
4 weeks
LEIDS-r
BDI
BAI
Improvement of total 
score and item  
‘rumination’ of 
LEIDS-r.
No difference of scores 
of Beck Depression 
and Beck Anxiety 
Inventory
NA 
Dickerson et 
al,54 2014
65 schizophrenia 
patients 
L. rhamnosus GG  
(ATCC 53103+
B. animalis subsp. lactis Bb12 
2 × 109
14 weeks 
PANSS No difference of toll 
score or positive, 
negative or general 
scores. 
Severe difficulty in 
bowel movement ↓
Vaghef-
Mehrabany 
et al,55 2014
46 patients with 
rheumatoid  
arthritis 
L. casei 01 108
8 weeks 
STAI No difference of  
STAI score
Dietary: NA 
Cytokines: pro  
inflammatory  
cytokine TNF-a,  
IL-6, and IL-12 ↓,  
anti-inflammatory 
cytokine IL-10 ↑
Dapoigny et 
al,56 2012
50 IBS patients L. casei subsp. rhamnosus 
LCR35
6 × 108
4 weeks
HADS No difference in 
HADS score
IBS severity score: 
only clinically  
relevant decreased  
in subtype IBS-D ↓
Presence of  
Lactobacillus in  
feces: 85% of patients 
Simrén et 
al,57 2010
74 IBS patients Milk fermented with yoghurt 
bacteria L. bulgaricus + S. 
thermophilus and containing  
L. paracasei F19 +  
L. acidophilus La5 +  
B. lactis Bb12 
2 × 1010
8 weeks 
HADS No difference of 
HADS score
Diet: same among 
groups
Whorwell et 
al,58 2006
362 female IBS 
patients 
B. infantis 35624 106, 108, 1010
4 weeks
HADS No difference in any  
of the dosages
IBS symptom: ↓  
in 108 group
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Table 2. Continued
Study Participants Probiotic
Dosage  
(CFU/day) 
and duration
CNS  
function
Outcome
Secondary  
outcome 
Reale et al,59
2012 
72 male smokers L. casei Shirota 4 × 1010
3 weeks
STAI No difference in  
STAI score
Natural killer cell 
activity ↑
CD16+ cell ↑
BMI: NA 
Bowel function ↑
Parracho et 
al,60 2010
15 children  
(4-16Y) with 
ASD 
L. plantarum WCFS1 4.5 × 1010
3 weeks
DBC No significant  
difference in DBC 
score
Bowel function: only 
different in stool 
consistency
Fecal microbiota: 
Lactobacillus Lab 
158 ↑, Clostridium 
Erec482 ↓
Messaoudi 
et al,39 2011
55 healthy  
volunteers
L. helveticus R0052 +  
B. longum R0175
3 × 109
4 weeks
HSCL-90
HADS
PSS
CCL
Improvement of  
anxiety, depression  
and problem solving,  
and reduced UFC  
level in probiotics 
group
Median urinary free 
cortisol ↓ 
Messaoudi 
et al,61 2011
25 healthy  
volunteers (with 
lower UFC levels 
than median 
value at baseline
L. helveticus R0052 +  
B. longum R0175
3 × 109
4 weeks
HSCL-90
HADS
PSS
CCL
Improvement of  
anxiety and depression 
in probiotics group
NA
Rao et al,51 
2009
35 CFS patients L. casei Shirota 2.4 × 1010
8 weeks
BDI
BAI
Decreased anxiety 
symptoms in probiotic 
group
Fecal microbiota: 
aerobes ↑, anaerobes 
↑ Bifidobacteria ↑, 
Lactobacillus ↑
Benton et 
al,62 2007
124 healthy  
volunteers 
L. casei Shirota  
(containing milk)
6.5 × 109
10/20 days
Questionnaire-based 
POMS
Episodic memory 
(Wechsler Memory 
Scale)
Retrieval from  
long-term memory
Verbal fluency
Eating-associated  
behavior
NART
Improved mood in the 
bottom third of the 
POMS depressed/
elated distribution at 
baseline in probiotics 
group after 20 days
Improved memory in 
probiotics group after 
20 days
NA 
Tillisch et 
al,63 2013
36 healthy females FMPP (B. lactis I-2494 
[DN-173 010], containing 
yogurt starters include S. 
thermophilus I-1630,  
L. bulgaricus I-1632 and 
I-1519) and Lactococcus 
lactis subsp lactis I-1631
B. lactis :  
1.25 × 1010
S. thermophilus 
and L. bulgaricus : 
1.2 × 109
4 weeks
Standard emotional 
faces-attention task 
for fMRI
Decreased activity to 
emotional faces in a 
large distributed  
network
Changes in midbrain 
connectivity during 
resting state 
NA 
STAI, State-Trait Anxiety Inventory; NA, not applicable; GHQ, General Health Questionnaire; DASS, Depression Anxiety and Stress Scale; HPA, hypothalamic-
pituitary-adrenal; BMI, body mass index; LEIDS-r, Leiden Index of Depression Sensitivity-Revised; BDI, Beck Depression Inventory; BAI, Beck Anxiety In-
ventory; PANSS, Positive and Negative Symptom Scale; IBS, irritable bowel syndrome; HADS, Hospital Anxiety and Depression Scale; ASD, autism spectrum 
disorder; IBS-D, diarrhea-predominant IBS; DBC, Development Behavior Checklist; HSCL-90, Hopkins Symptom Checklist; PSS, Perceived Stress Scale; CCL, 
Coping Checklist; UFC, urinary free cortisol; CFS, chronic fatigue syndrome; POMS, questionnaire-based Profile of Mood State; NART, National Adult Reading 
Rest; FMPP, fermented milk product with probiotic; fMRI, functional magnetic resonance imaging; B. animalis, Bifidobacterium animalis; B. breve, Bifidobac-
terium breve; B. bifidum, Bifidobacterium bifidum; B. infantis, Bifidobacterium infantis; B. lactis, Bifidobacterium lactis; B. longum, Bifidobacterium longum; L. 
acidophilus, Lactobacillus acidophilus; L. brevis, Lactobacillus brevis; L. bulgaricus, Lactobacillus bulgaricus; L. casei, Lactobacillus casei; L. helveticus, Lactoba-
cillus helveticus; L. paracasei, Lactobacillus paracasei; L. plantarum, Lactobacillus plantarum; L. rhamnosus, Lactobacillus rhamnosus; L. salivarius, Lactobacillus 
salivarius; S. thermophiles, Streptococcus thermophiles.
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recent study, also using L. casei Shirota, found decreased salivary 
cortisol levels in university students in response to stress, although 
no significant difference in STAI score was observed.50
However, other studies found no significant effect of their pro-
biotic interventions. Patients with schizophrenia showed no change 
in PANSS score after treatment with L. rhamnosus for 14 weeks.54 
Patients with rheumatoid arthritis showed no change in anxiety 
levels, as assessed with the STAI after 8 weeks of L. casei.55 Three 
studies conducted in IBS patients all looked into HADS scores 
before and after interventions, but found no effect of L. casei or 
fermented milk with L. paracasei and L. acidophilus.56-58 In healthy 
male smokers, a 3-week intervention with L. casei showed no effect 
on STAI score.59 In children with ASD, a 3-week intervention with 
L. plantarum did not change the DBC score.60
Memory and other cognitive abilities
The study of Benton et al62 measured different memory 
and cognitive abilities in healthy participants, including episodic 
memory, tested with the Wechsler Memory Scale, retrieval from 
long-term memory, verbal fluency, eating-associated behavior, and 
premorbid intelligence, tested with the National Adult Reading 
Test. However, L. casei Shirota decreased memory abilities in all 
participants compared with the placebo, and had no effect on verbal 
fluency or eating-associated behavior.
Neuroimaging study
There was only one neuroimaging study, using functional mag-
netic resonance imaging (fMRI), investigating the change in brain 
activity to emotional stimuli and basal brain activation after intake 
of a fermented milk product with probiotic (FMPP) containing 
B. lactis with yogurt starters, S. thermophilus, L. bulgaricus, and 
Lactococcus lactis subsp. lactis.63 The FMPP decreased activity of 
a large distributed network including affective, viscerosensory, and 
somatosensory cortices to emotional faces, and changed midbrain 
connectivity during the resting state.
Mechanisms of action
Two studies found reduced cortisol levels in saliva and urine 
after probiotic interventions with L. casei Shirota and multi-strain L. 
helveticus + B. longum, respectively.39,50 The immune system could 
be improved by the probiotic L. casei, with evidence of reduced 
pro-inflammatory cytokines (TNF-a, IL-6, and IL-12), increased 
regulatory cytokines (eg, IL-10), and increased natural killer cell 
activity in smokers.55,59 Only one study in humans investigated me-
tabolites of the tryptophan pathway but did not find any significant 
change by probiotics.52 Many of the human studies looked at bowel 
function, and they did find reduced difficulties in bowel movement, 
IBS severity, and symptoms in patients.54,56,58,60 Microbiota analysis 
helped to confirm that fecal microbiota were altered by probiotic in-
tervention: Lactobacillus was increased and Clostridium decreased 
by L. plantarum, whereas Bifidobacteria and Lactobacillus were 
increased by L. casei Shirota.51,60 More details are shown in Table 2.
Summarizing all the studies in animals and humans that fo-
cused on CNS functions, including psychiatry conditions (anxiety 
and depression) and memory abilities, Bifidobacterium and Lac-
tobacillus were the probiotics used most frequently. Doses ranged 
from 107 to 4 × 1010 CFU per day and most studies used 109 and 
1010 CFU in animals and 3 × 109 CFU in humans. The duration 
of intake ranged from 1 week to 6 months with the most frequent 
durations of 2 weeks in animals and 4 weeks in humans.
Discussion  
The number of studies using probiotics to improve central ner-
vous system function has increased over the past 10 years, though 
with a focus on effects in animals. Researchers have used various 
strains of probiotics and studied various CNS functions. Summa-
rizing the divergent findings motivated us to perform a systematic 
review of this research area. Previously, there was no systematic 
review or meta-analysis of the effects of probiotics on CNS function 
in animals and humans. To date, there are a few reviews on probi-
otic effects on infantile colic, which may reflect peripheral nervous 
system action, and one recent study reviewing only human stud-
ies.64-66 Similarly, among the 56 RCTs so far which tested probiotics 
in adults with IBS that have or have not shown effects on peripheral 
(bowel) functions,15 none have investigated whether any CNS effect 
was affected or improved. We identified studies applying probiotics 
as single- or multiple-strain preparations in animals and humans. 
Because of the diversity of the interventions and the CNS functions 
tested in these studies, we did not perform a meta-analysis.
Effects of Probiotics
Combining all the studies in animals and humans, probiotics 
appear to have a positive effect in improving central nervous system 
function. However, a publication bias toward positive results can-
not be excluded. Based on currently available studies, we can see 
that most of the studies used Bifidobacterium and Lactobacillus 
preparations, and most of them were effective in improving specific 
CNS functions. Again, however, negative results in relation to other 
functions may have been unreported, even in otherwise positive 
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studies. Doses of 109 and 1010 CFU have been used in most stud-
ies showing an effect on behaviors. An intake of the probiotic for 2 
weeks in animals and 4 weeks in humans is apparently sufficient to 
elicit measurable effects.
B. longum, B. breve, B. infantis, L. helveticus, L. rhamnosus, 
L. plantarum, and L. casei were the most commonly used prepara-
tions in these studies, as single- or multi-strain preparations, all of 
which were able to improve anxiety, depression, and memory re-
lated behaviors, based on animal models. All of these probiotics are 
regarded as “good” bacteria, presumably inhibiting the growth of 
harmful bacteria or pathogens and/or improving the immune sys-
tem.67-69 These probiotics were also found to reduce the symptoms 
of gastrointestinal disease, such as irritable bowel syndrome.15,16,58,70 
Probiotics may play an important role in gut-brain axis communica-
tion, thereby benefiting both the brain and the gut. 
While some studies found no significant effect of probiotic 
intervention, the evidence is inadequate to conclude that the in-
terventions were ineffective because some difficulties and/or weak 
points exist. For example, schizophrenia as a severe mental illness, 
and being closely related to a genetic disposition, may be a case in 
which probiotics can hardly be expected to have a significant effect 
on changing symptoms.54 Probiotic doses in some studies were be-
low the supposed effective dosages (at least 109 CFU), such as 108 
CFU in the study in rheumatoid arthritis patients and 106, 5 × 107, 
and 108 CFU in IBS patients.55-58 Also, in two studies, one in male 
smokers and one in children with ASD, the intervention periods 
were 3 weeks, shorter than the effective period, which seems to be 4 
weeks, that can make a measurable effect.59,60 
Also, caution is warranted when drawing conclusions from the 
human studies that used psychological questionnaires and/or scales 
rather than behavioral or neuropsychological experiments, resulting 
in subjective biases. The clinical efficacy of probiotic interventions 
and guidelines for their administration in diseases such as diarrhea, 
allergies, IBS, and inflammatory bowel disease has been addressed 
in previous reviews.15,71,72 More studies investigating probiotic ef-
fects in mental disorders are needed.
Mechanisms of Action of Probiotic Effects
The current state-of-the-art suggests several mechanisms: the 
endocrine system, immune system, action of enteric neurons, and 
commensal bacteria (or their metabolic activity). This evidence has 
come primarily from preclinical studies, while a few clinical stud-
ies have analyzed cortisol and cytokine levels in saliva and plasma. 
The HPA axis activity has been linked closely to mood disorders 
and memory abilities.73,74 Many probiotics reduced HPA axis ac-
tivity by decreasing CORT and/or ACTH levels, including most 
of the Lactobacillus strains tested: L. plantarum, L. helveticus, L. 
fermentum, L. rhamnosus, and L. casei.19,22,29,36,39,43,44,49 However, 
single strains of Bifidobacterium such as B. infantis, B. longum, 
and B. breve had no effect on CORT levels.27,29,36 BDNF is the key 
for neurogenesis and synaptic plasticity, which structurally support 
CNS function.75,76 Lactobacillus (L. plantarum, L. helveticus, L. 
fermentum), Bifidobacterium (B. longum), and C. butyricum in-
creased brain BDNF.34,37,43,46 Neuronal activation can be indicated 
by the nuclear localization of c-Fos; the effect of c Fos in the CNS 
depends on its location. The combination of L. rhamnosus + L. 
helveticus improved c Fos expression in the hippocampus and 
improved memory ability, while L. casei decreased it in the para-
ventricular nucleus of hypothalamus region and alleviated stress re-
sponses.45,50 Neurotransmitters 5-HT, DA, and GABA are closely 
related to psychiatric conditions, and were influenced directly by 
many strains of probiotic (L. plantarum, L. helveticus, L. fermen-
tum, L. rhamnosus, and B. infantis). The vagus nerve has been 
proposed as a pathway of probiotic effects because neurochemical 
and behavioral changes due to L. rhamnosus and B. longum were 
not seen in vagotomized animals. Direct evidence for the role of 
the vagus nerve also comes from studies showing that gastric vagal 
afferent activity was enhanced by L. casei. The excitability of the 
enteric nervous system, which is connected to the vagus nerve, has 
been shown to be modulated by B. longum.22
Probiotics also alter CNS function indirectly through several 
other pathways. L. helveticus, B. infantis, and B. fragilis enhanced 
serum tryptophan (precursor of 5-HT) levels and reduced its me-
tabolites. Most of the probiotics tested affected the immune system 
by decreasing pro-inflammatory cytokines and increasing anti-
inflammatory cytokines. Another important pathway through which 
probiotics may modulate CNS function is intestinal barrier perme-
ability, which is essential for maintaining the immune and nervous 
systems. Increased intestinal barrier permeability is associated with 
psychiatric disorders, such as depression and autism, while it can be 
restored by probiotic formulations of B. longum and L. helveticus, 
along with improved CNS function.31,41,77
According to the data reviewed, different probiotics exhibited 
several common effects; however, these effects were strain-depen-
dent and occurred via different pathways at a lower level of the 
CNS. Thus, more studies are needed for clarify which probiotics 
target which central biochemical substances and behaviors. In clini-
cal applications, interventions with a probiotics cocktail may have 
greater effects, because different probiotics may create their effects 
at the same time through different pathways. However, as yet, such 
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an approach currently lacks clinical evidence.15
Translation of Animal Studies
There are many animal studies about the gut microbiome-brain 
interaction using germ-free, specific pathogen free (SPF), or gno-
tobiotic animals, colonization with specific microbiota, probiotic in-
take, and infections to deliberately alter the GM and to manipulate 
CNS function.9,29,30,35,37,45,78-82 In humans, we are not able to adapt 
most of these models for ethical reasons. Ten of the animal studies 
included in our review used probiotics in animals whose health state 
had been disturbed by various manipulations, which included anti-
biotic treatment, gene knockout, inflammation, infection, maternal 
immune activation, hyperammonemia, and diabetic induction, and 
depression induced by myocardial infarction. All of the manipula-
tions were aimed at inducing changes in CNS function, including 
anxiety and depression-like behavior, memory impairment, or 
ASD-like behaviors. In humans, interfering with the participants’ 
healthy state is not an option. What is possible is to explore the GM 
composition, correlating it to certain behaviors, and using probiot-
ics to manipulate the GM-brain interaction. It is also possible to 
temporarily affect single functions, such as the stress response at the 
central level or the GM composition by varying the food or drugs 
used. As yet, evidence from studies using probiotics is confined to 
animal studies. Validity estimates of probiotic intervention from hu-
man studies are still missing and thus need to be carried out. 
The translation of behavioral models from animals to humans 
has both possibilities and limitations. The tests used to measure 
anxiety in animals, such as the elevate plus/Barnes maze, light/
dark box, defensive burying, open field/arms, and step-down, 
have no equivalents in humans, and neither do tests such as the 
forced swim and maternal separation for inducing depression and 
negative mood. In human studies, measurements of anxiety and 
depression rely primarily on scales such as the HADS, which has 
accuracy issues due to subjectivity and emotional bias from the 
participants/patients. Moreover, it remains questionable whether 
the behavioral tests used in animals do, in fact, adequately reflect the 
assumed CNS dysfunction (anxiety, depression) in humans and, 
more specifically, in patients. This leads to a demand for appropriate 
behavioral tests of anxiety and depression not only for patients with 
psychiatric disorders but also for the healthy population, and for 
adequate behavioral measures in animals that match these functions 
and dysfunctions in humans.
In addition to behavioral measurements, neuroimaging meth-
ods may provide insights as to what is altered in the brain that 
causes behavioral changes after the consumption of probiotics. An 
emotional faces attention task used in the fMRI study of Tillisch 
et al63 is one example: the brain response to emotional stimuli that 
may be related to psychiatric conditions was changed after a 4-week 
intake of probiotics. 
Learning and memory abilities can be tested via numerous 
paradigms in humans. For spatial memory, there are computerized 
versions of the Morris water maze (VMWT) and the Blue Velvet 
Arena (BVA), which is also a variant of the Morris water maze for 
humans.83-86 For non-spatial memory, object recognition tasks and 
fear conditioning have been used widely in humans. These memory 
tasks can be conducted in combination with neuroimaging experi-
ments, such as fMRI and magnetoencephalography (MEG) ex-
periments.
There are also several ways to experimentally induce stress in 
humans. The Trier Social Stress Test, developed 20 years ago, dur-
ing which participants are asked to play a role in a job interview, or 
in performing a public speech, can effectively increase the HPA 
axis and sympathetic-adrenal-medullary activity.87 Social stress 
can also be induced using the Cyberball paradigm, during which 
stress comes from social exclusion and/or ostracism.88,89 Noise as a 
stressor is easy to manipulate in a laboratory environment by expos-
ing participants to unpleasant sounds so as to induce psychological 
stress. Cognitive tasks can also stimulate stress responses with the 
advantage of being able to study the stress level by measuring task 
performance.90 Other and more physical stressors include cold pres-
sor tasks,91 heat pain,92 and the CO2 challenge test, inducing stress/
panic in participants by inhaling carbon dioxide-enriched air.93 All 
of these have also been shown to be compatible with brain imaging 
studies.
Conclusions and Indications
We reviewed the effect of probiotics on the central nervous 
system in randomized controlled trials in animals and humans, 
and analyzed the possibility of translating animal models to human 
studies because few human studies have been conducted to date. 
According to the qualitative analyses of current studies, we can pro-
visionally draw the conclusion that B. longum, B. breve, B. infantis, 
L. helveticus, L. rhamnosus, L. plantarum, and L. casei were most 
effective in improving CNS function, including psychiatric disease-
associated functions (anxiety, depression, mood, stress response) and 
memory abilities. Doses between 109 and 1010 CFU and durations 
of 2 weeks in animals and 4 weeks in humans have shown sufficient 
effects. Also, translations of animal studies to human studies may 
be applicable. Human studies can be conducted using the same 
probiotics and similar experimental paradigms in the emotional and 
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neurocognitive domains. More experimental designs in humans 
should be developed, and more neuroimaging studies should be 
conducted rather than using only psychological questionnaires or 
scales. In addition to studies in healthy populations, clinical studies 
in patients with mental diseases would be worthwhile, because those 
with gastrointestinal disorders and psychiatric comorbidities, in 
general, appear to benefit from probiotic interventions.
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A B S T R A C T
Objectives: The Cyberball paradigm is often used to study social stress by exclusion/rejection. We aimed to
review the existing neuroimaging literatures in order to provide an overview of the neurophysiological
mechanisms of social exclusion.
Method: Literature search was conducted to identify neurophysiological studies that investigated effects of social
exclusion on neural activity using the Cyberball game and the relevant influential factors on these effects.
Results: In total, 42 studies using different neuroimaging methods were considered. Regions of the insula,
anterior cingulate cortex, temporal and prefrontal cortex were activated to social exclusion. These neural
activities were pronounced at latencies ranging from 200 to 400 ms, and between 400 and 900 ms. Influential
factors were identified and categorized as intrinsic and extrinsic factors.
Conclusion: An integrated framework describing neural activities under social exclusion in terms of both,
temporal and spatial processes is provided. Furthermore, the summary of influential intrinsic and extrinsic
factors may help us to understand the diversity of the processes and may guide clinical therapy of stress related
disorders.
1. Introduction
A peer relationship is very important in adolescence and adults.
Ostracism and rejection by peers or by significant ones cause social pain
(Eisenberger, 2012; Eisenberger et al., 2003). Chronic experience of the
social exclusion may also be regarded as a stressful situation, which
may lead to development of depression.
A number of studies have used a standardized paradigm called
‘Cyberball game’ to study ostracism (Williams and Jarvis, 2006). In this
game, participants believe that they are playing an online ball-tossing
game with two players, while these two players are actually pro-
grammed. Participants are socially rejected in the so called ‘exclusion
condition’, by receiving the ball only a few times and less often than the
other players. The ‘exclusion condition’ is always compared with the
‘inclusion condition’, during which participants receive the ball equally
often as the other players. This paradigm has been proven reliable and
valid to induce feelings of rejection in adults and adolescents
(Eisenberger et al., 2003; Williams and Jarvis, 2006). According to a
post-game questionnaire with a ‘Need Threat Scale’ and ‘Mood Scale’,
participants indicated lower levels of belonging, self-esteem, control
and meaningful existence, and also higher distress after completing the
exclusion block as compared to the inclusion block (Williams and
Jarvis, 2006; Zadro et al., 2004). A recent published meta-analysis of
Cyberball studies showed a fairly large average ostracism effect
(Hartgerink et al., 2015).
Technical development in neuroimaging methods allows research-
ers to investigate how the human brain responds to the exclusion
situation during its occurrence rather than after the game, and to
explore the mechanisms that underlie the subjective feelings reported
after the game. Studies using different methods such as functional
magnetic resonance imaging (fMRI) and electroencephalography (EEG)
have discovered widely distributed brain regions involved in social
exclusion versus inclusion. Regions such as cingulate cortex (the
anterior and posterior parts) and insula are activated, which are related
to affects and emotions (Bolling et al., 2011a; Masten et al., 2009).
Being excluded, these neural activations appear to represent negative
emotions of sadness and distress. The activation of the prefrontal cortex
(PFC) has been taken as index of attention control and emotion
regulation (Sebastian et al., 2011). As yet, one quantitative meta-
analysis aimed to explore if the pain matrix was activated by social
rejection during Cyberball, by analyzing 12 fMRI studies with a total of
244 participants (Cacioppo et al., 2013). However, the authors stated
http://dx.doi.org/10.1016/j.neubiorev.2017.05.012
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that the evidences from the included studies were not sufficient to reach
an unambiguous conclusion. While numbers of studies have provided
information about brain activations during social exclusion/rejection,
so far results have only been pooled partly, ignoring studies using EEG
to a large part. Although fMRI studies have given us a clear insight in
specific locations of functional brain regions, they have limitations in
measuring precisely the temporal sequence of when neural activations
occur.
Therefore, currently we conduct a scoping review on relevant
literatures that have conducted neuropsychological measurements such
as using fMRI and EEG to investigate the neuronal processes underlying
responses to social stress induced by the Cyberball game. Through
mapping included studies according to their methodologies and results,
we aim to identify a common spatio-temporal pattern of neural
activations related to social exclusion and to analyze influential factors
modulating neural activations.
2. Method
The current scoping review was guided by the methodological
framework proposed by Arksey and O’Malley (2005). The framework
outlines a five-stages approach that includes identifying the research
question; searching for relevant studies; selecting studies; charting data;
and collating, summarizing, and reporting the results.
2.1. Identifying the research questions (stage 1)
We focused on following main research questions in our scoping
review: How were the neural activities of social exclusion measured in
currently existing literatures? What are the common features of the
neural activities across studies? Which factors influence these neural
activations?
2.2. Identifying relevant studies (stage 2)
Relevant studies were found by a search in the PUBMED databases.
Articles from 1950 to April 2016 were initially identified using the
search string “Cyberball”. We only included articles written in English.
The first search was undertaken by analyzing titles, abstracts, and the
key words describing the articles, to identify studies that met our
inclusion criteria. A second search was conducted using citations from
all identified reports and relevant review articles.
2.3. Selection of studies (stage 3)
Search results were screened on the basis of the titles and abstracts
before full texts were assessed. The abstracts of the retrieved papers were
screened for matching the following criteria: (1) the study included
participants aged from adolescents to adults; (2) participants can be in
different health status such as healthy control (HC), autism spectrum
disorder (ASD) and borderline personality disorder (BPD), etc.; (3) the
study used methods recording functional brain activity, including fMRI,
positron emission tomography (PET), transcranial magnetic stimulation
(TMS), magnetoencephalography (MEG), EEG, etc.; (4) the study mea-
sured neural responses during the Cyberball game and compared a social
rejection/exclusion condition (exclusion block and/or exclusive throw)
with an inclusion condition (inclusion block and/or inclusive throw).
Those that only analyzed effects of factors on neural response to social
exclusion without comparing exclusion with inclusion conditions were
not included in our study. All studies that did not meet our criteria were
regarded as irrelevant studies.
2.4. Charting data (stage 4)
The following data of the eligible articles were extracted for
assessment: first author, year of publication, country focus, type of
measurement method, population characteristics, experimental com-
parisons, and the primary outcomes measures of interests.
2.5. Collating, summarizing, and reporting results (stage 5)
We synthesized the data according our predefined research ques-
tions. The study characteristics were summarized and shown according
to country, study method (fMRI/EEG/TMS), study design (within/
between-subject design), and experimental comparison. Then, main
features of each study results were summarized for each study method
respectively.
3. Result
3.1. Study selection and characteristics
The literature search yielded an initial total of 123 citations, 4 of
which were identified through other sources. After a first screen of the
titles and abstracts of these articles, 52 studies were considered eligible
for our review, after excluding 71 studies only had behavioral
measurement. The full versions of these articles were reviewed and
10 studies were excluded due to absence of a comparison of neural
responses between conditions of exclusion and inclusion. In total, 42
studies remained for data analysis (Fig. 1).
Table 1 illustrates main characterizes of the included studies.
Among these studies, neural recording methods focused on EEG
(n= 13) (Catassi et al., 2013; Cristofori et al., 2015; Crowley et al.,
2009, 2010; Gutz et al., 2011, 2015; Kawamoto et al., 2013; McPartland
et al., 2011; Sreekrishnan et al., 2014; Themanson et al., 2013; van
Noordt et al., 2015; Weschke and Niedeggen, 2013, 2015), fMRI
(n= 28) (Bolling et al., 2011a, 2011b, 2011c, 2015; Bonenberger
et al., 2015; Cascio et al., 2015; Cristofori et al., 2015; Domsalla et al.,
2014; Eisenberger et al., 2003, 2007a, 2007b; Gonzalez et al., 2015;
Luo et al., 2016; Masten et al., 2011a, 2011b, 2011c; Maurage et al.,
2012; Moor et al., 2012; Nishiyama et al., 2015; Onoda et al., 2010;
Preller et al., 2016; Puetz et al., 2014; Rudolph et al., 2016; Sebastian
et al., 2011; van Harmelen et al., 2014; Will et al., 2015, 2016;
Wudarczyk et al., 2015), and rTMS (n= 1) (Fitzgibbon et al., 2016)
in these studies. Nearly half of the studies were conducted in the USA,
Fig. 1. PRISMA scheme of retrieved literature.
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and 40.5% of the studies from Europe. Only 3 studies were conducted in
Asia and 1 in Australia. Over half (54.8%) of the experiments used a
within subject design, to only study the effects of social exclusion. The
other 45.2% of the experiments used a between subject design, to
explore factors on neural activations of social exclusion. These 19
between-subject studies investigated intrinsic factors such as genes
(n= 3) (μ-opioid receptor (OPRM1), the serotonin transporter promo-
ter receptor (5-HTTLPR), and Monoamine Oxidase A (MAOA)), diseases
(n= 6) (social anxiety disorder (SAD), autism spectrum disorder
(ASD), borderline personality disorder (BPD), and alcohol-dependence
(AD)), psychological states (n= 1) (self-esteem) and development
(n= 2), and extrinsic factors of life experience (n= 4) (chronic
rejection, early life separation, victimization, and childhood emotional
maltreatment) and interventions (n= 3) (chemical anxiety cue, the
serotonin 2A/1A receptor (5-HT 2A/1A) stimulation, TMS).
To observe effects of social exclusion, different experimental
comparisons were made. All EEG studies compared exclusion to
inclusion between trials: five studies compared trials in which the
other two players played with each other during exclusion with
inclusion blocks, which were labeled as ‘exclusion’ and ‘not my run’
respectively; one study compared trials in which the participant threw
the ball to either of the other players during inclusion block with trials
in which the other players threw to each other during exclusion block;
three studies compared trials in which the other players threw to the
participant, with trials in which they did not throw to the participant in
all blocks; four studies compared trials in which the other players
received the ball with trials in which the participant received it. Most of
(25/28) the MRI studies compared blocks of inclusion with exclusion,
and only 3 of them compared between trials in each condition.
Among the included EEG studies, 10 studies examined neural
activity with event-related potential (ERP) analysis comparing social
exclusion with inclusion (Crowley et al., 2009, 2010; Gutz et al., 2011,
2015; Kawamoto et al., 2013; McPartland et al., 2011; Sreekrishnan
et al., 2014; Themanson et al., 2013; Weschke and Niedeggen, 2013,
2015), 1 of which also applied source analyses to estimate neural
generators of the ERPs (Crowley et al., 2010). Also, 4 studies used time-
frequency analyses to investigate neural oscillations under social
exclusion compared to inclusion (Cristofori et al., 2013, 2015;
Kawamoto et al., 2013; van Noordt et al., 2015). Among the fMRI
studies, all of them carried out whole-brain analyses in contrast of
social exclusion versus inclusion. In addition, 16 studies defined several
region of interest (ROI) analyses to address region-specific hypotheses:
ACC, MCC, insula, PFC, OFC, STG, IFG, MFG, hippocampus (Bolling
et al., 2011a, 2011b, 2011c, 2015; Cascio et al., 2015; Luo et al., 2016;
Masten et al., 2011a, 2011b; Moor et al., 2012; Nishiyama et al., 2015;
Preller et al., 2016; Rudolph et al., 2016; van Harmelen et al., 2014;
Will et al., 2015, 2016; Wudarczyk et al., 2015).
3.2. Neural activities of social exclusion
Data collected from the included studies were capable to support us
to build a conceptual framework, which provided temporal information
of when and what neural processes occurred and spatial information of
which brain regions were activated.
3.2.1. EEG studies
EEG studies have observed different event-related potentials (ERPs)
and neural oscillations that were pronounced during the exclusion
condition compared to inclusion. These neural indexes were summar-
ized according to different stages. The total sample size among all EEG
studies for each neural index was calculated (Table 2). An early stage
ranging from 200 to 300 ms was identified as frontal P2 and frontal and
parietal N2 (McPartland et al., 2011; Sreekrishnan et al., 2014;
Themanson et al., 2013; Weschke and Niedeggen, 2013). However, in
patients with ASD the frontal P2 was attenuated (McPartland et al.,
2011). Occipital-parietal P3 indexed early stage effects ranging from
300 to 400 ms (Crowley et al., 2010; Gutz et al., 2011, 2015; Kawamoto
et al., 2013; McPartland et al., 2011; Themanson et al., 2013; Weschke
and Niedeggen, 2013, 2015). For this marker, patients with BPD
revealed pronounced activity even during the inclusion condition
(Crowley et al., 2010; Gutz et al., 2015; Kawamoto et al., 2013). Late
stage effects ranging from 400 to 900 ms were indexed by the late slow
wave (LSW) in frontal and occipital-parietal cortex (Crowley et al.,
2009, 2010; McPartland et al., 2011; Sreekrishnan et al., 2014).
Exclusion-related changes in neural oscillations revealed alpha power
increase in frontal cortex and theta power increase in insula, subACC
and fusiform face area (FFA) as compared to the inclusion condition
(Catassi et al., 2013; Cristofori et al., 2015; Kawamoto et al., 2013; van
Noordt et al., 2015).
3.2.2. fMRI studies
Twenty-eight fMRI studies have found various brain regions acti-
vated during social exclusion and variability among different popula-
tions. Sample size through all studies for each of the main areas
identified was calculated and the corresponding influential factors that
were suggested to modulate the neural response due to social exclusion
were also summarized (Table 3).
The cingulate cortex was mostly reported: 24 out of 28 studies
found the anterior cingulate cortex (ACC) activation (24/28) (ventral,
dorsal and subgenual) (Bolling et al., 2011a, 2011b, 2011c, 2015;
Bonenberger et al., 2015; Eisenberger et al., 2003, 2007b; Gonzalez
et al., 2015; Luo et al., 2016; Masten et al., 2009, 2011a, 2011b, 2011c;
Maurage et al., 2012; Nishiyama et al., 2015; Onoda et al., 2010; Preller
et al., 2016; Puetz et al., 2014; Rudolph et al., 2016; Sebastian et al.,
2011; van Harmelen et al., 2014; Will et al., 2015, 2016; Wudarczyk
et al., 2015), and 6 of them found the posterior cingulate cortex (PCC)
activations (Bolling et al., 2011a, 2011b, 2011c, 2015; Maurage et al.,
2012; Preller et al., 2016). ACC activation was affected by several
factors: people with different MAOA gene polymorphisms showed
different levels of ACC activation; adolescents with ASD showed more
pronounced ACC activation than HC; early life separation lowered ACC
activation compared to normally developed individuals; chronic rejec-
Table 2
Convergent results from the EEG studies.
Stage Neural index (Ref.) Sample size Influential factor
Early stage (200–300 ms) Frontal P2 (Sreekrishnan et al., 2014; McPartland et al., 2011) 96 ASD
Frontal-central and parietal N2 (Themanson et al., 2013; Weschke and Niedeggen, 2013) 55
Early stage (300–400 ms) Occipital-parietal P3 (Crowley et al., 2010; Themanson et al., 2013; Gutz et al., 2011, 2015; Weschke and
Niedeggen, 2013, 2015; Kawamoto et al., 2013)
232 BPD
Late stage (400–900 ms) Frontal and occipital-parietal LSW (Crowley et al., 2009, 2010; Sreekrishnan et al., 2014; McPartland et al., 2011) 157 Na.
Whole time window (0–2 s) Frontal alpha wave (van Noordt et al., 2015; Kawamoto et al., 2013) 52 Na.
Insula, subACC, and FFA theta wave (van Noordt et al., 2015; Cristofori et al., 2013, 2015) 63 Na.
Abbreviations: P2 (known as the P200), a positive waveform component that peaks at about 200 ms after the stimulus onset; N2 (N200), is a negative-going wave that peaks at 200–350 ms
post-stimulus; P3 (P300), a positive-going wave with a latency of 250–500 ms; LSW (late slow wave), a component with peak latency at 400–900 ms; alpha wave, neural oscillations in the
frequency range of 8–15 Hz; theta wave, neural oscillations in the frequency range of 4–7 Hz; ASD, autism spectrum disorder; BPD, borderline personality disorder.
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tion enhanced ACC activation; people with lower trait self-esteem had
higher ACC activation; pharmacological stimulation with 5-HT 2A/1A
receptor agonist decreased ACC activation (Eisenberger et al., 2007b;
Masten et al., 2011a; Onoda et al., 2010; Preller et al., 2016; Puetz
et al., 2014; Will et al., 2016).
Over half of the fMRI studies (18/28) localized PFC during the
exclusion condition, including anterior, ventral medial, dorsal medial,
and ventrolateral PFC (Bolling et al., 2011a, 2011b, 2011c, 2015;
Cristofori et al., 2015; Eisenberger et al., 2003; Gonzalez et al., 2015;
Luo et al., 2016; Masten et al., 2011a, 2011b, 2011c; Maurage et al.,
2012; Onoda et al., 2010; Puetz et al., 2014; Sebastian et al., 2011; van
Harmelen et al., 2014; Will et al., 2015, 2016). PFC activation was also
affected by different factors. Gene polymorphisms of 5-HTTLPR influ-
enced the level of activation; HC with lower self-esteem showed
increased PFC activation; alcohol-dependent individuals and people
with early life separation had decreased PFC activation (Luo et al.,
2016; Masten et al., 2011a; Maurage et al., 2012; Onoda et al., 2010;
Puetz et al., 2014).
Insula (the anterior and posterior) activation was observed in 17
studies (Bolling et al., 2011a, 2011b, 2011c, 2015; Bonenberger et al.,
2015; Cristofori et al., 2015; Domsalla et al., 2014; Eisenberger et al.,
2003; Luo et al., 2016; Masten et al., 2011a, 2011c; Maurage et al.,
2012; Moor et al., 2012; Nishiyama et al., 2015; Onoda et al., 2010;
Puetz et al., 2014; Rudolph et al., 2016). Insula activation was
increased in ASD patients, alcohol-dependent and low self-esteemed
individuals, while decreased in those with early life separation (Masten
et al., 2011a; Maurage et al., 2012; Onoda et al., 2010; Puetz et al.,
2014). The temporal lobe (inferior/middle/superior temporal gyrus,
superior temporal sulci) (6/28) was activated by social exclusion as
well (Bolling et al., 2011a, 2011b, 2011c, 2015; Luo et al., 2016;
Maurage et al., 2012), and its activation was inhibited under chemo-
sensory anxiety cues (Wudarczyk et al., 2015).
Seven studies have analyzed functional connectivity between the
activated brain regions during social exclusion (Bolling et al., 2011a,
2011b, 2011c; Luo et al., 2016; Maurage et al., 2012; Onoda et al.,
2010; Puetz et al., 2014). Most of these studies (5/7) found connectivity
between ACC and PFC (Bolling et al., 2011a, 2011c; Maurage et al.,
2012; Onoda et al., 2010; Puetz et al., 2014). This ACC-PFC connectiv-
ity was reduced in alcohol-dependent individuals (Maurage et al.,
2012), and also, but higher, in people with high self-esteem (Maurage
et al., 2012; Onoda et al., 2010). Other areas connected to ACC were
middle temporal gyrus (MTG), the right interior parietal lobule (IPL),
precuneus, and temporoparietal junction (Bolling et al., 2011a; Puetz
et al., 2014). Connectivity between dorsal and rostral ACC was also
observed, but differentiated between people with different 5-HTTLPR
genotypes (Luo et al., 2016). There was also increased connectivity
between the right insula and the paracentral lobule for exclusion as
compared to inclusion (Bolling et al., 2011b).
3.2.3. TMS study
One recent study applied – in healthy adults – low-frequency rTMS
(1 Hz) at the vlPFC, which has been found activated during exclusion in
other studies (Fitzgibbon et al., 2016). However, there was no effect of
rTMS on subjective scores rating social exclusion, except for a positive
correlation between greater aversive impact scores to social exclusion
with personal distress in the rTMS group.
4. Discussion
To our knowledge, this review is the first approach summarizing all
of the current brain imaging data of social exclusion induced by the
Cyberball game, besides one systematic review which had only
included fMRI studies (Cacioppo et al., 2013), and one recent narrative
review, which provided a summary of neural processes during social
exclusion in their theoretical framework considering rather few studies
(Kawamoto et al., 2015). In their framework, they described neural
processes during social exclusion as intrapersonal processes, which
included detection, appraisal and regulation. ERP N2 and dACC
activations were assumed to be involved in the detection processes,
P3 and activities of dACC and AI were related to appraisal, and frontal
slow wave and vlPFC activation corresponded to regulation processes.
In our review, we have focused on neural activity during social
exclusion, which is defined as intrapersonal processes by Kawamoto
et al. (2015). We here provide a modified framework by analyzing
currently existing neuroimaging studies utilizing the Cyberball para-
digm, and summarize influential factors of the neural processes. In our
framework, we propose two stages of neural processing of exclusion
related information (Fig. 2). The temporal dynamics has been defined
based on results from the EEG studies: early stage neural processing are
indexed by P2, N2 and P3 and reflect modulation of attention, emotion,
arousal and appraisal. Later stage activities, indexed by slow waves
lasting from 400 ms to 900 ms, are regarded as cognitive processes of
emotion regulation. Due to lack of a fair spatial resolution of EEG
technique, the corresponding localizations of the neural processes in
each stage were identified by analyzing the results from the included
fMRI studies in addition to summarizing the results from EEG studies.
Also, we have summarized the influential factors that appeared to alter
the neural response to the social exclusion, consisting of intrinsic and
Table 3
Convergent results from the fMRI studies.
Main brain regions (Ref.) Total sample size Influential factor
ACC (Masten et al., 2009, 2011a, 2011b, 2011c; Bolling et al., 2011a, 2011b, 2011c, 2015; Rudolph et al., 2016; Eisenberger et al.,
2003, 2007b; Gonzalez et al., 2015; Puetz et al., 2014; Will et al., 2015, 2016; van Harmelen et al., 2014; Maurage et al., 2012;
Bonenberger et al., 2015; Wudarczyk et al., 2015; Preller et al., 2016; Sebastian et al., 2011; Nishiyama et al., 2015; Onoda
et al., 2010; Luo et al., 2016)
749 MAOA
ASD
ELS
Chronic rejection
Self-esteem
5-HT 2A/1A stimulation
PCC (Bolling et al., 2011a, 2011b, 2011c, 2015; Maurage et al., 2012; Preller et al., 2016) 128 Na.
PFC (Masten et al., 2009, 2011a, 2011b, 2011c; Bolling et al., 2011a, 2011b, 2011c, 2015; Eisenberger et al., 2003; Gonzalez et al.,
2015; Puetz et al., 2014; Will et al., 2015, 2016; van Harmelen et al., 2014; Maurage et al., 2012; Sebastian et al., 2011; Onoda
et al., 2010; Luo et al., 2016)
548 5-HTTLPR
ASD
AD
Early life separation
Self-esteem
Insula (Masten et al., 2009, 2011a, 2011c; Bolling et al., 2011a, 2011b, 2011c, 2015; Rudolph et al., 2016; Eisenberger et al., 2003;
Moor et al., 2012; Puetz et al., 2014; Domsalla et al., 2014; Maurage et al., 2012; Bonenberger et al., 2015; Nishiyama et al.,
2015; Onoda et al., 2010; Luo et al., 2016)
487 ASD
AD
Early life separation
Self-esteem
Temporal lobe (Bolling et al., 2011a, 2011b, 2011c, 2015; Maurage et al., 2012; Luo et al., 2016) 149 Na.
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extrinsic factors. These factors have been integrated into our frame-
work, indicating their effects on different neural processes.
As the results from the EEG studies, the frontal P2 is more
pronounced during social exclusion. P2 indicates perception and
processing of salient stimuli, for which attention is needed (Key et al.,
2005; Luck and Hillyard, 1994; Sreekrishnan et al., 2014). At the same
time, frontal-parietal N2 reflects neural alarm activation for conflict
monitoring, in response to the exclusion event (Themanson et al., 2013;
Weschke and Niedeggen, 2013). Also, the frontal theta activity in the
200–400 ms time range may reflect behavioral conflict and/or violation
of expectation to receive the ball and realization of not receiving it
(Cavanagh et al., 2013; van Noordt et al., 2015). In the early stage
interval from 300 to 400 ms, negative emotions are induced by the
exclusion event, followed by appraisal of the event. The P3 complex is
enhanced during social exclusion, with P3a and P3b indicating
differential neural processes. P3a (the first part of the P3 complex) is
related to negative mood induced by ostracism (Gutz et al., 2011;
Weschke and Niedeggen, 2013). P3a indicates the contributions of the
ACC and posterior insula, which may correspond to the fMRI studies
showing the ACC activations related to emotion and PI related to a
more visceral pain response to social exclusion (Bolling et al., 2011b;
Craig, 2009; Gutz et al., 2011; Polich, 2007; Volpe et al., 2007;
Weschke and Niedeggen, 2015). The ventral part of ACC reflects a
primary emotional reaction to exclusion, which is innate and sponta-
neous (Bolling et al., 2011c; Gonzalez et al., 2015; Somerville et al.,
2006). Some studies have stated that dACC reflects a secondary and
more cognitive process, which is associated with conflict monitoring,
emotional awareness, and reward-based decision making (Bolling et al.,
2011c; Cascio et al., 2015; Gonzalez et al., 2015; Jarcho et al., 2011;
McRae et al., 2008; Somerville et al., 2006; van Veen et al., 2009;
Weissman et al., 2003). Greater activity in subACC, mostly described as
a neural marker or predictor of depression, reflects higher negative
emotions induced by the exclusion event, since it is connected to other
limbic structures (Brody et al., 1999; Cascio et al., 2015; Greicius et al.,
2007; Haas et al., 2007; Keedwell et al., 2009; Masten et al., 2011b;
Sebastian et al., 2011). P3b indexes stimulus evaluation and categor-
ization started, which is presumed to be a posterior network, including
the temporal cortex and PCC (Bledowski et al., 2004; Gutz et al., 2011;
Weschke and Niedeggen, 2013, 2015; Wronka et al., 2012).
Cognitive processes of affect-regulation occur after 400 ms, and are
regarded as a late stage of neural processing (Sreekrishnan et al., 2014).
According to the EEG studies, the late positive slow wave (400–900 ms)
reflects emotional regulation (Crowley et al., 2009; Kross et al., 2011;
Ochsner et al., 2004; Phan et al., 2005). The negative slow wave in
frontal cortex reflects engagement of evaluative processes, when
anticipating various arousing stimuli (Baas et al., 2002; Crowley
et al., 2010). The frontal theta modulation at later processing stage is
closely linked to distress and anxiety, much like the frontal slow-wave
activity reported in other studies. It is suggested that the frontal theta
activity is related to higher and more stable levels of anxiety and
neurochemical changes in dopaminergic systems (Cavanagh and
Shackman, 2015; Themanson et al., 2013), and enhanced in persons
with a history of depression during processing of negative valence
outcomes (Cavanagh et al., 2011). Data from the fMRI studies allow us
to localize the sub-regions of the frontal cortex to be involved in the late
stage. Several studies have revealed that the vlPFC is activated during
social exclusion and negatively correlates with activities in the insula
and subACC, reflecting a function of emotion regulation (Eisenberger
et al., 2003; Gonzalez et al., 2015; Lorenz et al., 2003; Luo et al., 2016;
Masten et al., 2009). The rTMS study has also reported an effect of brain
stimulation at vlPFC on negative behavioral outcome of social exclu-
sion, which however, depends on individual traits (Fitzgibbon et al.,
2016). The mPFC is also involved, suggested to respond during self-
evaluation triggered by social exclusion (Kelley et al., 2002; Macrae
et al., 2004), and to regulate negative affect via connections with ACC
and amygdala (Buckholtz et al., 2008; Sebastian et al., 2011). Addi-
tionally, differing from the posterior insula, the anterior insula has
functions of subjective awareness and cognitive control, because of
connectivity to the middle and dorsal ACC (Bolling et al., 2011b; Cascio
et al., 2015; Craig, 2009; Deen et al., 2011; Dosenbach et al., 2007).
4.1. Functional connectivity
Functional connectivity has been found between main activated
regions during social exclusion, indicating a network of brain regions
involved in processing social exclusion and stress (Fig. 3).
Enhanced connectivity between PFC (mPFC and vlPFC) and ACC
(vACC and dACC) is supposed to be involved in regulating intra- and
inter-individual functioning (Bolling et al., 2011a; Onoda et al., 2010).
This frontal-cingulate connectivity is negative (increase of frontal
activity accompanies with decreased cingulate activity), as frontal
activity is associated with regulation and inhibition of negative mood,
by disrupting ACC activity (Maurage et al., 2012; Onoda et al., 2010).
Positive frontal-cingulate functional activity in individuals with low
self-esteem and alcohol dependence reveals a failure on the part of the
PFC to suppress ACC functioning (Puetz et al., 2014).
Fig. 2. Key processing during social exclusion and corresponding brain regions.
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A larger network in response to social exclusion is the connectivity
of vACC to mPFC, IPL and precuneus – three regions from the central
components of the default mode network (DMN) (Buckner et al., 2008).
This connectivity could result from engagement of reflective processing
during social exclusion, when the participants are no longer playing the
game and might begin to question the motives of other players, or to
ruminate generally on the situation (Bolling et al., 2011c). Therefore,
this pattern might come up during the later stage and be inversely
related to emotional processing since participants start to become
disengaged. The connectivity between vACC and DMN during rest has
been found stronger in people with depression compared to controls,
highlighting a potential relationship between vACC-DMN connectivity,
negative emotion, and rumination (Greicius et al., 2007).
4.2. Influential factors
The studies with between-subject designs have addressed factors
that influence neural activity of social exclusion among populations. We
summarized these factors as two categories: the intrinsic factors of
gene, disease (disorder), psychological state and development; and the
extrinsic factors of life experience and interventions. The impacts of
these factors were analyzed and integrated in our framework of neural
processes of social exclusion.
Neural process of attention and perception in the early stage was
influenced by the ASD. Children with ASD had decreased engagement
of attentional resources to social cues, indexed by a reduced amplitude
of P2 for rejecting events (Dawson et al., 2004; McPartland et al.,
2011).
In the following, emotions arousal and event appraisal in the early
stage were affected by many intrinsic and extrinsic factors. The
influential intrinsic factors include psychiatric disorders, psychological
trait and also genes. Children with ASD had attenuated vACC activity
suggesting a hypo emotion arousal due to social exclusion (Bolling
et al., 2011b). In contrast, patients with BPD had pronounced parietal
P3b ERPs which however were not distinctive between inclusion and
exclusion condition, suggesting negative perception of even inclusion-
ary event in this group (Gutz et al., 2015). People with low self-esteem
showed higher activation in the ventral and dorsal parts of ACC than
those with higher self-esteem suggesting higher emotion arousal and
deeper evaluation in the former group (Onoda et al., 2010). Genetically,
Single-Nucleotide Polymorphisms (SNPs) of MAOA gene, which en-
codes Monoamine Oxidase was influential to the dACC activation to the
social exclusion (Eisenberger et al., 2007b).
Extrinsic factors of previous life experience and drug interventions
influenced appraisal of social exclusion by altering activations of the
dACC. Children with chronic rejection and early life separation all felt
more distress due to exclusion compared to controls, but with differ-
ential dACC activities – higher in chronically rejected and decreased in
early life separation (Puetz et al., 2014; Will et al., 2016). Chronic
rejection and early life separation are both, life stress and a cause of
alterations in neural processes of social exclusion in later life, and may
increase the risk for developing mental disorders such as depression and
anxiety. Further studies need to clarify the function of dACC during
social exclusion. Intervention of the 5-HT 2A/1A receptor stimulation
reduced the distress induced by the social exclusion and modulated the
neural processes by decreasing the dACC activation (Preller et al.,
2016). Other studies also have shown that Acetaminophen reduced the
dACC and AI activations, and the 3,4-methylenedioxymethampheta-
mine alleviated perception of social exclusion by reducing participants’
subjective report of negative mood (Dewall et al., 2010; Frye et al.,
2014). Evidences of drug interventions influencing effects of social
stress may guide clinical therapy of stress-related disorders, such as
depression and anxiety, etc.
The late stage of the neural processes is essential since it regulates
the negative emotion induced during the early stage. Ontogenetic
development helps people to acquire strategies to regulate negative
emotion induced by social stress, indicated by higher activation of
vlPFC in adults compared to adolescents (Sebastian et al., 2011).
Patients with ASD have difficulties in making critical distinctions based
on social context at late processing stages, as indexed by the absence of
differential late slow wave (McPartland et al., 2011). Alcohol-depen-
dent individuals had decreased vPFC and the middle frontal gyrus
activities, indicating an impaired regulation of the exclusion feeling
(Maurage et al., 2012). People with low self-esteem also showed higher
activation in the PFC, indicated more emotion regulation which might
have been induced by higher early processes of the emotional arousal
and appraisal (Onoda et al., 2010). Differential activation of the PFC
among individuals with different SNPs of (5-HTTLPR), which is
involved in many mental conditions such as alcoholism, depression
and obsessive-compulsive disorder, suggested a neural mechanism of 5-
HTTLPR on the social cognition (Luo et al., 2016). Reduced activation
of PFC in children with early life stress suggested an negative effect of
previous rejection experience on processing and deficient regulation of
the negative affect during the current exclusion event (Puetz et al.,
2014).
5. Conclusion
A host of studies have applied the Cyberball paradigm to induce
neural responses to social exclusion/rejection and addressed the neural
signature of it. Despite sparse interpretations of the results, converging
data have pointed out the main brain areas of the neural activations,
and according to a systematic analysis, time frames of the activities can
be identified. Relevant influential factors have been also investigated
and categorized as intrinsic and extrinsic factors in our study. However,
several aspects in this topic are still missing and remain to be clarified.
On one hand, specific functions of sub regions in each activated
region are controversial, for example the dorsal ACC. Most of the
studies suggested the dACC was related to a more cognitive process as
concluded in our study (Jarcho et al., 2011; McRae et al., 2008;
Somerville et al., 2006; van Veen et al., 2009; Weissman et al., 2003),
while others argued that dACC activation was related to social
exclusion perception and associated affective distress, acting as com-
plementary processes of a neural alarm system (Eisenberger et al.,
2003; Maurage et al., 2012). This controversy also exists in subgenual
ACC, which is mostly associated negative emotion, however, it was
found positively related to vPFC activity and suggested to be important
in regulating negative affect (Masten et al., 2009).
On the other hand, supplement of the theoretical framework of the
neural processes under social exclusion is needed. Our theoretical frame
was based on a systematic review of both EEG and fMRI studies,
however, this still needs to be finally testified by experimental studies.
For instance, the neural processes of perception and attention has been
defined as happening from 200 to 300 ms with indexes of P2 and N2,
Fig. 3. Main functional connectivity during social exclusion.
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but the corresponding localizations are rather obscure due to limitation
of a fairly spatial resolution of EEG and temporal resolution of fMRI.
Therefore, an improvement of both high temporal and spatial resolu-
tion of neural activity of the social exclusion is needed and may be able
to be achieved by technique of a combined fMRI-EEG and/or MEG.
In sum, we have reviewed a multitude of brain data on social
exclusion/rejection induced by the Cyberball paradigm. Through map-
ping the studies using fMRI and EEG, we have integrated the results into
a theoretical framework of neural processes during this social stress,
including the influential factors as well. We hope this review could
guide further studies in this topic to help the understanding of the social
exclusion more comprehensively. Exploring the potential influential
factors may also benefit development of psychological and clinical
therapy for those suffer from stress-related disorders.
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8. Study III. Effects of rifaximin on central responses to social stress – a 
pilot experiment (under review) 
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Abstract  
Background & Aims: Probiotics that promote the gut microbiota have been reported to 
reduce stress responses, and improve memory and mood. Whether and how antibiotics that 
eliminate or inhibit pathogenic and commensal gut bacteria, also affect central nervous 
system functions in humans is so far unknown.  
Methods: In a double-blinded randomised study, 16 healthy volunteers (27.00±1.60 years; 
nine males) received either rifaximin (600mg/day) (a poorly absorbable antibiotic) or placebo 
for 7 days. Before and after the drug intervention, brain activities during rest and during a 
social stressor inducing feelings of exclusion (Cyberball game) were measured using 
magnetoencephalography (MEG). 
Results: Social exclusion significantly affected (p<0.001) mood and increased exclusion 
perception. MEG showed brain regions with higher activations during exclusion as compared 
to inclusion, in different frequency bands. Seven days of rifaximin increased prefrontal and 
right cingulate alpha power during resting state. Low beta power showed an interaction of 
intervention (rifaximin, placebo) x condition (inclusion, exclusion) during the Cyberball 
game in bilateral prefrontal and left anterior cingulate cortex. Only in the rifaximin group, a 
decrease (p=0.004) in power was seen comparing exclusion to inclusion; the reduced beta-1 
power was negatively correlated with a change in the subjective exclusion perception score. 
Conclusion: Social stress affecting brain functioning in a specific manner, is modulated by 
rifaximin. Contrary to our hypothesis that antibiotics have advert effects on mood, the 
antibiotic exhibited stress-reducing effects similar to reported effects of probiotics (Supported 
by NeuroGUT, a EU 7th Framework Programme ITN no. 607652; ClinicalTrials.gov 
identifier number NCT02793193).  
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1 Introduction 
The gut-brain axis is essential for communication between the enteric nervous system 
(ENS) and central nervous system (CNS) functions. The commensal gut microbiota therefore, 
may play an important role on this axis through neural, immune and endocrine pathways. 
Previous studies have found altered gut microbiota (GM) composition not only to affect ENS 
functions (1), but can also change CNS functions in animals and humans (2-4). Among the 
most frequently investigated CNS functions are social functions, learning and memory 
functions, and stress responsiveness in animals, yet few data are available in humans (5-8). 
While many tools are available to manipulate the microbiota in animals (germ-free or 
specifically colonized animals, antibiotic elimination of the microbiota, fecal microbiota 
tranfer between animals and from humans to animals, etc.) (9-12), few allow similar 
approaches in humans. As we have recently summarized (13), probiotics (and to a lesser 
degree prebiotics) have been used to affect CNS functions in animals and humans, with a 
variety of different bacterial strains but predominantly Lactobacillus and Bifidobacterium.  
While some of these were available as nutrient supplements even before their 
therapeutic benefit became evident, others have been developed specifically for the purpose 
to act as therapeutic agents in intestinal (e.g. irritable bowel syndrome, IBS; inflammatory 
bowel diseases, IBD) and extra-intestinal disorders (atopy, diabetes). More recently, 
disturbed CNS functions e.g. of neurological (autism spectrum disorder, ASD) or psychiatric 
nature (mood disorders) have come into focus (14-16), and first studies have evaluated the 
effects of probiotics on related CNS functions in healthy volunteers, while studies in 
respective patient populations are still scarce (17).
  63 
The mechanisms by which probiotics affect central functions are incompletely 
understood, but include - among others - direct effects on the commensal gut microbiota (via 
increased diversity and/or competitive colonization), enhancement of their metabolic 
functions, or stimulation of the enteric neural or immune system, all of which could directly 
or indirectly stimulate the gut-brain axis and elicit such central effects. 
Despite its wide use in every-day medicine, antibiotics have rarely been investigated 
for their effects on central functions, presumably for two reasons: their use in healthy subjects 
is limited by their ability to induce antibiotic resistance that may be detrimental in case 
antibiotics are needed for treatment of acute bacterial infections; and patients that are in need 
for antibiotics are suffering from acute infections, and any central effect seen may as well be 
a consequence of the acute disease rather than antibiotics-induced CNS consequences of 
manipulating the gut microbiota. While antibiotics-induced peripheral consequences, e.g. 
diarrhea and irritable bowel syndrome-type symptoms are well established, long-term CNS 
consequences of antibiotic use have not been investigated so far. 
Rifaximin is a locally (intestinally) acting broad-band antibiotic with poor 
bioavailability (<1% systemic absorption), thus with minimal risk for provoking antibiotic 
resistance (18). This specific property allows its use both in healthy volunteers as well as in 
patients without severe infection, e.g. in traveler’s diarrhea (19). A few trials have shown 
clinical efficacy in IBS (20, 21) and in small intestinal bacterial overgrowth (22, 23), but here 
the mechanism of action is less unclear.  
Most animal work of "psychobiotics" relate to their effects on standardized stress 
paradigms, specifically social stressors such as open-field (14) maternal separation (24), and 
defensive burying test (14, 25). In search for a stress paradigm that would allow the testing of 
social stress with neuroimaging methods in humans, we have identified the "Cyberball game" 
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(CBG), which is an virtual game that is often used to study social stress by 
exclusion/rejection (26). Different from other human stress tasks, such as the Trier Social 
Stress test (27), the CBG can be employed easily in a brain scanner, thus allowing direct 
evaluation of associated neurobiological processes, to compensate for the lack of direct 
physiological stress-markers in human research, as compared to animal studies. 
During this CBG, participants play a computer-simulated ball tossing game with two 
players whose behaviors are programmed. Participants feel distressed during the period when 
the other players barely throw a ball to him/her - a so-called exclusion or rejection 
(ostracism) condition, compared to the condition when all three players have the same chance 
to receive and throw the ball. In addition to the subjective reports of distress during the 
exclusion condition, studies also showed physiological changes such as raised cortisol level, 
higher skin conductance, and increased facial temperature (28-33).  
Various experimental set-ups of the CBG tests have been used in the past. A 
systematics review of neuroimaging studies summarized these setups and showed its 
reliability to induce social stress in healthy volunteers (34). Accordingly, regions of the 
insula, anterior cingulate cortex (ACC), temporal and prefrontal cortex (PFC) were activated 
to social exclusion (35-37). Neural oscillations are thought to play a key role in processing 
neural information, and different types of oscillatory activities are being studied for their 
functions. Exclusion-induced changes in neural oscillations such as alpha and theta frequency 
bands have also been reported in these areas (38-40).   
In order to investigate the involvement of brain areas and their modulation by 
rifaximin, magnetoencephalography (MEG), as a functional neuroimaging technique with 
fine spatial resolution and high temporal resolution was used to study the effects of CBG 
(41). In order to test the efficacy of MEG identifying neural response to the social stressor, 
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and the potential antibiotic effect of rifaximin on the stress effect, we conducted an 
exploratory experiment in healthy volunteers with a short-term (7 days) intake of rifaximin. 
Because of a putative antibiotic effect of rifaximin on the commensal microbiota, we 
hypothesized that rifaximin would, in contrast to known probiotic effects on CNS functions 
(13), increase the stress response following social exclusion. 
 
2 Materials and Method 
2.1 Participants 
Sixteen volunteers participated in the study. All participants met our inclusion criteria: 
1) non-smoker for at least 3 months, 2) with a body mass index of 18-30, 3) without any 
chronic allergies, 4) willing to discontinue the consumption of probiotic and prebiotic-
containing foods or potentially immune-enhancing dietary supplements, 5) receiving no 
immune-suppressing intervention and not having any immunosuppressive illness within the 
last year, 6) receiving no antibiotic therapy within the last 2 months, 7) having no psychiatric 
or gastrointestinal disorder, 8) having no non-removable metal parts in the body. Informed 
consent was obtained from all participants prior to joining the study. The protocol has been 
approved by the Ethics Board of the University of Tübingen Medical School (No. 
503/2015BO1, approved on 26.08.2015), and registered at ClinicalTrials.gov (identifier 
number NCT02793193).  
2.2 Study design 
Our pilot study was a randomized, double-blinded, and parallel-group design, in 
which the participants visited our laboratory twice for MEG measurements: at baseline and 
one day after the end of drug intake. The intervention and the control group took the 
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antibiotic rifaximin (3 x 200mg/d) or placebo pills, respectively for 7 days; drugs and 
placebos were provided by the university hospital pharmacy. The randomization scheme was 
unblinded after completion of the experiment and the data evaluation. 
During the intervention period, participants were instructed to avoid the consumption 
of food containing probiotics/prebiotics, or potentially immune-enhancing dietary 
supplements. This was supported by providing them with a list of "prohibited" foods 
(Appendix 1). 
2.3 Questionnaires 
To survey participants’ health status, the 36-item short-form health survey (SF-36) 
was used (42). The SF-36 includes eight concepts: physical functioning, bodily pain, role 
limitations due to physical health problems, role limitations due to personal or emotional 
problems, emotional well-being, social functioning, energy/fatigue, and general health 
perceptions. Participants were asked to finish the SF-36 during each of the two visits. 
After each of the inclusion and exclusion blocks (see below), participants needed to 
complete two questionnaires to assess their acute level of distress. We employed the self-
report measures of the Need Threat Scale (NTS), Mood questionnaire (MQ) and the 
subjective ‘exclusion perception’ (SEP) on a scale rating between 1-5  (Appendix 2); all 
these scales are validated standard for the CBG (26, 43). The NTS was designed to measure 
the feelings and emotional consequences of social rejection and higher scores related to 
higher distress level. Its four items comprised self-esteem, belonging, meaningful existence 
and control, and combined ratings have been used as a measure of social distress in previous 
studies. The MQ was used to assess mood, using questions (are you feeling bad/good, 
happy/sad, pleasant/angry, and friendly/unfriendly). The SEP was to record participants’ 
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feeling of being included/ostracized by asking them to rate two statements (‘I was ignored’ and 
‘I was excluded’).                                                                                          
 
2.4 Cyberball game   
In the CBG, the participants were asked to play a ball tossing game with two other 
virtual players programmed by the experimenter. They were made believe that the two 
players were real and were playing the game. To minimize gender effects, male participants 
played with 2 female players, and female participants played with 2 male players. During the 
game, the other players were depicted as cartoon characters with their photos aside and 
names below. The volunteering participant was represented by a cartoon in the middle lower 
part of the screen and could throw the ball to either of the other two players on the left or 
right, by pressing the left or right button on the response box (Figure 1). 
The CBG consisted of 4 blocks: inclusion - exclusion - inclusion – exclusion 
conditions; this order was maintained for all volunteers. In each inclusion blocks, there were 
108 trials, during 1/3 (36 trials) of which the participant received the ball from the other 
players (for another 1/3 the ball was played to one of the other players, and for the other 1/3 
between the other two players). The order of the ball throwing to the participant was pseudo-
randomized. The 1/3 of trials in the inclusion block when the virtual players threw the ball to 
each other and not to the participant, were called "not my turn" events.  
To equalize the numbers of analyzed trials when the virtual players threw the ball to 
each other and not to the participant, we set 47 total trials in each exclusion block. The 
participants received the ball 3 times (trials 14, 25 or 26, and 39 or 40 or 41 in block 2 and 4, 
respectively) to maintain their attention. The first 5 exclusion trials, the 3 trials of the 
participant receiving the ball, and the 3 trials of participant throwing the ball were not 
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analyzed but discarded. The remaining 36 so-called "rejection" events were used for 
comparison with the 36 "not my turn" events in the inclusion block. Visual stimuli of these 
trials did not differ in two conditions, so any difference of brain activities was supposed to be 
due to the participants’ inner state. The trial began with the ball being presented in the 
cartoon for 500-2000 ms randomly to imitate a real life situation. Then the ball was moving 
for 2000 ms before reaching the target player (Figure 1). After each of the inclusion and 
exclusion blocks, participants completed the Need Threat Scale, the Mood Questionnaire, and 
the exclusion perception question. 
Figure 1. Example of a trial in the Cyberball game. 
 
2.5 Magnetoencephalography recording 
Brain magnetic fields were measured with a 275-channel whole-head 
magnetoencephalograph. Participants were studied in supine position. During each recording 
session, 5 minutes resting state was recorded prior to recording while playing the CBG. 
During the resting state, participants were instructed to move as little as possible and to be 
awake, while keeping their eyes closed. During the CBG, task instructions were projected 
onto a screen in front of the participants via a video projector and a mirror system. 
Participants were asked to fixate the screen and hold a response box to get ready for the task. 
Participants were also instructed to move as little as possible. MEG signals were sampled at a 
rate of 585.94 Hz with an anti-aliasing filter set to 292.97 Hz. 
In order to overlay the brain activity derived from MEG on anatomical scans, high-
resolution (1 mm, isotropic) T1-weighted structural MR images were acquired using an 
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MPRAGE sequence with a 3-T MR scanner (University Hospital Tübingen, Germany) for 
each participant, but at a separate occasion. 
 
2.6 Data analysis 
2.6.1 Data analysis: questionnaires 
To test the intervention-related changes in participants’ health status scored by SF-36, 
changes from before to after the 7-days intervention were computed by subtracting the 
baseline assessment from the corresponding post-intervention values. To control the 
intervention-related changes on the NTS, the MQ and SEP during the CBG, changes after 
each intervention were computed for each condition. 
Data were analyzed using SPSS 21 (IBM, Armonk, NY, USA). Changes in SF-36 
were entered into a two-independent-sample Mann-Whitney U test of intervention (rifaximin 
vs. placebo), as this data was not normally distributed. The changes in NTS, MQ and SEP 
were entered in a 2 x 2 ANOVA of intervention as a between-subject factor (rifaximin vs. 
placebo) x condition as a within-subject factor (exclusion vs. inclusion). Where significant 
main effects or interaction were observed, pairwise comparisons were used to assess each 
time point with a Bonferroni adjusted threshold (α = 0.025).  
2.6.2 Data analysis: MEG data 
Preprocessing  
Analysis of the MEG data was carried out using Matlab (Mathworks, Natick, USA) 
and the open-source toolboxes Fieldtrip (44). The resting state dataset were cut into time 
windows of 2s. Data in this time window were filtered using a 4Hz high pass frequency filter. 
Non-physiological jumps in the MEG signal and trials with jump and muscle artifacts were 
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excluded by an automatic rejection algorithm. Any trial in each channel whose variance 
exceeded 10-25 T2 were excluded from further analysis. The continuously recorded dataset of 
the CBG was segmented with respect to stimulus onset (when one player threw the ball) and 
baseline adjusted using a [-1000: 2000] ms trial interval. Trials in which the other players 
threw the ball towards each other during the inclusion blocks were defined as ‘inclusion’ 
condition, and those during exclusion blocks were defined as ‘exclusion’ conditions.  
Time-frequency analysis  
The time-frequency analysis used the multitaper windowed fast fourier transform 
‘MTMFFT’ implemented in Fieldtrip. The 'multitaper method' (MTM) is based on Slepian 
sequences as tapers. The frequency of interest ranged from 4 to 30Hz with step of 2 Hz and 
the smoothing window is +/-3 Hz: 
Source analysis  
Using the time-frequency determined by the analysis described above, oscillatory 
sources of theta, alpha, beta-1, beta-2 and beta-3 bands (6, 11, 16, 21, and 26 Hz) were 
localized using beamformer techniques. We applied the Dynamical Imaging of Coherent 
Sources (DICS) method (45). In order to estimate the individual source activity, each 
participant’s brain recorded as T1-MR image was divided in a regular three dimensional grid 
with a 1 cm resolution and a spatial inverse filter was computed from both conditions and 
both visits, as common filter. Then we applied this common filter to each condition and each 
visit separately in order to obtain the respective source power. The MEG data in each 
condition was coregistrated with the individual structural MR images respectively. 
Source statistics  
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For testing effects of stress induced by the CBG, the source power in each frequency 
band from all the participants at the baseline visit were entered in a paired-samples T-test 
comparing exclusion with inclusion condition. For analyzing the effect of rifaximin, we 
performed source-level statistics for the data obtained from the resting-state condition and the 
CBG, respectively. For resting-state, changes in the source power in each frequency band 
was computed by subtracting the baseline from the post-intervention. The changes of the 
source power were entered into an independent T-test with intervention (rifaximin vs. 
placebo) as between factor. For the CBG, changes in the source power were computed by 
subtracting the baseline from the post-intervention in each condition in each frequency band. 
Changes of source power were entered in a two-way ANOVA of interventions (rifaximin vs. 
placebo) x conditions (exclusion vs. inclusion). The statistical analysis was done separately 
for each frequency band. To localize significant activations, the cluster-based permutation 
method for multiple comparisons (corrected) was used with a significance level of alpha of 
0.05. 
2.6.3 Correlation between behavioral and MEG data 
To correlate the neural activity and subjective stress reports, for each condition source 
power in the clusters that differed significantly between conditions during the first visit was 
averaged. The averaged source power was correlated with the scores of NTS, MQ and SEP 
for each condition separately, using Pearson correlations. These correlations were considered 
significant at a corrected threshold of p < .05. 
To correlate the change in neural activity with change in the subjective reports by 
rifaximin, correlations were done for the resting state task and the CBG, respectively. For the 
resting state task, averaged source power was calculated for clusters that differed 
significantly between both visits. The averaged source power was correlated with changes in 
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health status, for each group separately. For the CBG, for each condition and each 
intervention, source power in the clusters that differed significantly between both visits was 
averaged. The averaged source power was correlated with changes in the scores of NTS, MQ 
and SEP in each condition and each group, using Pearson correlations. These correlations 
were considered significant at a corrected threshold of p < .05. 
3. Results  
Sixteen healthy participants met the inclusion criteria of the study and completed the 
experiment (9 males; age: 27.00 ± 1.60 years age; BMI: 22.21 ± 0.48). Eight participants 
completed the intervention with rifaximin (6 males, age: 26.50 ± 1.05; BMI: 22.48 ± 0.58) 
and eight with placebo (3 males, mean age: 27.50 ± 3.12; BMI: 21.94 ± 0.81).  
3.1 Stress effect by the Cyberball game  
There was a significant difference between inclusion and exclusion in the global score 
of the NTS (t15 = 5.06, p < 0.001). In the exclusion condition, participants reported higher 
scores of the global NTS score. The score of the MQ is significantly lower in the exclusion 
condition compared to inclusion condition (t15 = -5.40, p < 0.001). Also, in the SEP 
participants revealed a significantly higher score of exclusion perception (t15 = 13.64, p < 
0.001). 
Source statistics of MEG power in each frequency band showed brain regions that had 
significantly higher activations during the exclusion compared to the inclusion condition 
(Figure 2): in the theta frequency band (6 Hz), the left fusiform gyrus, the right inferior and 
superior parietal lobule, the right thalamus and the left middle occipital gyrus (p = 0.008); in 
the alpha frequency band (11 Hz), the bilateral posterior cingulate gyrus, the bilateral inferior 
and superior parietal lobule, the left hippocampus and parahippocampal gyrus and the left 
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fusiform gyrus (p = 0.002); in the beta 1 frequency band (16 Hz), the bilateral inferior and 
middle temporal lobule, the bilateral fusiform gyrus, the bilateral hippocampus, the left 
inferior and middle occipital cortex (p = 0.01); in the beta 2 frequency band (21 Hz), the right 
cingulate gyrus, the bilateral fusiform gyrus, the bilateral hippocampus, the left occipital 
cortex, the right parahippocampal gyrus (p = 0.008); in the beta 3 frequency band (26 Hz), 
the left posterior cingulate gyrus, the bilateral fusiform gyrus, the bilateral hippocampus and 
parahippocampal gyrus, the bilateral inferior, middle, superior temporal lobule, and the 
bilateral thalamus (p = 0.01).  
Figure 2 
 
To investigate whether the neural activity during the CBG was correlated to the 
subjective report of the social stress, we correlated the averaged power changes in each 
cluster for each frequency band and scores of NTS, MQ and SEP. No significant correlation 
was found.  
3.2 Intervention effect by rifaximin  
3.2.1 Physical and psychological health status 
Comparing the scores of the questionnaires between the rifaximin and the placebo 
group at baseline, no group differences were found for any score of the SF36-item survey. 
After intervention, only the difference in “Emotional well-being”, a sub-item of the SF36-
item survey, was significant between groups (U = 11, p = 0.02). There was a significantly 
higher increase of “Emotional well-being” in the rifaximin group (Median = 11.13) than the 
placebo group (Median = 5.88).  
3.2.2 Effects of Rifaximin on resting-state MEG 
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We tested the effects of the intervention on the source power in each frequency band 
during resting state. An independent T-test showed a significant cluster of increased power in 
the alpha band (11 Hz) in the right superior and inferior frontal cortex, the bilateral middle 
cingulate gyrus extending to the left insula in rifaximin group as compared to the placebo 
group (Figure 3, p = 0.05). 
Figure 3 
 
3.2.3 Resting-state and health status 
To investigate whether the increase of neural activity during resting-state was 
correlated to the participants’ health state, we correlated the averaged power changes in the 
significantly activated cluster with the changes in SF-36 scores. However, no correlation was 
found, neither across both groups nor within each group.  
3.2.4 Rifaximin effect on neural response to the Cyberball game  
To test effects of interventions and conditions on the neural response to the CBG, a 
two-way ANOVA test was carried out. No significant main effect of Intervention or 
Condition was found. Only in beta-1 band (16H), a significant interaction of Interventions 
and Conditions was found in the left inferior and superior and the bilateral middle frontal 
cortex, and the left anterior cingulate gyrus (Figure 4; p < 0.05). As a post hoc analysis, we 
compared brain activity changes between two conditions (exclusion vs. inclusions) for each 
intervention group separately. Only in the rifaximin group, a decrease in beta-1 power, in the 
bilteral inferior, supperior and middle frontal cortex, the bilateral anterior, middle and 
posterior cingulate gyrus, the bilateral parietal and postcentral cortex, could be demonstrated 
for exclusion as compared to inclusion (Figure 5; p = 0.002). A summary of frequency bands 
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and neuroanatomical areas found to be related with social stress, rifaximin intervention and 
their interaction is provided (Table 1). 
 Figure 4, Figure 5 
Table 1 
 
3.2.5 Neural activity and subjective report of the social exclusion  
A correlation between neural activity change and subjective report changes of social 
exclusion was tested only in case of a significant difference of neural activity changes 
between intervention groups. Therefore, we only tested correlations between neural activity 
changes in the cluster with changes of the subjective report of NTS, MQ and SEP for each 
condition during the CBG, respectively. Only in the rifaximin group, a significant correlation 
was obtained between SEP score changes and beta-1 power changes (Figure 6; r = 0.86, p = 
0.006) 
Figure 6 
 
4 Discussion  
Using MEG, we observed an effect of stress, induced by the CBG, on the neural 
oscillations in different frequency bands and at distributed brain areas. Daily intervention of 
600 mg rifaximin for one week significantly increased the frontal and cingulate alpha power 
during resting state, and decreased prefrontal and cingulate low beta power during social 
exclusion compared to inclusion. These neural changes were only observed in the group that 
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consumed rifaximin, indicating that one-week intervention of rifaximin did have effects on 
CNS functions in healthy volunteers.  
4.1 Stress effect 
Numerous studies have used fMRI and electroencephalogram (EEG) to measure 
neural response to the CBG, while our study is the first one using MEG that has found that 
social exclusion produced larger neural oscillatory activities in various frequency bands in 
certain brain areas. The fusiform facial area was more activated in all the frequency bands 
from theta, alpha to beta waves. This finding is consistent with previous studies, suggesting 
an enhanced processing of the other players’ faces and learning of the social value of their 
faces according to the unpleasant/negative social exclusive event. Activations of the parietal 
area were found in low frequency band – theta and alpha waves, and temporal activations in 
beta bands. In a recent scoping review of neuroimaging data of CBG, the summarized key 
neural processing of social exclusion pointed out that parietal activity was involved in an 
early stage process including perception and attention (34). Hereby, we may suggest that 
theta and alpha oscillations play a crucial role in perception and attention of the exclusion 
event. Temporal activations in beta bands may reflect an emotional arousal and event 
appraisal processes (35, 46). Interestingly, in addition to the cingulate gyrus which has been 
reported by many previous studies, we have also obtained significant activations of 
hippocampus and parahippocampal gyrus in alpha and beta bands, indicating stronger 
memory consolidation and retrial during the social exclusion.  
Our results reveal different neural oscillations as compared to previous studies that 
mainly showed increased power in theta band in the frontal cortex, insula, subgenual ACC 
during exclusion as compared to the inclusion condition (38-40, 47). Absence of frontal areas 
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and insula activation in response to the social exclusion may be due to the limited sample size 
of the current trial, and needs further investigation.  
4.2 Rifaximin effect  
Rifaximin has been approved for the use in humans to treat acute and chronic 
gastrointestinal infections and disorders. However, few studies have been done to investigate 
its role in the gut-brain axis, while probiotics have been more commonly addressed for its 
positive effects on both, gut and brain functions (13, 48-50). Therefore, it is worthwhile to 
conduct clinical research to test the influence of rifaximin on the brain according to its safety 
and efficiency on preventing traveler diarrhea and treating gastrointestinal disorders (51).  So 
far, there are only few studies that have investigated the central effect of rifaximin. Several 
cognition functions, including working memory in patients with liver cirrhosis, have been 
reported to improve with rifaximin (52, 53). In the study by Ahluwalia et al., eight-week 
intake of rifaximin enhanced working memory and inhibitory control with altered brain 
activities in patients with liver cirrhosis (52). Despite the lack of a placebo control group in 
this study, the patients showed raised activations of subcortical regions (e.g. thalamus, 
caudate insula and hippocampus) and operculum, and enhanced functional connectivity 
between these regions during the working memory task; and decrease in frontal-parietal 
activations during the inhibitory control task. The author suggested the central effects of 
rifaximin to be mediated by the gut-liver-brain axis by modulating gut bacteria, serum 
bilirubin and systemic endotoxemia. 
While previous studies have found central effects of rifaximin only in patients, any 
improvement in well-being might be mediated by the alleviation of symptoms of the disease 
from which patients were suffering. Our study is the first one exploring direct effects of 
rifaximin on the CNS in healthy individuals. Our preliminary results showed that rifaximin 
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increased volunteers’ emotional well-being and alpha oscillation in the frontal and cingulate 
cortex during the resting state. When experiencing social stress during CBG, the rifaximin 
group had a decrease of low beta power in the prefrontal cortex and the anterior cingulate 
cortex after intervention period.  
From our results, one could conclude that rifaximin is beneficial in improving mental 
health by relieving stress, both, in resting conditions and in stressful situations. Finding that 
volunteers taking rifaximin became less nervous, calmer and happier after the intervention (as 
is reflected by the respective SF36 items), an improvement of emotional well-being was 
achieved. Larger frontal and cingulate alpha power that was observed for the rifaximin group 
during resting-EEG has often been observed when participants were more relaxed, e.g. as 
effect of music therapy leading to reduced anxiety levels (54, 55).  
During socially stressful situations as induced by the exclusion condition in the CBG, 
a decreased frontal and cingulate low beta power was found for rifaximin group. Also, beta-1 
band power reduction was negatively correlated to the change of SEP after rifaximin 
intervention, showing that as the participants perceived more exclusion, there was higher 
reduction of the beta-1 power in the PFC and ACC. Frontal beta power has been reported to 
occur in mental fatigue and appears negatively related to mental stress level (56). In a study 
investigating central effects of the phosphatidylserine supplement, which can decrease 
perceived stress and improve mood, a reduced frontal beta-1 power by phosphatidylserine 
after an induction of stress has been reported (57). In that study, the author suggested the 
decreased beta-1 power at the frontal region was associated with a more relaxed state. 
Similarly, a moderate massage also decreased the beta activity in the brain as well as 
participants’ stress level (58, 59). As activations in the PFC and ACC have been reported 
involved in emotion regulation during social exclusion (34, 46), the reduced beta-1 power 
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band in these areas may be related to higher demands for emotion regulation of the perceived 
exclusion as well as to reduce mental stress.  
Additional evidences can be provided by two fMRI studies investigating alteration of 
neural processes of emotional stimuli by probiotics intervention. One study using fermented 
milk product with probiotic, reported a brain activity shift from arousal-based resting-state 
network to a regulatory network, and reduced neural activities in affective and viscerosensory 
cortices to emotional stimuli after 4 weeks’ intervention (60). A recent study in IBS patients 
showed Bifidobaterium longum NCC3001 also reduced neural responses in amygdala and 
fronto-limbic regions to fearful stimuli (17). Changed activations in amygdala and fronto-
limbic have indicated modulated hypothalamic-pituitary axis activity and emotion regulation 
due to the stimuli (61, 62). According to these convergent evidences, the reduced power in 
the frontal and cingulate regions in beta power found in our study may indicate less mental 
fatigue and a higher level of ongoing mental regulation during the stressful event. In 
summary, rifaximin may have effects of improving relaxation while reducing anxiety levels 
and stress responses by modulating central processing of emotion.  
Rifaximin is known because of its benefits in modulating the gastrointestinal 
functions and treating IBS.  Moreover, it has been shown that rifaximin is effective to prevent 
travelers’ diarrhea (51). Furthermore, rifaximin has been found in some studies to promote 
beneficial bacteria in the gut such as Bifidobacteria and Lactobacilli (63-65). Rifaximin 
induced changes of CNS functions might be mediated by rifaximin-induced altered gut GM 
composition or diversity that lead to changes of metabolites such as short-chain fatty acids 
and tryptophan, which in turn can influence the CNS (14, 66). Similar to probiotics, rifaximin 
influences immune system mucosal inflammation by reducing level of certain interleukins 
and tumor necrosis factor a (65). Thereby, the improved immune function could affect the 
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endocrine and nervous system (67). As yet, probiotics and not antibiotics, have been regarded 
as having positive effects on gastrointestinal and increasingly also on central functions by 
modulating the gut microbiota through the gut-brain axis. However, our findings indicate that, 
also certain antibiotics such as rifaximin may act on the CNS by modulating the GM in a 
similar way as probiotics.  
The present study had some limitations that need discussion. First, as a pilot study 
that explored whether modulation of GM might have any effect on CNS functions we did not 
collect stool samples for microbiome analysis, which could give more insight of the 
mechanism of action of rifaximin. Second, the stress response induced by the CBG was 
testified by subjective measures of distress, but neither physiological nor hormonal stress 
responses were measured and correlated with the neural responses. Third, no power 
calculation was performed because of the exploratory character of the trial, which was 
supposed to generate a hypothesis that was planned to be tested in a future study, but the 
serendipity of the finding motivated us to report it separately. For the same reason, no sex 
differences were expected on the pilot data. Additionally, the limited sample size may have 
concealed further behavioral and/or neural changes induced by the social stress and/or the 
rifaximin intervention. The present study provides evidence that it is worthwhile to compare 
effects of rifaximin and probiotics as well as their combination on central nervous system 
functions. Further research should in particular study the effect of rifaxmin comprehensively 
by correlating the microbiological, physiological, psychological, and neural responses due to 
stress and intervention effects.  
 
5 Conclusion  
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Using MEG we were able to identify a neural signature of social stress and its 
modulation due to rifaximin. Oscillatory neuromagnetic activity in different frequency bands 
and brain areas reflected aspects of neural processes during social exclusion. One-week of 
rifaximin intervention influenced the prefrontal and cingulate alpha oscillation in the resting 
state and the prefrontal and cingulate low beta oscillation as a response to social stress. To 
our knowledge, our study is the first one exploring the central effect of an antibiotic in 
healthy volunteers. Further studies investigating this effect in a larger population are expected 
to confirm these findings and might highlight even more subtle effects on brain activities and 
social well-being. Including peripheral physiological parameters in the study and testing 
patients with functional gastrointestinal disorders appear to be promising to elucidate the 
pathways and mechanisms how GM affects brain functions.  
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Table 1. Summarized frequency bands and neuroanatomical areas found to be 
associated with social stress, the application of rifaximin, and interaction of both. 
Comparison Frequency band Brain region Hemisphere P 
vale 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stress effect : 
Exclusion vs. 
 
 
6 Hz 
Fusiform gyrus Left  
 
0.008 
 
Inferior parietal lobule Right 
Superior parietal lobule Right 
Thalamus Right 
Middle occipital gyrus Left 
 
 
11 Hz 
Posterior cingulate gyrus Bilateral  
 
 
0.002 
 
Inferior parietal lobule Bilateral 
Superior parietal lobule Bilateral 
Hippocampus Left 
Parahippocampal gyrus Left 
Fusiform gyrus Left 
 
 
 
16Hz 
Inferior temporal cortex Bilateral  
 
 
0.01 
Middle temporal cortex Bilateral 
Fusiform cortex Bilateral 
Hippocampus Bilateral 
Inferior occipital cortex Left 
 
21 Hz 
Cingulate gyrus Right  
 
0.008 
Fusiform cortex Bilateral 
Hippocampus Bilateral 
Parahippocampal gyrus Right 
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inclusion Occipital cortex Left 
 
 
 
 
26 Hz 
Posterior cingulate gyrus Left  
 
 
 
 
0.01 
Fusiform gyrus Bilateral 
Hippocampus Bilateral 
Parahippocampal gyrus Bilateral 
Interior temporal lobule Bilateral 
Middle temporal lobule Bilateral 
Superior temporal lobule Bilateral 
Thalamus Bilateral 
 
Rifaximin 
effect on 
resting state: 
rifaximin vs. 
placebo 
 
 
11 Hz 
Inferior frontal gyrus Left  
 
0.05 
Middle frontal gyrus Left 
Superior frontal gyrus Bilateral 
Middle cingulate gyrus Right 
Insula Left 
Rifaximin 
effect * stress 
effect on the 
Cyberball 
game: 
(Rifaximin vs. 
placebo) * 
(exclusion vs. 
inclusion) 
 
 
 
16 Hz 
Inferior frontal gyrus Left  
 
 
0.05 
Superior frontal gyrus Left 
Middle frontal gyrus Middle 
Anterior cingulate gyrus Left 
 
  90 
Legend of figures 
Figure 1. Schematic outline of a trial in the Cyberball game. 
Figure 2. Activation in different frequency bands during exclusion vs. inclusion 
condition. A. Theta frequency band (6 Hz): the left fusiform gyrus, he right inferior and 
superior parietal lobule, the right thalamus and the left middle occipital gyrus (p = 0.008); B. 
Alpha frequency band (11 Hz): the bilateral posterior cingulate gyrus, the bilateral inferior 
and superior parietal lobule, the left hippocampus and parahippocampal gyrus and the left 
fusiform gyrus (p = 0.002); C. Beta 1 frequency band (16 Hz): the bilateral inferior and 
middle temporal lobule, the bilateral fusiform gyrus, the bilateral hippocampus, the left 
inferior and middle occipital cortex (p = 0.01); D. Beta 2 frequency band (21 Hz): the right 
cingulate gyrus, the bilateral fusiform gyrus, the bilateral hippocampus, the left occipital 
cortex, the right parahippocampal gyrus (p = 0.008); E. Beta 3 frequency band (26 Hz): the 
left posterior cingulate gyrus, the bilateral fusiform gyrus, the bilateral hippocampus and 
parahippocampal gyrus, the bilateral inferior, middle, superior temporal lobule, and the 
bilateral thalamus (p = 0.01). 
Figure 3. Difference of changed brain activity during resting-state comparing rifaximin 
vs. placebo. A cluster including the left inferior and middle frontal cortex, the bilateral 
superior frontal cortex, the right middle cingulate gyrus and the left insula showed 
significantly more increased power in alpha band (11 Hz), p < 0.05. 
Figure 4. Difference of neural activity change in 16 Hz during the Cyberball game by 
interaction of interventions and conditions effects. A cluster including the left inferior and 
superior and the bilateral middle frontal cortex, and the left anterior cingulate gyrus, showed 
a reduced neural activity change in beta-1 band (16 Hz) comparing exclusion vs. inclusion 
and rifaximin vs. placebo, p < 0.05. 
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Figure 5. Difference of neural activity change in 16 Hz during the Cyberball game 
comparing exclusion vs. inclusion conditions in the rifaximin group. Regions of the 
bilteral inferior, supperior and middle frontal cortex, the bilateral anterior, middle and 
posterior cingulate gyrus, the bilateral parietal and postcentral cortex, showed a reduced 
neural activity change in beta-1 band (16 Hz) comparing exclusion vs. inclusion conditions, p 
< 0.002. 
Figure 6. Correlation between change of neural activity with the change of SEP in the 
rifaximin group. Change of the averaged beta-1 band (16 Hz) power in the activated cluster 
during exclusion correlated negatively with the change of SEP (r = -0.86, p = 0.02, n = 8). 
Table 1. Summarized frequency bands and neuroanatomical areas found to be 
associated with social stress, the application of rifaximin, and interaction of both. 
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Figure 1 
 
 
Figure 2. 
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Figure 3. 
 
 
Figure 4. 
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Figure 5. 
 
 
Figure 6 
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Appendix 1. Probiotic/prebiotic containing food not to eat during intervention 
Probiotic richly containing food: 
Yogurt containing probiotics (eg. Dannon Activia, Yakult, or any other brands you know) 
Goat’s milk 
Soy milk 
Kefir 
Sauerkraut 
Pickles 
Kimchi 
Umeboshi plums 
Tempeh 
Dark chocolate 
Microalgae 
Natto 
Poi (kind of mashing cooked taro plant) 
Miso soup 
Kombucha Tea 
Prebiotic richly containing food: 
Raw Chicory root 
Raw Jerusalem artichoke 
Raw Dandelion greens 
Raw garlic 
Raw leek 
Raw onion  
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Appendix 2: Assessment of Need Threat Scale, Mood Questionnaire and Exclusion Perception. 
All items need to be rated on a scale from 1 ('not at all') to 5 ('very much'). (R) = reversed scored. 
Need 
Belonging: 
1. I felt disconnected with one or more players. 
2. I felt rejected by other players.    
3. I felt like an outsider.   
4. I felt belonged to the group. (R)                        
5. The other players interacted with me a lot. (R)                    
Self-esteem: 
6. I felt good about myself. (R)                                                                      
7. My self-esteem was high. (R)                                                        
8. I felt I was liked. (R)                                                                                  
9. I felt insecure.                                                                                   
10. I felt satisfied. (R)                                                                                 
Meaningful existence: 
11. I felt invisible.                                                                                   
12. I felt meaningless.                                                                            
13. I felt non-existent.                                                                                 
14. I felt important. (R)                                                                                 
15. I felt useful. (R)                                                                                        
Control: 
16. I felt powerful. (R)                                                                                    
17. I felt I had control over the course of the game. (R)                               
18. I felt I had the ability to significantly alter events. (R)                           
19. I felt I was unable to influence the actions of others.                              
20. I felt the other players decided everything.                                              
Mood 
During the game I felt: 
1. Good (R) 
2. Bad  
3. Happy (R)                                                                                                       
4. Sad                                                                                                      
5. Pleasant (R)                                                                                                   
6. Angry                                                                                             
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7. Friendly (R)                                                                                                  
8. Unfriendly 
 
Exclusion perception 
1. I was ignored.                                                                                             
2. I was excluded
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9. Study IV. Psychobiotic Bifidobacterium longum 1714 modulates brain 
activity of healthy volunteers during social stress (in preparation) 
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Abstract  
Background/aims: Probiotics have been described as “psychobiotics” with beneficial effects 
on mental status or health. Preclinical and clinical studies have found probiotics to reduce 
stress responses and associated behaviors, and to improve cognitive abilities. It has become 
increasingly interesting to use neuroimaging methods to identify where and how 
psychobiotics affect cortical activation. 
Methods: In a randomized, double-blinded, placebo-controlled trial, we studied effects of 
Bifidobacterium longum 1714 on neural responses to social stress, induced by the “Cyberball 
game”, a standardized social psychology stress paradigm. Forty healthy volunteers received 
either B.longum 1714 or placebo for four weeks. Their health status was assessed using the 
36-item short-form health survey (SF36), and brain activation during resting state and social 
stress using magnetoencephalography.  
Results: B. longum 1714 affected resting state neural oscillations with an increase in theta 
band in the frontal and cingulate cortex (p < 0.05) and a decrease in beta-3 band in the 
hippocampus, fusiform, and temporal cortex (p < 0.05), both of which were associated with 
subjective vitality changes, as measured by SF36. All groups showed increased distress to 
social stress after 4-weeks intervention. Only the group received probiotics but not the 
placebo group showed neural activity changes following social stress, with increased theta 
and alpha band power in the frontal and cingulate cortex and supramarginal gyrus (p = 0.03; 
0.04).  
Conclusion: Our results indicate that B.longum 1714 affects resting state neural oscillations 
in theta and beta band that may be related to enhanced arousal and reduced mental fatigue. 
The probiotic strain modulated neural oscillations of theta and alpha bands during social 
stress, indicative of counter-regulation of negative emotions.  
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1 Introduction 
Probiotics have been described as“psychobiotics", a family of bacteria that, ingested 
in appropriate quantities, have a positive mental health benefit (1). Studies assessing the 
effects of psychobiotics on central nervous system (CNS) functions include preclinical 
studies conducted in rodent animals, and translational studies in healthy volunteers, 
psychiatric patients, and patients with irritable bowel syndrome (2-5). The effects have been 
summarized in many reviews as anxiolytic, antidepressant and memory improving (6, 7).  
Studies on psychobiotics have been put forward to neuroscience investigations, most 
of which are preclinical in nature. However, clinical studies using neuroimaging methods are 
less abundant but have started to emerge, which provide insight into modulations of CNS 
functions in humans. The first study to demonstrate neural effects of probiotics in humans 
was using functional magnetic resonance imaging (fMRI) (8). Brain activations to emotional 
faces were altered by a fermented dairy drink with probiotics in comparison to placebo. A 
more recent study in patients with irritable bower syndrome (IBS) also revealed improvement 
in psychiatric comorbidity and reduction in limbic activity to negative emotional stimuli (3).  
Stress is a crucial factor for many mental disorders such as anxiety and depression. 
Administration of Lactobacillus rhamnosus JB-1 attenuated behavioral deficits induced by a 
chronic psychosocial stressor in mice, and prevented related immunoregulatory alterations 
(9). In healthy humans, studies have directly measured stress responses such as cortisol levels 
and stress perception, and showed effects of probiotics on modulating these responses. For 
example, Takada et al. used academic examinations as a stressor in students and found that 
Lactobacillus casei Shirota suppressed stress-induced increases in saliva cortisol and physical 
symptoms (10). Allen et al. reported attenuated cortisol output and subjective stress to a cold 
pressor (11). Despite the increasing number of studies, it is still unclear and interesting to 
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investigate where and how probiotics affect cortical activations in response to a stressful 
situation.   
Social stress induced by social exclusion/rejection is considered as a chronic stressor 
that is able to induced emotional, behavioral and physiological changes (12). Numerous 
studies have utilized a standardized paradigm, called“Cyberball Game”(CBG), to study the 
effects of social stress and ostracism (exclusion), and the corresponding neural response (13). 
The CBG is “an online ball-tossing game that participants believe they are playing with two 
or three players” (13). Participants feel more distressed in periods when the other players 
most of the time only play with each other and do not involve them in the game, compared to 
the periods in which all players have the same chance to receive and throw the ball. 
Physiological changes of cortisol levels and skin conductance have been observed during 
such social stress situations (14-17). According to a scoping review summarizing 
neuroimaging studies that have used MRI and electroencephalography (EEG) during the 
CBG, regions of the prefrontal cortex (PFC), anterior cingulate cortex (ACC) and temporal 
cortex are involved in neural processing of this type of social stressor (18). Also, social stress 
during the CBG was consistently associated with altered neural oscillations in certain brain 
areas, such as increase in alpha band power in frontal cortex and theta band power in the 
ACC, insula and fusiform areas (19-22).  
In a recent study, we have verified the efficacy of magnetoencephalography (MEG), a 
neuroimaging technique with fine spatial resolution and high temporal resolution (23, 24), to 
measure neuromagnetic oscillations during social stress induced by the CBG (25). In this 
study we tested effects of a locally (intestinally) acting antibiotic (rifaximin) on the stress 
effect, and found that 7-days of rifaximin intake alleviated the stress response by reducing 
low beta band power in the PFC and ACC. Also, frontal and cingulate alpha band during 
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resting state was reduced after rifaximin intake, reflecting a raised relaxation status. 
Rifaximin has been reported to relieve IBS symptoms (26), treat small bacterial overgrowth 
(27), and prevent travelers’diarrhea (28). Studies in animals and humans have revealed that 
rifaximin reduces toxic intestinal bacterial growth and promotes beneficial bacteria in the gut 
such as Bifidobacteria and Lactobacilli (29-31), which may be responsible to mediate its 
"eubiotic" (25) neural effect on the stress response (30).  
In the current trial, we tested whether Bifidobacterium longum 1714 affected healthy 
volunteers’ health status and neural activities during a resting state measurement. We also 
investigated whether B.longum 1714 – in comparison to placebo – was able to alter neural 
oscillations associated with the CBG-induced social stressor. We selected this specific strain 
as our test organism, as it had previously been demonstrated to modulate stress related 
behaviors in animals (32, 33). Supporting evidence is also provided by a clinical study that 
showed reduced stress responses and improved cognitive activity following treatment (11). 
We hypothesized that the probiotic strain B.longum 1714 would show effects on resting brain 
activity and on neurophysiological responses to CBG induced social stress. In particular, we 
assumed that during the resting state, B.longum 1714 would show similar effects as rifaximin, 
causing an increase of alpha band power associated with higher level of relaxation. During 
the CBG, stress-related neural oscillations of the theta and alpha band power would be 
changed after probiotic treatment; similarly to the effects of rifaxmin, beta band power would 
also be reduced by B.longum 1714.   
 
2 Materials and methods  
2.1 Participants  
  105 
Based on previously published data (11), we estimated that - with a power of 0.95 for 
a 2 x 2 repeated measure ANOVA - a minimum sample size of 34 was required to 
demonstrate an effect size f = 0.2 at a = 0.05 in a parallel-group designed study. The study 
was completed with 40 healthy volunteers, after having recruited initially sixty-one 
participants. Eighteen participants were excluded because they did not meet the inclusion 
criteria, and three of them could not be included in the final analysis because of the intake of 
an antibiotic during the intervention period (see Figure 1 for detailed trial profile). Criteria 
for inclusion were: 1) non-smoker for at least 3 months, 2) a body mass index (BMI) of 18-30, 
3) no chronic allergies, 4) willing to discontinue their normal consumption of probiotics and 
prebiotic-containing foods or potentially immune-enhancing dietary supplements, 5) 
receiving no immune-suppressing intervention and not having any immunosuppressive illness 
within the last year, 6) receiving no antibiotic therapy within the last 2 months, 7) having no 
chronic psychiatric or gastrointestinal disorder, 8) and having no non-removable metal parts 
in the body. Informed consent was obtained from all participants prior to joining the study. 
The protocol had been approved by the Ethics Board of the University of Tübingen Medical 
School (No. 503/2015BO1, as of August 26, 2015), and was registered at ClinicalTrials.gov 
(identifier No. NCT02793193). 
Figure 1. 
 
2.2 Design 
A randomized, double-blinded, and parallel-group design was employed. Participants 
were screened for the irritable bowel syndrome and psychiatric disorders using the Rome III 
criteria (34) and the Patient Health Questionnaire (PHQ) (35). Demographic and baseline 
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psychological information was also recorded. After screening, participants were randomly 
allocated in different intervention groups and took either probiotic or placebo for 4 weeks (28 
days). The probiotic and placebo preparations in equally looking sachets were provided by 
Alimentary Health Ltd, Cork, Ireland. The randomization scheme was only unblinded after 
completion of the experiment and complete data evaluation. At baseline and one day after the 
intervention period, participants visited our lab for the MEG measurements. In addition, they 
visited the lab for acquiring structural MR images on a different day, regardless of their 
intervention schedule.  
During the intervention period, participants were instructed to avoid consumption of 
food containing probiotics/prebiotics, or potentially immune-enhancing dietary supplements. 
This was supported by providing them with a list of "prohibited" foods (Appendix 1). 
2.3 Materials  
Each probiotic sachet contained 20 g of 109 colony-forming units B.longum 1714 
strain with maltodextrin and magnesium stearate; each placebo sachet contained only 20 g of 
maltodextrin and magnesium stearate. Participants were instructed to consume one sachet 
every morning with food within 15 minutes, by mixing the content into 50 ml of water. 
2.4 Questionnaires  
To record participant’s health status, the 36-item short-form health survey (SF36) was 
used (36). The SF36 includes eight subscales: physical functioning, bodily pain, role 
limitations due to physical health problems, role limitations due to personal or emotional 
problems, emotional well-being, social functioning, energy/vitality, and general health 
perceptions. Participants were asked to finish the SF36 at the beginning of each of the two 
visits. 
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After each block of the CBG (see below), participants needed to complete three 
questionnaires to assess their acute level of distress. We employed the self-report measures of 
the Need Threat Scale (NTS), the Mood Questionnaire (MQ) and the Subjective ‘Exclusion 
Perception’ (SEP) (Appendix 2); all these scales are validated standards for the CBG (13, 
37). The NTS was designed to measure the feelings and emotional consequences of social 
rejection, and higher scores related to higher distress level. Its four items (rated between 1 
and 5 for “weak” to “strong”) comprised self-esteem, belonging, meaningful existence and 
control, and combined ratings have been used as a measure of social distress in previous 
studies. The MQ was used to assess mood, using 8 questions (are you feeling bad, good, 
happy, sad, pleasant, angry, friendly and unfriendly), all rated between 1 and 5. The SEP was 
to record participants’ feeling of being included/ostracized by asking them to rate two 
statements (‘I was ignored’ and ‘I was excluded’) between 1 and 5.                                                                                          
2.5 Cyberball game 
In the CBG, the participants were asked to play a ball tossing game with two other 
virtual players programmed by the experimenter. They were made believe that the two 
players were real and were playing the game. To minimize gender effects, male participants 
played with 2 female players, and female participants played with 2 male players. During the 
game, the other players were depicted as cartoon characters with their photos aside and 
names below. The volunteering participant was represented by a cartoon in the middle lower 
part of the screen and could throw the ball to either of the other two players on the left or 
right, by pressing the left or right button on the response box (Figure 2). 
Figure 2. 
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The CBG consisted of 4 blocks: inclusion - exclusion - inclusion – exclusion 
conditions; this order was maintained for all volunteers. In each inclusion block, there were 
108 trials, during 1/3 (36 trials) of which the participant received the ball from the other 
players (for another 1/3 the ball was played to one of the other players, and for the other 1/3 
between the other two players). The order of the ball throwing to the participant was pseudo-
randomized. The 1/3 of trials in the inclusion block when the virtual players threw the ball to 
each other and not to the participant, were called "not my turn" events. 
To equalize the numbers of analysed trials when the virtual players threw the ball to 
each other and not to the participant, we set 47 total trials in each exclusion block. The 
participants received the ball 3 times (trials 14, 25, or 26, and 39, 40, or 41 in block 2 and 4, 
respectively) to maintain their attention. The first 5 exclusion trials, the 3 trials the participant 
receiving the ball, and the 3 trials the participant was throwing the ball were not analysed but 
discarded. The remaining 36 so-called "rejection" events were used for comparison with the 
36 "not my turn" events in the inclusion block. Visual stimuli of these trials did not differ in 
two conditions, so any difference of brain activities was supposed to be due to the 
participants’ inner state. The trial began with the ball being presented in the cartoon for 500-
2000 ms randomly to imitate a real life situation. Then the ball was moving for 2000 ms 
before reaching the target player (Figure 2). After each of the inclusion and exclusion blocks, 
participants completed the NTS, the MQ, and the SEP. 
2.6 Magnetoencephalography recording 
Brain magnetic fields were measured with a 275-channel whole-head 
magnetoencephalograph (CTF Omega, Port Coquitlam, Canada). Participants were studied in 
supine position. During each recording session, 5 minutes resting state was recorded prior to 
recording while playing the CBG. During the resting state, participants were instructed to 
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move as little as possible and to be awake, while keeping their eyes closed. During the CBG, 
task instructions were projected onto a screen in front of the participants via a video projector 
and a mirror system. Participants were asked to fixate the screen and hold a response box to 
get ready for the task. Participants were also instructed to move as little as possible. MEG 
signals were sampled at a rate of 585.94 Hz with an anti-aliasing filter set to 292.97 Hz. 
In order to overlay the brain activity derived from MEG on anatomical scans, high-
resolution (1 mm, isotropic) T1-weighted structural MR images were acquired using an 
MPRAGE sequence with a Siemens MAGNETOM Trio 3T scanner (Siemens AG, Erlangen, 
Germany) (12-channel array head coil) for each participant, but at a separate occasion. 
2.7 Data Analysis  
2.7.1 Data analysis: questionnaires 
Data analysis was conducted using SPSS 21 (IBM, Armonk, NY, USA). To examine 
whether there was a significant difference in health status between groups at baseline, scores 
of SF36 during the first visit were entered into a non-parametric two-independent-sample 
Mann-Whitney U test of Intervention as between factor (B.longum 1714 vs. Placebo), as 
parametric assumptions of these data were violated. To test the intervention-related changes 
in participants’ health status scored by SF36, changes from before to after the 4-weeks 
intervention were computed by subtracting the baseline assessment from the corresponding 
post-intervention values. Non-parametric two-independent-sample Mann-Whitney U test was 
used to examine the change of SF36 between Intervention (B.longum 1714 vs Placebo). 
To examine whether subjective ratings for the CBG were different between groups at 
baseline, scores of NTS, MQ, and SEP acquired during the first visit were entered into an 
independent T-test with Intervention as between factor (B.longum 1714 vs. Placebo). To 
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control the intervention-related changes of the NTS, the MQ and SEP during the CBG, 
changes after each intervention were computed for each condition and entered into a 2 x 2 
repeated measure ANOVA with Intervention as a between-factor (B.longum 1714 vs. Placebo) 
x Condition as a within-factor (exclusion vs. inclusion). Where significant main effects or 
interaction were observed, pairwise post-hoc comparisons were used with a Bonferroni 
adjusted threshold (α = 0.025). Mean data are reported as M + SD. 
2.7.2 Data analysis: MEG - data  
Preprocessing  
Analysis of the MEG data was carried out using Matlab (Mathworks, Natick, USA) 
and the open-source toolboxes Fieldtrip (38). The resting state dataset were cut into time 
windows of 2 s. Data in this time window were filtered using a 4 Hz high pass frequency 
filter. Non-physiological jumps in the MEG signal and trials with jump and muscle artifacts 
were excluded by an automatic rejection algorithm that excluded all trial in which the 
variance exceeded 10-25 in any channel.  
The continuously recorded dataset during the CBG was segmented in epochs of 3 s 
with 1 s of pre-stimulus interval time-locked to the moment at which the players started to 
throw the ball). Trials in which one of the virtual players threw the ball towards the other 
virtual player during the inclusion blocks were defined as ‘inclusion’ condition, and those 
during exclusion blocks were defined as ‘exclusion’ condition.  
Time-frequency analysis  
The time-frequency analysis used the multitaper windowed fast fourier transform 
‘MTMFFT’ implemented in Fieldtrip. The 'multitaper method' (MTM) is based on Slepian 
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sequences as tapers. The frequency of interest ranged from 4 to 30Hz with step of 2 Hz. The 
frequency smoothing window is +/-3 Hz: 
Source analysis  
Using the time-frequency determined by the analysis described above, oscillatory 
sources of theta, alpha, beta-1, beta-2 and beta-3 bands (6, 11, 16, 21, and 26 Hz) were 
localized using beamformer techniques. We applied the Dynamical Imaging of Coherent 
Sources (DICS) method (39). In order to estimate the individual source activity, each 
participant’s brain recorded as T1-MR image was divided in a regular three dimensional grid 
with a 1 cm resolution. A spatial inverse filter was computed from both conditions and both 
visits, as common filter. The common filter was applied to each condition and each visit 
separately in order to obtain the respective source power. The MEG data in each condition 
were coregistered with the respective individual structural MR images respectively. 
Source statistics  
We performed source-level statistics to assess effects of intervention on the data 
obtained from the resting-state condition and the CBG, respectively. To check if there was 
any difference between groups at baseline prior to any intervention, resting-state at baseline 
source power was compared with an independent T-test with Intervention (B.longum 1714 vs. 
placebo) as between factor. Then, intervention-induced changes in source power were 
computed in each frequency band by subtracting the baseline from the post-intervention. The 
changes of the source power were entered into an independent T-test with Intervention 
(B.longum 1714 vs. placebo) as between factor. For the CBG, source power at baseline in 
each frequency band was also tested with an independent T-test with Interventions (B.longum 
1714 vs. placebo) as between factor to check if brain activations showed differences between 
groups. Subsequently, changes in the source power after intervention were computed by 
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subtracting the baseline values from the post-intervention for each condition in each 
frequency band. Changes of source power were entered in a two-way ANOVA of 
interventions (B.longum 1714 vs. placebo) x conditions (exclusion vs. inclusion). The 
statistical analysis was done separately for each frequency band. To localize significant 
activations, the cluster-based permutation method for multiple comparisons was used with a 
significance level of alpha of 0.05. 
2.7.3 Correlation between questionnaire and MEG data 
To investigate the relationship between changes in neural activity and changes in the 
subjective reports induced by B.longum 1714, correlations analyses were carried out for both, 
the resting state recording and the CBG, respectively. For the resting state recording, 
averaged source power within clusters was calculated for the clusters differing significantly 
between both visits. The averaged source power was correlated with changes in health status 
(SF36) for each group separately. For the CBG, for each condition and each intervention, 
source power within the clusters that differed significantly between both visits was averaged 
for each condition and each group. The averaged source power was correlated with changes 
in the scores of NTS, MQ and SEP separately for each condition and each group, using 
Pearson correlations.  
 
3 Result  
A total of 40 participants were included in the analysis with half of them receiving 
B.longum 1714 intervention. Sex of participants was matched between groups. Age and BMI 
of participants were not significantly different between groups (See Table 1 for details).  
3.1 Effects on subjective ratings 
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At baseline, no significant differences of SF36 scores or CBG subjective scores (NTS, 
MQ, and SEP) were seen between groups (also see Table 1). 
A non-parametric two-independent-sample test was conducted to compare changes of 
SF36 scores after intervention between groups. No significant difference was found. 
An ANOVA (Intervention x Condition) testing changes of the NTS, MQ and SEP 
revealed significant main effects of condition on NTS (F (1, 33) = 5.91, p = 0.02) and on SEP 
(F (1, 36) = 5.61, p = 0.02). Participants in all groups reported increased scores of NTS 
(exclusion: M = 5.20 ± 2.37; inclusion: M = -4.32 ± 1.85) and SEP (exclusion: M = 0.94 ± 
0.42; inclusion: M = - 0.30 ± 0.16) in the exclusion compared to inclusion condition, after 
four weeks of intervention (Figure 3).  
Figure 3.  
 
3.2 MEG data 
3.2.1 Resting state  
At baseline, no group difference of source power during resting state was observed in 
any frequency band. After the intervention, an increased theta band (6Hz) power was found 
in one cluster, including regions of bilateral inferior, middle and superior frontal cortex (IFC, 
MFC and SFC), and the bilateral anterior and middle cingulate cortex (ACC and MCC), 
comparing B.longum 1714 with the placebo group (p < 0.05; Figure 4A). Also, a reduced 
beta-2 band (26Hz) power was obtained in a cluster, consisting of the bilateral fusiform gyrus 
(FFG), the bilateral hippocampus (HIPP), the left inferior and superior temporal and bilateral 
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middle temporal cortex (ITC, STC, and MTC), the left cerebellum (CBL), comparing both 
groups (p < 0.05; Figure 4B). 
Figure 4. 
 
To investigate whether the changes of neural activity during resting state were 
correlated to changes of the participants’ health state, we correlated the changes of averaged 
power within activated clusters (shown above) in theta and beta-2 bands, with changes in 
SF36 scores. In both groups, a significant positive correlation was obtained between changes 
of the SF36 subscale “Energy/Vitality” with changes of theta band power in the cluster (r = 
0.33, p = 0.04; Figure 5A).  
Group-specific correlations, revealed that only in the B.longum 1714 group ,changes 
of SF36 score for ‘Energy/Vitality’ positively correlated with changes of averaged theta band 
power (r = 0.61, p = 0.007), and negatively correlated with changes of beta-3 band power in 
the activated clusters during the resting state, respectively (r = -0.50, p = 0.04; Figure 5B). 
3.2.2 Cyberball Task 
At baseline, source power in each frequency band during the CBG showed no 
significant difference between groups. After the 4-week intervention, main effects of 
B.longum 1714 were seen for changes of source power in theta (6Hz) band and alpha band 
(11Hz). Theta band showed an increased power in one cluster, consisting of the right IFC and 
the bilateral MFC and SFC, the left ACC the bilateral MCC, and the right supramarginal 
gyrus (SMG), comparing B.longum 1714 with placebo in both conditions inclusion and 
exclusion (p = 0.03; Figure 6A). Alpha band also showed an increased power in the cluster, 
including regions of the right IFC the bilateral MFC and SFC, the bilateral ACC and MCC, 
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and the right SMG, for B.longum 1714 compared to placebo in both conditions (p = 0.04; 
Figure 6B). No main effect of condition or interaction of intervention and condition were 
observed.  
Figure 6. 
 
Correlation analysis between changes of averaged power within activated clusters (as 
shown above) and changes of NTS, MQ and SE ratings revealed an association between the 
neural activity changes and the subjective effects: Only with B.longum 1714 and only during 
the exclusion condition, NTS changes positively correlated with changes of the theta band 
power (r = 0.62, p = 0.008) and alpha band power (r = 0.54, p = 0.03; Figure 7).  
Figure 7. 
Summaries of frequency bands and neuroanatomical areas found to be related to 
B.longum 1714 intervention, and associations of neural activity changes and subjective 
effects are provided in Table 2 and Table 3, respectively.  
 
4 Discussion  
The current study used a functional neuroimaging method, MEG, to show that 4-
weeks intake of the probiotic strain B.longum 1714 had significant effects on neural activities 
in both, the resting state and the response to a social stressor in healthy participants. 
Comparing B.longum 1714 with placebo, the neural activities during resting state showed 
increased power in theta band in the frontal and cingulate cortex, and decreased power in 
beta-3 band in the fusiform cortex, hippocampus, temporal cortex and cerebellum. While no 
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changes in SF36 (general health) scores were found with B.longum 1714, alterations in the 
resting brain activity were associated with the SF36 scale “Energy/Vitality”, which asked for 
energy and fatigue experienced during the preceding 4 weeks. In response to the social 
stressor CBG, all groups showed higher distress levels and reported higher exclusion 
perception after the intervention period. However, only in B.longum 1714 group, neural 
responses during the CBG showed increases in theta and alpha bands power in the frontal and 
temporal cortex and supramarginal gyrus for both CBG conditions (inclusion and exclusion 
conditions). The increased neural activities associated with higher subjective distress 
occurred in the probiotic group only for exclusion condition.  
Specifically, during the resting state, after the probiotic intervention, theta band power 
- in the frontal and cingulate cortex - was higher and beta-3 band power - in the fusiform 
cortex, hippocampus, temporal cortex and cerebellum - was lower. Although no significant 
change of SF36 was noted following the 4-week probiotic intake, the increase of theta band 
and the decrease of beta-3 band power found for the resting state were associated with an 
increase of perceived energy levels, as assessed by the SF36. Contrary to our hypothesis of 
larger alpha band power in the frontal and cingulate cortex, which is supposed to indicate 
improved relaxation, the increase of the theta and the decrease of the beta-3 band power can 
instead be seen as improvement of energy status. In the literature, increased power in theta 
band (whole brain, especially prominent in the frontal regions) on a resting-state EEG was 
observed after consumption of a major source of metabolic energy – glucose, and went along 
with improved attention and arousal (40, 41). A decrease in theta band power in cingulate 
cortex was correlated with subjective level of fatigue in one MEG study (42). Similarly, an 
increase in beta band power could be caused by mental fatigue (43), and inversely, reduced 
beta power could index increased alertness and arousal, accompanied with decreased anxiety 
and stress (44, 45). It has been well studied that probiotics can alter metabolism of short-
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chain fatty acids and vitamin thus increasing ATP production and providing energy (46). 
Based on these findings, we may speculate that the effects of B.longum 1714 are due to 
enhanced participants’ quality of life and especially their energy status and decreasing fatigue. 
This enhanced vitality/energy status is also reflected by participants’ altered resting neural 
activity. Considering the effects of probiotics on individuals’ energy balance appears to be an 
attractive, yet admittedly speculative, explanation that nicely links subjective ratings of 
individual states and neurophysiological findings of resting state activity in our study. 
Measures of metabolic changes may help to elucidate these and other putative mechanism of 
action of B.longum 1714 in the future.  
All participants reported higher distress level during the exclusion condition 
compared to the inclusion condition after 4-weeks of intervention. The increased level of 
distress was observed regardless of the type of intervention (probiotic, placebo). Social 
exclusion/rejection from others can occur in daily life as a chronic stressor, thus repetition of 
this stress may reinforce the feeling of being excluded and consolidate the memory of the 
stressful event. This general increase of distress ratings was not observed in our last study 
testing the effects of rifaximin (25)  in the same paradigm, probably due to the shorter period 
of the intervention. While in the previous study rifaximin was administered for 1 week, in the 
current study the intervention lasted for 4 weeks. 
After administration of B.longum 1714, theta and alpha bands power were increased 
in the frontal and cingulate cortex (ACC and MCC).  In the CBG increased alpha and theta 
power was observed in SMG during all conditions when participants observed the other 
players throwing the ball to each other. Although both groups reported higher subjective 
distress, changes in neural processing of social stress was changed only following B.longum 
1714 and not placebo. Similarly, the correlation of changes of subjective distress with neural 
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activities was only seen with B.longum 1714. Thus, our data support the notion that B.longum 
1714 plays a role in managing stress responses by modulating the relevant neural processes; 
B. longum 1714 affecting individuals’  neurophysiology is a novel findings and was 
previously only reported for behavioral data in animals and humans (11, 32, 33). 
As hypothesized, B.longum 1714 altered theta and alpha band power of stress-related 
neural oscillations in frontal and cingulate cortex. However, unlike rifaximin in our previous 
study, B.longum 1714 did not influence beta band activity in the CBG (25). Our current 
results are consistent with previous studies using EEG revealing that ostracism distress is 
related to pronounced alpha band power by the stressor at the frontal cortex and theta band 
power in the ACC, FFA and insula (19, 20, 22). Previously reported ACC activations were 
related to processing of negative emotions and event appraisal due to the social 
stress/exclusion, and PFC activation was related to emotional regulation (18, 47-49). Theta 
band in ACC and insula was described as a marker of social pain in the context of the CBG 
and was also found during a cold pressor test and physical pain (50, 51). In our study, the 
increased theta band activity could be associated with induced negative emotions and 
relevant appraisal processes elicited by the exclusion event (19, 20, 22). Similar changes of 
theta band activity induced by B.longum 1714 during the CBG were also observed in the 
resting state data of the current study, which were attributed to increased arousal conditions. 
Enhanced arousal levels in the CBG might be related to more intense responses to the social 
stressor. 
In previous EEG studies (21, 22), alpha band increase in frontal brain areas was 
involved in the neural processes during social stress, indexing either a high level of distress 
or the correlation of stress management/regulation. Lower frontal alpha power was found in 
anxiety, which might be considered as a specific mode of stress (52, 53). With respect to our 
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study, one might speculate that the increased alpha activity indexes inhibition of limbic 
activity and thereby counter-regulate negative emotions and stress. Taking this argument 
further, we may suggest that in contrast to placebo, B. longum 1714 reduced participants’ 
stress response and enabled them to manage the increased distress level by upregulating 
processes appraising stressful events and downregulating negative emotions.    
Comparing the B.longum 1714 group with the placebo group, a significant alleviation 
of perceived stress during the CBG, as assessed by subjective ratings, was missing. This may 
be because that stress-reducing effect of the probiotic strain was not strong enough at the 
behavioral level to counteract the enhanced stress effect over time. Alternative explanations 
would be that – despite their validation in CBG studies – the assessment tools were not 
sensitive enough for our study in volunteers, the implementation of the CBG was not optimal, 
or the effect size induced by the 4-week probiotic intake. Nevertheless, we believe that 
probiotic B.longum 1714 acts on a neural level managing social stress, consistent with 
previous studies. The strain B.longum 1714 has been shown in preclinical and clinical studies 
to reduce stress, anxiety and depression-like behaviors and, most strikingly also improve 
memory performance (11, 32, 33).  
Other studies - in line with our data - showed neural modulation by different 
psychobiotic strains, and provided some clues of the potential mechanisms involved. 
Preclinical studies have reported a rise of serotonin and dopamine levels, two crucial 
neurotransmitters regulating mood and emotions, in brain regions of mice such as prefrontal 
cortex after interventions with L.planatraum and L.helveticus (54-56). Another study showed 
L. rhamnosus (JB-1) modulated GABAergic system and reduced stress-related psychiatry-
like behaviors in mice. Some of the effects have been found to be mediated by the vagus 
nerve (2). However, effects of the same strain were not found in a clinical study in healthy 
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volunteers, indicating possibly the challenge of translating preclinical studies into clinical 
relevance (57).   
Two studies using fMRI measuring brain activations to negative emotional stimuli 
showed reduced activations in regions such as the insula, somatosensory, amygdala and 
fronto-limbic areas, which are associated with neural processing of stress and emotion (3, 8). 
In our recent study, rifaximin had effects on the neural response to the social stress implying 
negative emotions, but on different brain activities - reduced frontal and cingulate beta band 
power (25). Therefore, although affecting neural response to emotional processing like 
probiotics, rifaximin may act through different neural pathways than probiotics. Although the 
central mechanisms by which rifaximin affects stress management are not well understood, 
one may speculate on an "eubiotic" effect of probiotics promoting beneficial bacteria such as 
Bifidobacteria and Lactobacilli (30, 31).  Therefore, although such "psychobiotic" effects 
appear to be strain-dependent, results of existing studies help to understand the possible 
pathways of the strain we used in the current trial. Effects of different strains on diverse 
neural oscillations in response to stress are recommended to obtain a detailed picture of the 
effects of probiotics on brain functioning.  
 
5 Conclusion 
As a putative psychobiotic, B.longum 1714 showed effects on influencing resting 
neural activities associated with reduced mental fatigue, and on neural responses to social 
stress induced by an virtual online game. Our results have provided new evidence for this 
“psychobiotic” strain to affect central functions through activation of certain brain regions. 
The understanding of neural oscillations activated by stress and their modulation by 
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psychobiotics is still at its beginning. Studies that examine the mechanisms of this 
psychobiotics along the gut-brain axis and to compare their effects on other central nervous 
system functions with other interventions are warranted. In order to get the full picture of the 
effects of B.longum 1714 on the brain future research should consider also its effects on other 
central nervous system functions, for example pain sensitivity, mood, memory abilities, both 
in healthy controls and in patients with psychiatric (depression, anxiety), neurologic 
(neurodegenerative), and gastrointestinal disorders such as IBS.  
 
6 Conflicts of interest  	
Eileen Murphy is Research Director at Alimentary Health. Alimentary Health 
provided the placebo and probiotic containing the B. longum 1714 strain, but had no further 
influence on the design of the study, the data collection, and the data evaluation. The authors 
declare no potential conflicts of interest.  
 
7 Acknowledgements  
The research leading to these results has received funding from the People 
Programme of the European Union's Seventh Framework Programme under REA grant 
agreement no. 607652 (NeuroGut). PE is responsible for the integrity of the work - the 
inception of the study and publication of the work. HW contributed to the design of the study, 
data collection and analysis, drafting of the manuscript, and critical revisions of the 
manuscript. CB and PE contributed to the design of the study, data analysis, critical revisions 
of the manuscript. All authors approved the final version of the manuscript. 
  122 
Reference  
1. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol 
Psychiatry. 2013;74(10):720-6. 
2. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. 
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor 
expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-
5. 
3. Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, et al. Probiotic 
Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A 
Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017;153(2):448-
59.e8. 
4. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, et al. A 
randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional 
symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1(1):6. 
5. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized 
controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad 
mood. Brain Behav Immun. 2015;48:258-64. 
6. Romijn AR, Rucklidge JJ. Systematic review of evidence to support the theory of 
psychobiotics. Nutr Rev. 2015;73(10):675-93. 
7. Wang H, Lee IS, Braun C, Enck P. Effect of Probiotics on Central Nervous System 
Functions in Animals and Humans: A Systematic Review. J Neurogastroenterol Motil. 
2016;22(4):589-605. 
8. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of 
fermented milk product with probiotic modulates brain activity. Gastroenterology. 
2013;144(7):1394-401, 401 e1-4. 
9. Bharwani A, Mian MF, Surette MG, Bienenstock J, Forsythe P. Oral treatment with 
Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic 
social stress. BMC Med. 2017;15(1):7. 
10. Takada M, Nishida K, Kataoka-Kato A, Gondo Y, Ishikawa H, Suda K, et al. 
Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by 
modulating the gut-brain interaction in human and animal models. Neurogastroenterology 
and motility : the official journal of the European Gastrointestinal Motility Society. 
2016;28(7):1027-36. 
11. Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, et al. 
Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, 
electrophysiology and neurocognition in healthy volunteers. Translational psychiatry. 
2016;6(11):e939. 
12. Krieger N. Theories for social epidemiology in the 21st century: an ecosocial 
perspective. Int J Epidemiol. 2001;30(4):668-77. 
  123 
13. Williams KD, Jarvis B. Cyberball: a program for use in research on interpersonal 
ostracism and acceptance. Behavior research methods. 2006;38(1):174-80. 
14. Beekman JB, Stock ML, Marcus T. Need to Belong, Not Rejection Sensitivity, 
Moderates Cortisol Response, Self-Reported Stress, and Negative Affect Following Social 
Exclusion. The Journal of social psychology. 2016;156(2):131-8. 
15. Blackhart GC, Eckel LA, Tice DM. Salivary cortisol in response to acute social 
rejection and acceptance by peers. Biol Psychol. 2007;75(3):267-76. 
16. Kelly M, McDonald S, Rushby J. All alone with sweaty palms--physiological arousal 
and ostracism. International journal of psychophysiology : official journal of the International 
Organization of Psychophysiology. 2012;83(3):309-14. 
17. McQuaid RJ, McInnis OA, Matheson K, Anisman H. Distress of ostracism: oxytocin 
receptor gene polymorphism confers sensitivity to social exclusion. Soc Cogn Affect 
Neurosci. 2015;10(8):1153-9. 
18. Wang H, Braun C, Enck P. How the brain reacts to social stress (exclusion) - A 
scoping review. Neuroscience and biobehavioral reviews. 2017;80:80-8. 
19. Cristofori I, Harquel S, Isnard J, Mauguiere F, Sirigu A. Monetary reward suppresses 
anterior insula activity during social pain. Soc Cogn Affect Neurosci. 2015;10(12):1668-76. 
20. Cristofori I, Moretti L, Harquel S, Posada A, Deiana G, Isnard J, et al. Theta signal as 
the neural signature of social exclusion. Cerebral cortex (New York, NY : 1991). 
2013;23(10):2437-47. 
21. Kawamoto T, Nittono H, Ura M. Cognitive, Affective, and Motivational Changes 
during Ostracism: An ERP, EMG, and EEG Study Using a Computerized Cyberball Task. 
Neuroscience journal. 2013;2013:304674. 
22. van Noordt SJ, White LO, Wu J, Mayes LC, Crowley MJ. Social exclusion modulates 
event-related frontal theta and tracks ostracism distress in children. Neuroimage. 
2015;118:248-55. 
23. Cohen D, Cuffin BN. Demonstration of useful differences between 
magnetoencephalogram and electroencephalogram. Electroencephalography and clinical 
neurophysiology. 1983;56(1):38-51. 
24. Hall EL, Robson SE, Morris PG, Brookes MJ. The relationship between MEG and 
fMRI. Neuroimage. 2014;102:80-91. 
25. Wang H, Braun C, Enck P. Effects of rifaximin on central responses to social stress - 
a pilot experiment. Neurotherapeutics. Submitted. 
 
26. Li J, Zhu W, Liu W, Wu Y, Wu B. Rifaximin for Irritable Bowel Syndrome: A Meta-
Analysis of Randomized Placebo-Controlled Trials. Medicine (Baltimore). 
2016;95(4):e2534. 
  124 
27. Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective 
and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharm Ther. 
2017;45(5):604-16. 
28. Ng QX, Ho CYX, Shin D, Venkatanarayanan N, Chan HW. A meta-analysis of the 
use of rifaximin to prevent travellers' diarrhoea. Journal of travel medicine. 2017;24(5). 
29. Maccaferri S, Vitali B, Klinder A, Kolida S, Ndagijimana M, Laghi L, et al. 
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro 
approach using a continuous culture colonic model system. The Journal of antimicrobial 
chemotherapy. 2010;65(12):2556-65. 
30. Ponziani FR, Scaldaferri F, Petito V, Paroni Sterbini F, Pecere S, Lopetuso LR, et al. 
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. 
Dig Dis. 2016;34(3):269-78. 
31. Xu D, Gao J, Gillilland M, 3rd, Wu X, Song I, Kao JY, et al. Rifaximin alters 
intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in 
rats. Gastroenterology. 2014;146(2):484-96 e4. 
32. Savignac HM, Kiely B, Dinan TG, Cryan JF. Bifidobacteria exert strain-specific 
effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterology 
and motility : the official journal of the European Gastrointestinal Motility Society. 
2014;26(11):1615-27. 
33. Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF. Bifidobacteria modulate 
cognitive processes in an anxious mouse strain. Behav Brain Res. 2015;287:59-72. 
34. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. 
Functional bowel disorders. Gastroenterology. 2006;130(5):1480-91. 
35. Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire 
Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. General hospital 
psychiatry. 2010;32(4):345-59. 
36. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. 
Conceptual framework and item selection. Med Care. 1992;30(6):473-83. 
37. Sebastian C, Viding E, Williams KD, Blakemore SJ. Social brain development and 
the affective consequences of ostracism in adolescence. Brain Cogn. 2010;72(1):134-45. 
38. Oostenveld R, Fries P, Maris E, Schoffelen JM. FieldTrip: Open source software for 
advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell 
Neurosci. 2011;2011:156869. 
39. Gross J, Kujala J, Hamalainen M, Timmermann L, Schnitzler A, Salmelin R. 
Dynamic imaging of coherent sources: Studying neural interactions in the human brain. Proc 
Natl Acad Sci U S A. 2001;98(2):694-9. 
40. An YJ, Jung KY, Kim SM, Lee C, Kim DW. Effects of blood glucose levels on 
resting-state EEG and attention in healthy volunteers. J Clin Neurophysiol. 2015;32(1):51-6. 
  125 
41. Wang C, Szabo JS, Dykman RA. Effects of a carbohydrate supplement upon resting 
brain activity. Integrative physiological and behavioral science : the official journal of the 
Pavlovian Society. 2004;39(2):126-38. 
42. Ishii A, Tanaka M, Watanabe Y. The neural mechanisms underlying the decision to 
rest in the presence of fatigue: a magnetoencephalography study. PLoS One. 
2014;9(10):e109740. 
43. Tanaka M, Ishii A, Watanabe Y. Neural effects of mental fatigue caused by 
continuous attention load: a magnetoencephalography study. Brain Res. 2014;1561:60-6. 
44. Diego MA, Field T, Sanders C, Hernandez-Reif M. Massage therapy of moderate and 
light pressure and vibrator effects on EEG and heart rate. Int J Neurosci. 2004;114(1):31-44. 
45. Field T, Ironson G, Scafidi F, Nawrocki T, Goncalves A, Burman I, et al. Massage 
therapy reduces anxiety and enhances EEG pattern of alertness and math computations. Int J 
Neurosci. 1996;86(3-4):197-205. 
46. LeBlanc JG, Chain F, Martin R, Bermudez-Humaran LG, Courau S, Langella P. 
Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins 
produced by commensal and probiotic bacteria. Microb Cell Fact. 2017;16(1):79. 
47. Bolling DZ, Pelphrey KA, Vander Wyk BC. Unlike adults, children and adolescents 
show predominantly increased neural activation to social exclusion by members of the 
opposite gender. Social neuroscience. 2016;11(5):475-86. 
48. Luo S, Yu D, Han S. Genetic and neural correlates of romantic relationship 
satisfaction. Soc Cogn Affect Neurosci. 2016;11(2):337-48. 
49. Preller KH, Pokorny T, Hock A, Kraehenmann R, Stampfli P, Seifritz E, et al. Effects 
of serotonin 2A/1A receptor stimulation on social exclusion processing. Proc Natl Acad Sci 
U S A. 2016;113(18):5119-24. 
50. Chang PF, Arendt-Nielsen L, Chen AC. Dynamic changes and spatial correlation of 
EEG activities during cold pressor test in man. Brain Res Bull. 2002;57(5):667-75. 
51. Chen AC, Dworkin SF, Haug J, Gehrig J. Topographic brain measures of human pain 
and pain responsivity. Pain. 1989;37(2):129-41. 
52. Luijcks R, Vossen CJ, Hermens HJ, van Os J, Lousberg R. The Influence of 
Perceived Stress on Cortical Reactivity: A Proof-Of-Principle Study. PLoS One. 
2015;10(6):e0129220. 
53. Roozendaal B, McEwen BS, Chattarji S. Stress, memory and the amygdala. Nat Rev 
Neurosci. 2009;10(6):423-33. 
54. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of Lactobacillus 
helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by 
chronic restraint stress. Neuroscience. 2015;310:561-77. 
  126 
55. Liu WH, Chuang HL, Huang YT, Wu CC, Chou GT, Wang S, et al. Alteration of 
behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free 
mice. Behav Brain Res. 2016;298(Pt B):202-9. 
56. Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, et al. Psychotropic effects of 
Lactobacillus plantarum PS128 in early life-stressed and naive adult mice. Brain Res. 
2016;1631:1-12. 
57. Kelly JR, Allen AP, Temko A, Hutch W, Kennedy PJ, Farid N, et al. Lost in 
translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate 
stress or cognitive performance in healthy male subjects. Brain Behav Immun. 2017;61:50-9. 
 
  
  127 
 
 
Table 1. Demographic and baseline information. 
 B.longum 1714 Placebo P value  
Sex 
 Male 
 Female 
 
N=7 
N=13 
 
N=7 
N=13 
 
n/a 
Birth delivery  
 Caesarean section 
 Vaginal delivery  
N=2 
N=18 
N=2 
N=18 
n/a 
Age 31.00±2.28 33.00±2.83 ns. 
BMI 23.00±0.68 22.00±0.55 ns. 
SF36 
Physical functioning 
 Role limitations due to physical 
health 
 Role limitations due to emotion 
problems 
 Energy/Vitality 
 Emotional well-being 
 Social functioning 
 Pain 
 General health 
 
96.84±1.03 
100.00±0.00 
 
100.00±0.00 
 
72.25±2.42 
85.78±1.22 
100.00±0.00 
88.75±2.67 
82.50±2.31 
 
97.63±0.80 
100.00±0.00 
 
95.00±5.00 
 
75.25±2.94 
84.42±1.75 
94.74±2.20 
89.75±2.80 
87.37±2.40 
 
 
 
 
ns. 
Cyberball game 
  NTS 
  -Inclusion 
  -Exclusion 
  MQ 
  -Inclusion 
  -Exclusion 
  SEP 
  -Inclusion 
  -Exclusion  
 
 
-28.30±3.55 
14.33±4.55 
 
13.80±1.47 
2.38±2.25 
 
-4.68±0.28 
0.15±0.92 
 
 
-36.90±2.28 
26.90±3.48 
 
18.03±0.99 
-5.48±2.17 
 
-5.30±0.21 
2.23±0.61 
 
 
 
 
 
ns. 
Abbreviations: BMI, body mass index; SF36, 36-item short-form health survey NTS, Need 
Threat Scale; MQ, mood questionnaire; SEP, subjective exclusion perception; ns. not 
significant. 
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Table 2. Summarized neuroanatomical areas and frequency bands of changed neural 
activities influenced by effect of condition, intervention and/or interaction of condition 
and intervention.  
Comparison Frequency 
band 
Brain region Hemisphere P vale 
 
 
Intervention 
effect on 
resting 
state: 
B.longum 
group vs. 
Placebe 
group 
 
 
 
Theta ­ 
IFC B  
 
<0.05 
 
MFC B 
SFC  B 
ACC B 
MCC  B 
 
 
Beta-3 ¯ 
FFG B   
 
 
<0.05 
HIPP B 
ITC L 
MTC B  
STC L 
CBL L  
 
Intervention 
effect on the 
Cyberball 
game for all 
conditions: 
B.longum 
group vs. 
Placebo 
group 
 
 
Theta ­ 
IFC  R  
 
 
0.03 
MFC B 
SFC B 
ACC L  
MCC B 
SMG  R  
 
 
Alpha ­ 
IFC  R  
 
 
0.04 
MFC B 
SFC B 
ACC B 
MCC B 
SMG  R  
Abbreviations: IFC, inferior frontal cortex; MFC, middle frontal cortex; ACC, anterior 
cingulate cortex; MCC, middle cingulate cortex; FFG, fusiform gyrus; HIPP, hippocampus; 
ITC, inferior temporal cortex; STC, superior temporal cortex; MTC, middle temporal cortex; 
CBL, cerebellum; SMG, supramarginal gyrus; B, bilateral; L, left; R, right.  
 
  
  129 
Table 3. Summarized correlations of changes of averaged power in activated areas with 
changes of subjective results. The changes of neural activation during resting state was 
correlated with changes of SF36, and the changes of the neural activation during 
Cyberball game was correlated with changes of the NTS, respectively for each of the 
two conditions of exclusion and inclusion.  
Groups Subjective 
item 
Resting state MEG  Functional MEG during 
Cyberball 
Theta band 
power change 
Beta-3 band 
power change  
Theta band 
power change   
Alpha band 
power change   
Both 
groups  
SF36-
Energy/ 
Vitality  
r = 0.33 
p = 0.04 
-  -  -  
 
B.longum 
group  
SF36-
Energy/ 
Vitality 
r = 0.61 
p = 0.007 
r = -0.50 
p = 0.04 
-  -  
NTS   r = 0.62 
p = 0.008 
r = 0.54 
p = 0.03 
Abbreviations: SF36, 36-item short-form health survey; NTS, Need Threat Scale; MEG, 
magnetoencephalography. 
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Figure legend 
Figure 1. The CONSORT flow diagram of the clinical trial 
Figure 2. Schematic outline of a trial in the Cyberball game. 
Figure 3. Main effects of condition on NTS and SEP. Participants in all groups reported 
increased scores of NTS and SEP in the exclusion condition compared to inclusion condition, 
after 4 weeks’intervention. 
Figure 4. Difference of neural activity change during resting-state comparing B.longum 
1714 vs. placebo. A. After the intervention, an increased theta band (6Hz) power was 
obtained in a cluster including regions of bilateral IFC, MFC, and the bilateral ACC and 
MCC, comparing B.longum 1714 with the placebo group (p < 0.05). B. After the intervention, 
reduced beta-2 band (26Hz) power was obtained in a cluster, consisting of the bilateral FFG 
and HIPP, left ITC and STC, bilateral MTC and left CBL, comparing B.longum 1714 with 
the placebo group (p < 0.05). 
Figure 5. Correlation between neural activity change and SF36 change. A. In all group, a 
positive correlation was obtained between changes of SF36 item “Energy/Vitality” with 
changes of theta band power in the cluster (r = 0.33, p = 0.04). B. In only B.longum 1714 
group, changes of SF36 item ‘Energy/Vitality’ positively correlated with change of averaged 
theta band power (r = 0.61, p = 0.007), and negatively correlated with change of beta-3 band 
power in the activated clusters during the resting state, respectively (r = -0.50, p = 0.04). 
Figure 6. Difference of neural activity change during the CBG comparing B.longum 
1714 vs. placebo. A. Theta band showed an increased power in a cluster, consisting of the 
right IFC and the bilateral MFC and SFC, the left ACC the bilateral MCC, and the right 
supramarginal gyrus (SMG), comparing B.longum 1714 group and the placebo group in both 
conditions (p = 0.03). B. Alpha band power also showed an increased power in cluster, 
including regions of the right IFC the bilateral MFC and SFC, the bilateral ACC and MCC, 
and the right SMG, comparing B.longum 1714 group and the placebo group  in both 
conditions (p = 0.04). No main effect of condition or interaction of intervention and 
condition were observed.  
Figure 7. Correlation between neural activity change during the CBG and 
subjective score changes. Only in B.longum 1714 group and only during the exclusion 
condition, NTS changes positively correlated with changes of the theta band power (r = 0.62, 
p = 0.008) and alpha band power (r = 0.54, p = 0.03). 
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Appendix 1. Probiotic/prebiotic containing food not to eat during intervention (same as Page 95)  
Appendix 2. Assessment of Need Threat Scale, Mood Questionnaire and Exclusion Perception 
(same as Page 96) 
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10. Conclusion and indication  
According to the results in study I, II, III and IV, we conclude: 1) probiotics, also 
considered psychobiotics, play a role in gut-brain axis and have effects on central nervous 
system functions. Bifidobacterium and Lactobacillus are most effective in improving 
psychiatric disease associated functions (anxiety, depression, mood and stress response). 2) 
While the animal models are mostly standardized, developing experiment models in clinical 
trials to study effects of probiotics on CNS functions are applicable and in need. 3) Stress 
response is a crucial element influencing other CNS functions, and also mediates gut-brain 
interaction. There are paradigms to study stress response in humans, but feasibility of 
adapting these paradigms to neuroimaging experiments need to be verified. 4) The Cyberball 
game is a widely used social psychological paradigm that can induce stress. It involves 
different stages of neural processes in certain brain regions, which are influenced by many 
factors such as psychological health conditions and early life experience. 5) The neural 
signature of social stress by the CBG can be identified by MEG, showing oscillatory 
neuromagnetic activities in different frequency bands ranging from theta to beta oscillations. 
6) Rifaximin as an antibiotic, can modulate brain activity associated with improved the 
relaxation status during a resting state and during the social stress. 7) Probiotic B.longum 
1714 can alter resting neural activity associated with mental vitality and neural response 
during social stress by enhancing emotion regulation. 
Indicated by the results of our studies, future studies could be carried out in the 
following aspects: 1) specification of the effects of a single probiotic strain, 2) development 
of human models in GM-gut-brain axis, 3) correlation of microbiome composition and 
physiological parameters with cortical activities, 4) clinical studies in patients with mental 
disorders and GI disorders, e.g. IBS. 
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According to the systematic review in study I, different types of probiotics treatments 
in either single strain or multiple strains, were applied in the previous studies. Although some 
of the treatments showed influences on more or less common CNS functions, they appeared 
to go through diverse pathways – either by altering immunomodulating cytokine levels, or 
neurotransmitter metabolisms, or via the vagus nerve (110). Also, it happened that the same 
strain showed effects in different situations, e.g. L. plantarum PS128 had general anxiety 
reducing effects in mice under different experiment set ups while antidepressant effect only 
in mice that experienced early stress but not in GF mice (35, 36). Therefore, more studies 
need to be conducted to explore the specific effects of single probiotics on changes of 
biochemical substances and behavior. In addition, combinations of multi-strains of probiotics 
have been reported to have larger/greater health benefits (111). Although the relevant 
evidences are yet limited, it would be interesting to test interaction effects of multiple 
probiotic strains and also their efficacy on CNS functions.  
Human studies in this field are less abundant compared to animal studies, and most of 
them utilized only psychological questionnaires or scales, rather than measuring behavioral 
or neural changes by probiotics during an experimental task. Possible experimental setups 
have been described in study I, and thus will not be expanded here again. Worthy to note that, 
multimodel neuroimaging technique such as EEG-fMRI may allow an ongoing investigations 
of neural effects of probiotics/antibiotics in both, high temporal and spatial resolutions (112). 
Nevertheless, studies are needed to bridge the gap between preclinical and clinical studies.  
As considered as “eubiotics”, rifaximin and probiotics B.longum 1714 may promote 
the growth of certain bacteria and produce a favorable gut microbiota environment so as to 
foster the their beneficial effects on the brain (1).  A further comprehensive analysis of the 
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correlation of GM composition, physiological changes, cortical activities and behavioral 
output would be helpful to understand the effects of these eubiotics in the gut-brain axis. 
Effects of probiotics and rifaximin have both been tested for their effects on relieving 
IBS symptoms (113, 114). However, although probiotics have also been investigated for 
effects on psychiatric comorbidities of IBS, no convincing evidence has been demonstrrated 
(115-117). Only a recent fMRI study has reported an alleviated depression symptom and 
reduced limbic brain activations to emotional stimuli in IBS patients (67). More similar 
studies using neuroimaging methods in patients with psychiatric and GI disorders are 
required. Also, antibiotic rifaximin may be a promising candidate as well to study its neural 
functions in clinics.  
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